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 IV  
Abstract 
Src is a 60 kDa tyrosine kinase that is expressed in most of animal tissues. Src has three 
splice variants, C-src, which is ubiquitously express d, and N1- and N2-src, which are 
neuronal specific splice variants. The srcs are diff rentially spliced at their SH3 domains, 
therefore the hypothesis is that this splicing allows them to have different binding 
partners and perform different roles in neurons. The aim of this project is to identify new 
interactions for the three src splice variants in neurons and their possible functional roles.  
The SH3 domains, kinase active truncated proteins (∆80) and kinase dead mutant full 
length versions of the three splice variants of src were cloned from a rat brain cDNA 
library into bacterial expression vectors. GST-pull downs from nerve terminal lysates 
showed that different src splice variants had different binding partners. These partners 
were identified by mass spectrometry and confirmed by western blotting. C-src binding 
partners included dynamin, synapsin, and synaptojanin, while N2-src binding partners 
included synaptophysin, Munc18-1, and NSF. The interaction between N2-src and Munc 
18-1 was characterized further; however a number of in vitro interaction assays and 
kinase assays showed that Munc 18-1 may not be a direct binding partner for N2-src or 
substrate.  
N1-src displayed a stimulation-dependent interaction with dynamin I. This was shown to 
be phosphorylation-dependent in contrast to C-src binding. The major phosphorylation 
sites on dynamin I, S774 and S778, were not involved in the regulation of N1-src 
binding. The binding site for N1-src on dynamin I was different to C-src, with extensive 
mutagenesis studies suggesting that the interaction site is at the tail of the dynamin I xa 
splice variant, which has an additional two phosphorylation sites. 
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Phosphorylation (adding a phosphate group to an amino acid of a protein) and 
dephosphorylation (taking away the phosphate group) are well known mechanisms in 
cell signalling and function. Enzymes that utilize high energy donor molecules such 
as ATP to phosphorylate other proteins are known as protein kinases, while proteins 
that dephosphorylate these proteins are known as protein phosphatases (Tatosyan and 
Mizenina, 2000). The amino acids that can be phosphrylated and dephosphorylated 
are serine, threonine, tyrosine, and histidine (Steeg et al., 2003; Roskoski, 2005).  
Tyrosine phosphorylation is an important mechanism that regulates many important 
processes in all cell types including, the central nervous system (Purcell and Carew, 
2003; Alonso et al., 2004). Protein tyrosine kinases are involved in many cell 
activities including, signalling, motility, proliferation and differentiation (Sandilands 
and Frame, 2008). There are approximately 90 protein tyrosine kinase in the human 
genome (Manning et al., 2002). There are two groups of protein tyrosine kinases that 
are classified: 1) receptor tyrosine kinases, which are trans-membrane proteins that 
contain an extra-cellular domain that interacts with ligands from outside the cell, and 
2) non-receptor tyrosine kinases, which are cytosolic proteins (Tatosyan and 
Mizenina, 2000; Bromann et al., 2004; Cohen, 2005; Roskoski, 2005; Sandilands and 
Frame, 2008).  
 
1.2 The src family of protein tyrosine kinases (SFKs)  
The src family kinases (SFKs) is an important group f non-receptor tyrosine kinases 
that contains 11 members: src, fyn, yes, yrk, lyn, hck, fgr, lck, blk, frk/rak and 
iyk/bsk (Engen et al., 2008). The members of the src family share amino acid 
 3 
homology and domain architecture (Superti-Furga, 1995; Thomas and Brugge, 1997; 
Summy et al., 2000). The src family is present in all metazoan cells, however they 
have different distribution patterns in different tissues, and some of them have splice 
variants that are found in specific tissues (Engen et al., 2008). Src, fyn and yes are 
expressed in all tissues, however src has two neuro-specific isoforms with fyn having 
one T cell specific isoform. Yrk is expressed in all tissues but only in chicken. Lyn, 
hck, fgr, blk, and lck are expressed mainly in blood related tissues, and frk and iyk 
are expressed only in epithelial cells (Bolen and Brugge, 1997; Thomas and Brugge, 
1997; Parsons and Parsons, 2004; Engen et al., 2008). The distribution of these 
kinases suggests the presence of several src family members in any cell type but at 
possibly different locations (e.g. while src is found at the cell membrane or 
endosomes, fgr is found at the nucleus) and also more than one isoform from some 
members in the same cell (Robinson et al 1995; Li et al 1996; Thomas and Brugge 
1997; Engen et al 2008).  
SFKs are now known to be widely expressed in the CNS of adult mammals and are 
involved in a range of neuronal functions (Kalia et al., 2004). The activity of these 
kinases is critical for normal cell function, abnormal conditions and appropriate cell 
responses to external stimuli and is regulated by several factors including growth 
factors, cytokines, adhesion, and antigen receptors (Zamoyska et al., 2003; Boggon 
and Eck, 2004; Lowell, 2004; Cohen, 2005; Okutani et al., 2006; Rivera and Olivera, 
2007; Abram and Lowell, 2008; Engen et al., 2008; Sandilands and Frame, 2008; 
Kim et al., 2009). The SFKs family members share similar multi-domain structure 




Src was first charactarized as a cellular protein similar to the Rous sarcoma virus 
gene product (Collett et al., 1978; Collett et al.,1979; Oppermann et al., 1979). Src 
has a molecular weight of about 60 kDa and was referred to as PP60c-src (PP = 
phosphoprotein) (Bunte and Moelling, 1983). There are some differences between v-
src and C-src in activity, substrates and in amino acid sequence (Vojtechova et al., 
2004). Src is expressed in most of vertebrate cells; however neurones, osteoclasts, 
and platelets express high levels of src that could be 5-200 times more than other cell 
types (Golden et al., 1986; Horne et al., 1992; Brown and Cooper, 1996). The 
location of src within the cell is not restricted to one area but it is usually found 
attached to membranes via myristoylation, using fibroblasts as an example; src can 
be found binding to endosomes, perinuclear membranes, secretory vesicles, and the 
cytoplasmic surface of the plasma membrane, where it can interact with growth 
factors and integrin receptors (Roskoski, 2004).  
The role of src is usually related to its kinase activity. Activated src can 
phosphorylate a variety of proteins associated with in racellular signalling and cell 
structure. This includes the non-receptor focal adhesion tyrosine kinase (FAK), and 
the cytoskeleton associated proteins vinculin, talin, tubulin, cortactin, and actin 
filament-associated protein-110 (Ito et al., 1983; Thomas and Brugge, 1997; Lodyga 
et al., 2002; Destaing et al., 2008). Even though src is expressed in most of cell 
types, it is expressed in high levels in cells thatare specialized for regulated secretion 
such as neurons and is concentrated at the site of exocytosis in nerve terminals 




  1.3.1 Structure of src 
The src family members share a common modular structure, and C-src is considered 
as the prototype of this family (Schwartzberg, 1998; Engen et al., 2008). C-src in all 
species has the same structure with some amino acid differences (Lowell, 2004). 
Since C-src was first discovered in chicken, the amino acid numbering of chicken C-
src is usually used by researchers. C-src contains an N-terminal 14 carbon myristoyl 
group (SH4), a unique segment, a src homology 3 (SH3) domain, a src homology 2 
(SH2) domain, a protein-tyrosine kinase domain or src homology 1 (SH1) domain, 
and a C-terminal regulatory tail (figure 1.1 A) (Superti-Furga, 1995; Tatosyan and 
Mizenina, 2000; Boggon and Eck, 2004; Lowell, 2004; Roskoski, 2005; Sandilands 
and Frame, 2008). The most obvious structural difference between C-src and the 
viral homologue v-src is that v-src lacks the final 7 C-terminal amino acids (Martin, 
2001). 
1.3.1.1 The src N-terminus 
The N-terminal region, which is also called the src homology 4 (SH4) domain is the 
myristoylation region, where a myristoyl group is added to src through an amide 
bond on a glycine residue (Boutin, 1997; Sicheri and Kuriyan, 1997; Roskoski, 2004; 
Engen et al., 2008). Myristoylation facilitates srcattachment to membranes, and it is 
also required for src function in the cell (Resh, 1994; McLaughlin and Aderem, 
1995; Song et al., 1997; Roskoski, 2004). The initial 7 amino acids of the N-terminal 
begin with glycine and these are essential for myristoylation. A relationship has been 




src to transform the cell into a neoblast, however my istoylation does not guarantee 
membrane association, suggesting there might also be specific binding proteins for 
the src N-terminal region that enhances its localisation (Brown and Cooper, 1996; 
Roskoski, 2004). The v-src interaction with calcium-bound calmodulin is regulated 
by myristoylation (Hayashi et al., 2004), which supports this assumption. 
1.3.1.2 Src SH3 domain 
The src homology 3 (SH3) domain is a common protein r cognition module that has 
60-80 amino acids and is seen widely in different types of proteins. Proteins that 
contain an SH3 domain are involved in many cellular activities including signal 
transduction, cytoskeleton organization, and membrane traffic (Koyama et al., 1993; 
Feller et al., 1994; Weng et al., 1995; Birge et al., 1996; Dalgarno et al., 1997; 
Camara-Artigas et al., 2009). The src SH3 domain binds to proline rich domains 
(PRD) with a left handed helical conformation. There are two types of PRDs that 
bind to src. The first (Class I src SH3 domain ligand) has the preferred structure of 
RPLPPLP, while the second (Class II src SH3 Domain ligand) has the preferred 
structure of ФPPLPXR (where Ф is a hydrophobic amino acid, L is leucine and X is 
any amino acid) (Feng et al., 1994; Tatosyan and Mizenina, 2000; Roskoski, 2004). 
The SH3 domain exhibits a number of possible regulatory roles in src interactions 
and function that can be summarized in four main points. First, it constrains the 
enzymatic activity of src by an intramolecular interaction with the linker between the 
SH1 small lobe and the SH2 domain (Gonfloni et al., 1997; Xu et al., 1997; Brabek 
et al., 2002; Boggon and Eck, 2004) . The linker does not have the structure of an 
SH3 binding motif; however it does have a left handed helical conformation allowing 
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the SH3 domain to bind (Xu et al., 1997; Brabek et al., 2002; Boggon and Eck, 
2004). The crystal structure of src in the closed conformation illustrates the binding 
between the SH3 domain and the linker (Figure 1.1 B). This negative regulation 
means that mutations in the SH3 domain would cause src activation, and v-src indeed 
has several point mutations within its SH3 domain (Parsons and Weber, 1989; 
Schwartzberg, 1998; Roskoski, 2004). Second, proteins that have SH3 binding 
motifs can bind to the SH3 domain of src, where they can be attracted to specific 
cellular locations. Third, by displacing the intramolecular SH3 domain-linker 
interaction, proteins can enhance src kinase activity (Brabek et al., 2002; Roskoski, 
2004; Onofri et al., 2007). Fourth, proteins that bind to the src SH3 domain may also 
be substrates for its tyrosine kinase activity (Onofri et al., 1997; Roskoski, 2004; 
Onofri et al., 2007). 
 
1.3.1.3 Src SH2 domain 
The src homology 2 (SH2) domain is a protein recognition module that recognises 
short phospho-tyrosine containing sequences (Schlessinger, 1994; Garcia-Echeverria, 
2001; Bradshaw and Waksman, 2002). SH2 domains are about 100 amino acids long, 
and share a common structure. They contain one β-sheet that is flanked from both 
sides with α helices. The pockets between these sheets are the binding site for the 
phospho-tyrosine containing sequence (Waksman et al., 2004; Machida and Mayer, 
2005). The amino acid sequence C-terminal to the phos o-tyrosine residue 
contributes to the binding specificity of the SH2 domain (Yaffe, 2002). These 
sequences vary from three to six amino acids in length (Songyang et al., 1993). The 
src SH2 domain binds with a preferred sequence of pYEEI (where pY is a 
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phosphorylated tyrosine). This is the same sequence that is preferred by some other 
members of src family such as Fgr, Fyn, and Lck (Songyang and Cantley, 1995; 
Waksman et al., 2004). The SH2 domain can bind other p ospho-tyrosine sequences, 
such as the C-terminus of the src protein (Tatosyan and Mizenina, 2000; Zheng et al., 
2000). More than 90% of src is phosphorylated at tyrosine residue 527 of the C-
terminus during basal conditions (Zheng et al., 2000). SH2 binding to this 
intramolecular site is not strong, because it is not its preferred ligand. Thus binding is 
strong enough to keep the protein in its inactive state, but weak enough to allow src 
activation by other proteins (Porter et al., 2000; Yaffe, 2002; Waksman et al., 2004). 
SH2 domain binding to phospho-tyrosine 527 has two possible roles; the first is to 
regulate kinase activity via intramolecular binding to the C-terminal region of the src 
molecule, and the second is to promote interactions with other components of the cell 
(Yaffe, 2002; Waksman et al., 2004; Machida and Mayer, 2005). In a study on one of 
the src family members (Hck) by Porter and co-workers (2000), the intramolecular 
binding site of SH2 was mutated to pYEEI, which resulted in a form of the protein 
that could not be activated by exogenous SH2 binding sequences (Porter et al., 
2000). Thus the SH2 domain shares a regulatory function with the SH3 domain in 
both kinase activity and protein-protein interactions (Schwartzberg, 1998; Boggon 
and Eck, 2004; Roskoski, 2004).  
 
1.3.1.4 Src SH1 domain 
The tyrosine kinase domain, src homology 1 (SH1) domain is highly conserved in 
the src family (Brown and Cooper, 1996; Tatosyan and Mizenina, 2000). It consists 
of a bi-lobal architecture, where the first lobe (the N-lobe) is smaller (about 71 amino 
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acids from 267 to 337). The second lobe (the C-lobe) is approximately 180 amino 
acids (from 341 to 520) with the catalytic site betw en these two lobes (Hubbard, 
2002; Boggon and Eck, 2004; Roskoski, 2004). The kinase domain plays a role in 
substrate specificity (Brown and Cooper, 1996). The sit  for ATP binding and the 
phosphotransferase reaction is very similar in all tyrosine kinases (Tatosyan and 
Mizenina, 2000). The two lobes can close the cleft containing the catalytic site, by 
moving toward each other. While opening the cleft is necessary to allow ATP to 
access the catalytic site and also to release ADP, closing brings the substrates to the 
catalytic site. Preventing opening or closing of the cleft is inhibitory for kinase 
activity. Each lobe has a polypeptide segment that has active and restrained positions 
(Kefalas et al., 1995). The amino acid sequence that is preferably phosphorylated by 
src is EEEIYG/EEFD (Tatosyan and Mizenina, 2000). There is a tyrosine residue 
(Y416) in the kinase domain that can be phosphorylated; phosphorylation of Y416 
stimulates kinase activation and provides a binding s te for other proteins such as the 
phosphotyrosine binding domain (PTB) of Cb1 (Sanjay et al., 2001). 
 
1.3.2 Activity and regulation 
Src has two important phosphorylation sites that regulate its tyrosine kinase activity. 
Auto-phosphorylation of Y416 stimulates kinase activity, while phosphorylation of 
Y527 inhibits kinase activity (Yaciuk and Shalloway, 1986; Gould and Hunter, 1988; 
Okada and Nakagawa, 1989; Cary et al., 2002; Sun et al., 2002). The result is a 
restrained form of the enzyme (closed conformation) (Figure 1.1 C) (Kefalas et al., 
1995). In the restrained form, neither the SH3 nor the SH2 are accessible to their 
ligands, and thus not only the kinase activity is affected but also protein-protein 
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interactions via SH3 and SH2 domains (Schwartzberg, 1998; Roskoski, 2004). 
Binding to phosphorylated Y527 by the SH2 domain forms a latch, which stabilizes 
the attachment of SH2 with the large lobe (Tatosyan and Mizenina, 2000; Brabek et 
al., 2002; Yeatman, 2004). Mutation of Y527 to phenylalanine produced an active 
oncogenic protein, highlighting the importance of this residue in src function 
regulation (Hunter, 1987). 
 
1.3.2.1 Src inhibition   
The kinase that phosphorylates Y527 is called C-terminus src kinase (Csk), which is 
a cytoplasmic kinase that is expressed in most of cell types. Y527 is also 
phosphorylated by Csk homologus kinase (Chk) which has limited expression to 
some tissue types including neurons and breast cells (Okada and Nakagawa, 1989; 
Zrihan-Licht et al., 1997; Bjorge et al., 2000; Kawabuchi et al., 2000; Takeuchi et al., 
2000; Dey et al., 2005; Roskoski, 2005). The phosphrylation at Y527 resulted in 
decreasing src activity by at least 80 %. Furthermore, Csk is very specific in its 
phosphorylation of src where mutation of Y527 to phenylalanine resulted in a 500 
fold decrease in src phosphorylation by Csk (Cole et al., 2003; Roskoski, 2005). Chk 
can also inhibit src activity via direct binding to the src SH1 domain inhibiting src 
auto-phosphorylation at Y416 (Chong et al., 2004). Src can also be phosphorylated at 
Y213 in the SH2 domain and at Y138 in the SH3 domain by the PDGF receptor. This 
results in reducing SH2 domain binding to phospho-Y527 and SH3 domain binding 
to the linker between the SH2 domain and the SH1 domain, resulting in unclamping 
src and overriding the inhibitory effect of Csk phosphorylation (Stover et al., 1996; 
Broome and Hunter, 1997).   
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1.3.2.2 Src activation   
Dephosphorylation of phospho-Y527 is the major activ tor of src kinase activity by 
shifting the clamp conformation of src to open and thus activating src. There are 
several phosphatases that can dephosphorylate P-Y527 including protein tyrosine 
phosphatase-1B (PTP1B), SH2 domain-containing tyrosine phosphatases 1 and 2 
(Shp1 and Shp2), CD45 (cluster of differentiation) a d protein tyrosine phosphatase-
α (PTPα) (Roskoski, 2005). PTP1B is the main tyrosine phosatase for phospho-
Y527, in fact more than 50% of src Y527 dephosphorylation is catalysed by PTP1B 
activity (Roskoski, 2005). PTPα, a transmembrane protein that is abundant in brain, 
is known to dephosphorylate src Y527 and regulate src kinase activity (Su et al., 
1999; Zheng et al., 2000; Brandt et al., 2003). 
Dephosphorylation of phospho-Y416 results in decreasing src activity. PTP-BL, a 
cytosolic tyrosine phosphatase, dephosphorylates Y416 (Palmer et al., 2002). The 
phosphatases that catalyse the dephosphorylation of Y138 in the SH3 domain and 
Y213 in the SH2 domain have not yet been identified (Roskoski, 2005). Src might 
also be activated by displacing the SH3 domain or the SH2 domain or both from their 
intramolecular binding sites via binding to their ligands in other proteins (Brabek et 
al., 2002; Onofri et al., 2007). 
   
1.4 Src function in non-neuronal cells 
Src can be found in two distinct locations in the cell. The first is non-raft regions on 
the plasma membrane and this population can be rapidly activated upon receptor 
stimulation. The second population is found in perinuclear endosomes and can be 
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translocated to lipid rafts after receptor stimulation (Cary et al., 2002; Yeatman, 
2004; Seong et al., 2009). Many signal transduction cascades are mediated by 
tyrosine phosphorylation of intracellular proteins; for example src activation by 
receptor tyrosine kinases such as the platelet derived growth factor (PDGF) receptor 
and epidermal growth factor (EGF) receptor. PDGF binding to its β-receptor results 
in auto-phosphorylation of its cytoplasmic region at several tyrosine residues. The 
SH2 domain of src then binds to these phosphotyrosine residues causing src 
activation and subsequent src tyrosine phosphorylation of many proteins in the cell 
such as Shc ((Src homology 2 domain containing) transforming protein) which will 
result in stimulation of DNA synthesis and cell growth (Kefalas et al., 1995; 
Courtneidge, 2002; Waters et al., 2005). Src activation by PDGF is required for 
endothelial cell proliferation and migration, and src kinase activity is necessary for 
cells during mitosis (Mureebe et al., 1997). The rol  of src in mitosis and cell cycle 
and its involvement in gene expression is most likely mediated by phosphorylation of 
Sam 68 (Taylor et al., 1995; Bjorge et al., 2000). Furthermore src plays an important 
role in PDGF β-receptor endocytosis (Ahn et al., 2002; Waters et al., 2005). 
Internalization of the PDGF receptor leads to associati n of mitogen-activated 
protein kinase (MAPK) with the complex on the endocyt sed vesicle and results in 
activation of MAPK (Waters et al., 2005). 
Activation of src by different signalling results in activation of different downstream 
proteins. Src activation by EGF receptor led to phos rylation of Stat3 (Signal 
transducer and activator of transcription 3) and cortactin, whereas src activation by β-
adrenergic receptor caused phosphorylation of Shc and subsequent ERK 
(extracellular signal-regulated kinase) activation (Goi et al., 2000).  
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1.4.1 Src function in vesicle trafficking 
Activated src is internalized from the plasma membrane either constitutively or in 
association with growth factor receptors such as the EGF receptor. EGF receptor 
internalization regulates the duration and location of signal transduction and it is co-
internalized with src (Donepudi and Resh, 2008). Overexpression of active src 
prolongs the activity of EGF receptor inside the cell, which might explain the role of 
src activity in cancer (Donepudi and Resh, 2008).  
Src also plays an important role in agonist mediate angiotensin II receptor 
internalization. Src binding to β-arrestin and angiotensin II receptor complex results 
in the binding of the clathrin adaptor protein AP2 to β-arrestin. This recruits clathrin 
and results in internalization of the angiotensin II receptor (Fessart et al., 2005). Src 
binding to the AP2 and β-arrestin complex induces phosphorylation of the β2-adaptin 
subunit of AP2 by src and results in dissociation of the AP2 - β-arrestin complex 
(Fessart et al., 2007; Zimmerman et al., 2009). Src mediated phosphorylation of AP2 
is a common mechanism for ligand-induced receptor internalization for many 
receptors such as EGF receptor and angiotensin II receptor (Zimmerman et al., 
2009).   
Src is also involved in endosomal trafficking in many cell types, an important 
process for internalizing and recycling membrane proteins and many receptor types, 
including hormone receptors as well as membrane lipids (Sandilands and Frame, 
2008). Src also plays a role in caveolae mediated en ocytosis in internalizing 
substances such as albumin. Albumin receptors, for example, will cluster upon 
binding to its ligand and then move to caveolae to activate their endocytosis 
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(Sverdlov et al., 2007). Addition of cargo results in activation of src and caveolae 
mediated endocytosis, which is dependent on tyrosine phosphorylation by src, since a 
dominant negative src or  kinase inhibitors such as PP2 blocked caveolae endocytosis 
(Sverdlov et al., 2007). This role is mediated by src phosphorylation of several 
proteins including caveolin 1 and 2 and dynamin II (Sverdlov et al., 2007). Caveolin 
1 (which is probably the primary src substrate in caveolae) is phosphorylated at Y14 
(Orlichenko et al., 2006). Mutations in this site rsulted in decreased caveolae 
endocytosis (Li et al., 1996), whereas src overexprssion or application of vanadate, 
a phosphatase inhibitor, resulted in increased endocytosis, suggesting that caveolin 1 
tyrosine phosphorylation by src is essential for caveolae endocytosis (Botos et al., 
2007). There have been several proposed functions fr caveolin-1 phosphorylation 
(including regulation of its oligomerization) but there are only two proteins that bind 
to caveolin 1 in a phosphorylation dependent manner Csk and Grb7 (Lee et al., 2000; 
Cao et al., 2002).  Caveolin 2 is not essential for caveolae formation, but it influences 
caveolae size by forming heteromers with caveolin 1. It is also phosphorylated by src 
at Y19 and Y27 and this phosphorylation affects its oligomerization with caveolin 1 
(Lee et al., 2002a; Wang et al., 2004). Dynamin 2 phos horylation by src at Y231 
and Y579 results in increased GTPase activity (Ahn et al., 1999; Ahn et al., 2002), 
and binding to caveolin 1, resulting in directing dynamin 2 to the caveolae neck and 
consequently caveolae endocytosis (Oh et al., 1998; Kim and Bertics, 2002; Yao et 
al., 2005).  
Src is also involved in Golgi apparatus structure and regulation and KDEL receptor 
transport to endoplasmic reticulum. Src KO cells have  compact Golgi apparatus 
with bloated cisternae that can be restored to normal structure by expressing active 
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src (Bard et al., 2003). When trafficking from the endoplasmic reticulum to cis-Golgi 
increases, src is activated and binds to the cytoplasmic region of the KDEL receptor. 
This binding results in src activation and subsequent phosphorylation of several 
proteins including the KDEL receptor, atypical protein kinase C ι/λ and 
glycerylaldehyde-3-phosphate dehydrogenase (GAPDH) which will interact with rab 
2 and stimulate COPI-vesicle formation (Tisdale and Artalejo, 2007; Asp and 
Nilsson, 2008).  
 
1.4.2 Src function in permeability 
In addition to its role in vesicle trafficking, src regulates the permeability of 
endothelial cells in response to inflammatory signals via phosphorylation of myosin 
light chain kinase (MLCK). The phosphorylated myosin light chain then initiates 
cross bridge formation between myosin and actin which results in cell contraction, 
cytoskeleton rearrangement and shape changes that will lead to increased endothelial 
(Birukov et al., 2001; Hu et al., 2008; Kim et al., 2009). Src also phosphorylates 
junctional proteins such as β-catenin which alters the interaction between these 
junctional proteins and the cytoskeleton again increasing endothelial permeability 
(Hu et al., 2008).  
Focal adhesion kinase (FAK), located in the focal adhesion complex, is also a src 
substrate; FAK phosphorylation by src is essential for integrin-dependent FAK 
attachment to actin stress fibers, which increases va cular endothelial cell 
permeability (Mitra and Schlaepfer, 2006; Hu et al., 2008). Src phosphorylation of 
integrin also promotes cell migration (Cary et al.,2002). Sex-steroid hormones such 
as estradiol and progesterone stimulate src activity through their receptors in many 
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cell types including prostate cells, vascular endothelial cells, fibroblasts and platelets 
(Migliaccio et al., 2007).  
 
1.4.3 Src function in migration and proliferation 
 Src plays a major role in cell migration and proliferation. Smooth muscle cell 
migration is one of the cell activities that require activation of src. Src mediates its 
effect by causing focal adhesion complex dissociation and reformation and its 
interaction with cytoskeleton (Mureebe et al., 1997). Osteoclast cells express high 
levels of src, with most associated with intracellular organelle membranes (Horne et 
al., 1992). Osteoclast migration and normal bone resorption require both src presence 
and activity; Cb1 phosphorylation by src and the subsequent activation of 
phosphatidylinositol 3 kinase (PI3K) causes cytoskeleton reorganization and results 
in osteoclast cell migration (Miyazaki et al., 2006).  Even kinase dead src could still 
restore some osteoclast functions in src KO cells, suggesting that src might be acting 
as a scaffolding molecule as well as its function as a tyrosine kinase (Miyazaki et al., 
2006).  Src also plays a role in shape changing and cell migration mediated by 
fibroblast growth factor 1 (FGF1). This role involves cortactin phosphorylation by 
src that increases its association with cytoskeleton and actin filaments (Liu et al., 
1999).  
 
1.5 Src splice variants  
As described above C-src has numerous essential roles in non-neuronal cells. In 
neurons there are two neuronal specific splice variants of src; N1-src which has 6 
extra amino acids, and N2-src which has 17 extra amino acids (Levy et al., 1987; 
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Pyper and Bolen, 1990; Matsunaga et al., 1993; Chan and Black, 1995). These extra 
amino acids are inserted in the SH3 domain between exo 3 and exon 4 (Figure 1.2) 
(Pyper and Bolen, 1990; Wagner and Garcia-Blanco, 2001).  The N1-src splice 
variant has higher expression in the CNS compared to the PNS. On the other hand 
cancer cells such as neuroblastoma cells express all rc splice variants (Bjelfman et 
al., 1990; Matsunaga et al., 1993). The majority of N1-src mRNA is found in the 
mesencephalon, cerebellum, pons, medulla and telecephalon, while C-src has a 
different distribution pattern with its mRNA levels highest in hippocampus, thalamus 
and cerebellum (Sugrue et al., 1990; Yagi, 1994). Immunohistochemical analysis 
also showed that N1-src and C-src proteins have diff rent patterns of distribution 
within neurones (Sugrue et al., 1990; Yagi, 1994; Mukherjee et al., 2003). N1-src is 
localized in the cell soma, dentritic processes, and synaptosomal membrane; however 
C-src and N1-src are both expressed in the synaptic reg on. This suggests that if N1-
src has a role in synaptic transmission, it is most likely to be different from C-src 
(Sugrue et al., 1990; Yagi, 1994; Onofri et al., 2007), Even though both isoforms are 
found in growing tips and growth cones of neurons (Worley et al., 1997), C-Src and 
N1-Src differentially modify axonogenesis and intracellular phosphotyrosine levels, 
providing evidence that the activities of C-Src and N1-Src perform non-equivalent 
roles (Worley et al., 1997). In contrast, there is very little information about N2-src 
expression or distribution. 
Splicing of src is controlled by a sequence that flnks the N1-src intron called 
downstream control sequence (DCS). This sequence is CUCUCU and it binds to 
splicing repressor proteins (Chan and Black, 1995; Chou et al., 2000). The protein 
that represses N1-src splicing is polypyrimidine trac  binding protein (PTB), also 
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Figure 1.2- The Differences between various src splices.
C-src amino acids in the bottom, N1-src extra six amino acids and N2-src extra  
seventeen amino acids are shown above. Extra amino acids that are inserted in SH3 
domains of N1-src and N2-src share 5 amino acids and the sixth one was changed from 
arginine in N1-src to serine in N2-src. Arrows on top of N2- src show the possible 
phosphorylation sites that are inserted.
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called heterogeneous nuclear ribonucleoprotein 1 (hnRNP 1) (Chan and Black, 1997; 
Chou et al., 2000; Grabowski and Black, 2001). In neuronal cells, a neuron specific 
form of PTB dissociates from the binding site in the presence of ATP and allows N1-
src splicing (Chou et al., 2000; Grabowski and Black, 2001). There is a complex of 
proteins that binds to the DCS to allow splicing; this complex includes KH-type 
splicing regulator protein (KSRP), nPTB, (hnRNP F) and hnRNP H (Chou et al., 
1999; Grabowski and Black, 2001). Although these proteins are expressed in many 
cell types they act as splicing regulators only in neuronal cells, which might be 
related to a neuronal specific splice variant of PTB that enhances complex formation 
(Grabowski and Black, 2001). It seems to be essential to have the N1-src insertion 
when expressing the N2-src splice variant. It is not clear why there is no splice 
variant of src that has the N2-src insert of 11 amino acids while skipping only the 
N1-src intron but not N2-src intron (Pyper and Bolen, 1990). 
 
1.6 Src function in the nervous system 
Since src has two neuronal-specific splice variants, it uggests src has additional 
neuronal functions. C-src is expressed in high amounts in neurons (Cotton and 
Brugge, 1983). Embryonic brain expresses higher amounts of C-src as well as higher 
kinase activity than the adult brain, suggesting a role of src in brain development, 
proliferation and differentiation (Cartwright et al., 1988; Grandori and Hanafusa, 
1988; Kalia et al., 2004). Neuronal differentiation was accompanied by an increase in 
src activity that is mediated by C-src activation by RPTPα (Receptor Protein 
Tyrosine Phosphatase α) (den Hertog et al., 1993). Growth cone membranes contain 
nine fold more C-src than the subcellular fractions accompanied with an elevated 
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kinase activity, which suggests an important role in growth cone mediated neurite 
extention (Maness et al., 1988; Bixby and Jhabvala, 1993). C-src involvement in 
lipid rafts at the growth cones is necessary for its activation and function in 
triggering neurite outgrowth (Zhao et al., 2009). Furthermore, induction of 
neurobastoma cells to neuronal differentiation result d in elevated expression levels 
and activity of both C-src and N-src, suggesting that neuronal differentiation is 
accompanied by elevated expression and activity of src splice variants (Bjelfman et 
al., 1990). The same elevation for both C-src and N1-src expression levels and 
activity was observed in embryonic neuronal cell differentiation (Cartwright et al., 
1987). In some areas of the brain such as the hippocampus, src expression increases 
after birth and remains high even in adult (Cartwright et al., 1988). In fact, in the 
hippocampus region of rat brain, src expression at day two after birth is twice as high 
as its expression at embryonic day 18 (Cartwright et al., 1987). The high expression 
of src in hippocampus after birth and through the life of the animal might reflect its 
importance in this region which is involved in learning and memory 
 
1.6.1 Src function in learning and memory 
Src kinase activity is essential for normal brain development and function. One of 
these functions is in learning and memory formation. Src is required for both short 
term and long term memory, since src inhibitors blocked both (Bevilaqua et al., 
2003).  C-src activation is essential and sufficient for long term memory formation 
since blocking src by using an anti-src1 antibody prevented LTP in CA1 pyramidal 
cells (Lu et al., 1998). Src activation also enhanced AMPA (α-amino-3-hydroxyl-5-
methyl-4-isoxazole-propionate) receptor and NMDA (N-methyl-D-aspartic acid) 
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receptor response (Lu et al., 1998). In agreement with a role for C-src, its expression 
increases during memory formation. For example, C-src mRNA levels in the CA3 
region of rat hippocampus were increased after maze learning (Zhao et al., 2000). 
Furthermore, C-src protein levels in hippocampal synaptosomes were increased in 
parallel to an increase in its kinase activity (Zhao et al., 2000). In addition C-src 
association with and phosphorylation of the presynaptic nerve terminal proteins 
synapsin 1 and synaptophysin and also the postsynaptic NR2 subunits of the NMDA 
receptor increased after maze learning, suggesting that C-src is involved in the 
learning process and is activated as a tyrosine kinase both presynaptically and 
postsynaptically (Zhao et al., 2000).  
 
1.6.2 Src function in nerve regeneration 
C-src and N1-src are also involved in nerve regeneration and myelination. Both C-src 
and N1-src levels and activity were increased during peripheral axonal regeneration 
(Le Beau et al., 1991). Furthermore, Schwann cells also expressed high amounts of 
C-src at the same time of myelination in the regenerated nerve; Schwann cells 
usually express only low levels of C-src, suggesting that C-src is important in 
differentiation during regeneration (Le Beau et al., 1991). However, when C-src and 
N1-src were overexpressed in retinal cells, both impaired axonogenesis. This may 
has been due to uncontrolled activity of the kinase which resulted in untargeted 
activity, or an excess of phosphorylation with respect to axonogenesis (Worley et al., 
1997). Similar results with abnormal dendritic and growth cone formation were 
observed in cerebral Purkinje cells overexpressing wild-type N1-src but the effect 
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was more severe with constitutively active N1-src. These abnormal features were 
rescued using the selective src inhibitor PP2 (Worley et al., 1997).  
C-src is also important in maintaining the neuromuscular junction by 
phosphorylating the acetylcholine (ACh) receptor and maintaining receptor clusters 
and interaction with the cytoskeleton (Sadasivam et al., 2005). The presence of C-src 
is able to stabilize ACh receptor clusters in postsynaptic neuromuscular junctions 
even during PP2 treatment (Smith et al., 2001). C-src also phosphorylates the C-
terminal region of QKI (quaking homolog KH domain RNA binding) a signal 
transduction activator of RNA, to regulate its binding to mRNA; QKI is an mRNA 
binding protein that regulates myelin production during brain development by 
enhancing myelin basic protein production through its b nding to mRNA to protect it 
from degradation (Zhang et al., 2003). 
 
1.6.3 Src function in neuro-inflammation 
Src is also involved in inflammation, infection and injury healing in the brain. For 
example, the amount of C-src and its activity were both increased up to three fold 
after sciatic nerve injury (Zhao et al., 2003). Schwann cells, which play a scaffolding 
role for the injured nerve regeneration, also showed high expression levels and 
activity of src distal to the site of injury. This resulted in the activation of adhesion 
sites and cytoskeleton assembly to generate a pulling force for the newly formed 
growth cone (Zhao et al., 2003). Furthermore, active C-src was located at the sites of 
injured axons and after the injured nerve was healed, src levels returned to normal. 
PDGFβ receptors might have an essential role for C-src activation in injured 
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neurones. The receptor may direct C-src to the plasma membrane of the injured 
neurones and activate the pathway for nerve regeneration (Isozumi et al., 1997).  
C-src is also involved in interleukin I (IL-1) signalling of inflammation. C-src is 
activated in hypothalamic neurones by IL-1 receptor activation. This activation of C-
src results in hyperpolarization and decreased firing ates of these neurones, which is 
most likely related to ion channel regulation. Furthe more, this inhibition can be 
blocked by using the src inhibitor PP2 (Davis et al., 2006). On the other hand, 
activation of the IL-1 receptor and subsequent activ tion of C-src in hippocampal 
neurons resulted in phosphorylation of NMDA receptors and potentiation of neuronal 
damage, which was blocked by the src inhibitor PP2 (Viviani et al., 2003). NMDA 
phosphorylation by C-src in interleukin I receptor activation resulted in increasing 
Ca2+ influx and subsequent hyperexitability, seizures and a proconvulsive effect 
(Balosso et al., 2008). Furthermore, C-src is activted in NMDA receptor induced 
hyperalgesia in the spinal area, and this effect can be overcome by using the src 
inhibitor PP2 (Sato et al., 2003).  
 
1.6.4 Src function in the synapse 
1.6.4.1 Post-synaptic function of src  
One well established function of C-src in neuronal cel s is its role in upregulating 
post synaptic NMDA glutamate receptor function (Yu and Salter, 1999; Kalia et al., 
2004). The NMDA receptor consists of four subunits. Two subunits are represented 
by the NR2 subunit, which has four splice variants (A-D), and is the binding site for 
glutamate, and the other two are NR1 subunits which are the binding site for the co-
agonist glycine (Furukawa et al., 2005). Immunopreci itation of either NR1 or C-src 
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resulted in coprecipitation of the other protein, suggesting that src is associated 
physically with the NR1 subunit of the NMDA receptor (Yu et al., 1997).  However 
the NR1 subunit has only one tyrosine residue in its cy osolic C-terminal region, with 
no evidence of tyrosine phosphorylation (Salter, 1998). The NR2A, NR2B and 
NR2D subunits of the NMDA receptor have a very long i tracellular C-terminal tail 
of more than 600 amino acids (Salter, 1998; Salter nd Kalia, 2004). NR2B is mainly 
phosphorylated by Fyn, whereas NR2A is phosphorylated by C-src at multiple sites 
(Y1292, Y1325 and Y1387) (Salter and Kalia, 2004).  
C-src is implicated in the enhancement of NMDA receptor function during LTP (Lu 
et al., 1998). There are several ways that C-src is proposed to upregulate NMDA 
receptor function. For example, NMDA receptor phosphorylation by src increases its 
signal transduction and permeability (Kohr and Seeburg, 1996; Salter, 1998; Lu et 
al., 2000).  Another possible mechanism involves the phosphorylation of other 
proteins in the NMDA receptor complex; one of which is the scaffolding protein 
PSD93, which might alter NMDA receptor channel gating (Salter and Kalia, 2004). 
Alternatively, phosphorylation of NR2A and NR2B subunits of the NMDA receptor 
could recruit signalling proteins that contain SH2 domains, such as PLCγ and PI3 
kinase, to the plasma membrane (Salter and Kalia, 2004). Tyrosine phosphorylation 
of these subunits protects NMDA receptors from degradation by Ca2+-activated 
proteases (Salter and Kalia, 2004).  
A consequence of C-src phosphorylation of the NMDA receptor is induction of LTP 
(Salter and Kalia, 2004). This is mediated by increasing the number of NMDA 
receptors at the plasma membrane (Grosshans et al., 2002), since C-src mediated 
tyrosine phosphorylation of NMDA receptor subunits s abilize the receptor at the 
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plasma membrane via decreasing its association with the clathrin-mediated 
endocytosis machinery (Grosshans et al., 2002; Salter nd Kalia, 2004).  
What are the mechanisms via which C-src is activated to phosphorylate the NMDA 
receptor? Activation of G-protein coupled receptors such as the acetylcholine M1 
muscarinic receptor potentiates NMDA receptor respon es in hippocampal neurons 
(Salter and Kalia, 2004). This potentiation can be blocked by src inhibitors, 
suggesting that M1 muscarinic receptor potentiation of NMDA receptor function is 
mediated by C-src (Salter and Kalia, 2004). C-src activ tion can also be induced by 
brain ischemia (Liu et al., 2001). Activation of C-src via both routes involves both 
PKC and the FAK (focal adhesion kinase) CAKβ (also known as Pyk2). CAKβ auto-
phosphorylation at Y402 creates a binding site for the C-src SH2 domain, which 
results in src activation and subsequent NMDA receptor otentiation (Henley and 
Nishimune, 2001; Liu et al., 2001; Salter and Kalia, 2004). In support of this, NMDA 
receptor NR2B subunit phosphorylation at Y1472 after tetanic stimulation occured 
concurrently with CAKβ and C-src activation in the CA1 region of the hippocampus 
(Ali and Salter, 2001). 
Src activation also leads to enhanced AMPA receptor function (Grosshans et al., 
2002). AMPA is a glutamate receptor ion channel that consists of four subunits in a 
heterodimer structure of GluR1-GluR4 (Song and Huganir, 2002). Most AMPA 
receptors contain GluR2 which gives them Ca2+ impermeability (Song and Huganir, 
2002). The AMPA receptor GluR2 subunit is phosphorylated by C-src at Y876 and 
this phosphorylation is essential for regulating AMPA receptor internalization and 
also may contribute to stimulation dependent long term plasticity (Hayashi and 
Huganir, 2004). GluR2 subunit tyrosine phosphorylation is required for either insulin 
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or low frequency stimulation-dependent AMPA receptor endocytosis and long term 
depression an effect blocked by the src inhibitor PP2 (Ahmadian et al., 2004). 
 
1.6.4.2 Pre-synaptic functions of src  
C-src is also found in the pre-synaptic region and there are many proteins that both 
interact with src and are phosphorylated by src. In fact both C-src and N1-src are 
found in all synaptic preparations, and C-src is the major src family kinase member 
in synaptic vesicle preparations, suggesting it has roles at the synaptic vesicle (Onofri 
et al., 2007). In support of this, C-src is 4-5 times more concentrated in purified 
synaptic vesicles than homogenized whole brain (Greengard et al., 1993). The 
concentration of N1-src is higher in synaptic membrane preparations compared to 
synaptic vesicles suggesting a role for N1-src at the plasma membrane (Onofri et al., 
2007). 
Src activity has previously been implicated in synaptic vesicle turnover in nerve 
terminals. The src inhibitors PP1 and PP2 caused an increase in Ca2+-dependent 
glutamate release from rat brain nerve terminals and dopamine release from PC12 
cells suggesting a negative regulatory role of src (Ohnishi et al., 2001; Baldwin et al., 
2006). On the other hand, experiments using PP2 resulted in a suppression of 
glutamate release in cerebrocortical synaptosomes sugge ting a positive role of src in 
synaptic vesicle exocytosis (Wang, 2003). The conflicting results from these 
experiments suggest that there are differences in the response mechanisms since 
different types of cells and stimulation conditions were used in these reports. 
Stimulation conditions in experiments showing inhibitory role of src involved a 
substantial increase in Ca2+ concentration whereas the stimulation in the other 
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experiment is more likely to produce a physiological like Ca2+ concentration.  Src 
also activates L-type Ca2+ channels in cerebellar granule neurons after depolarization 
and enhances neurotransmitter release, which requires a prior tyrosine 
phosphorylation of FAK and vinculin (Evans and Pocock, 1999). Using a prolonged 
KCl stimulation or a tyrosine phosphatase inhibitor, such as vanadate, enhanced L-
type Ca2+ activation and subsequently increased neurotransmitter release suggesting 
a regulatory role for src in neurotransmitter release (Evans and Pocock, 1999).     
 
1.7 The synaptic vesicle life cycle 
Nerve terminals are secretory machines that are engaged in repeated cycles of 
neurotransmitter release. The synaptic vesicle, where the neurotransmitter is stored, 
is the smallest eukaryotic organelle with an averag diameter of 42 nm in the 
mammalian CNS (Jahn and Sudhof, 1994; Rizzoli and Betz, 2004; Smith et al., 
2008). The synaptic vesicle cycle involves both fusing the vesicle membrane with the 
plasma membrane to release neurotransmitter (exocytosis) and retrieving this 
membrane back to form a new vesicle (endocytosis) (F gure 1.3) (Heuser and Reese, 
1973; Gandhi and Stevens, 2003).  
Synaptic vesicles are clustered close to the pre-synaptic membrane (De Camilli and 
Takei, 1996; Schweizer and Ryan, 2006). This clustering involves actin filaments 
and the synaptic vesicle protein synapsin, where synapsin is attached to both the 
vesicle membrane and actin filaments to keep vesicles in position (Hirokawa et al., 
1989; Evergren et al., 2007). The vesicles then dock at the membrane of the active 
zone and then undergo a series of priming reactions after which they fuse with the 
plasma membrane and release neurotransmitter cargo. Vesicle fusion occurs in 
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response to action potential stimulation and a subsequent increase in Ca2+ 
concentration in the nerve terminal due to voltage gated Ca2+ channel opening (Nofal 
et al., 2007; Rizo and Rosenmund, 2008). There are a number of different routes 
through which a synaptic vesicle can recycle back to the nerve terminal. The first two 
pathways could be named flicker fusion, where vesicl  retrieval happens very 
quickly (Smith et al., 2008); the first is called kiss and stay, where the vesicle is 
retrieved from the plasma membrane after fusion pore pening to allow 
neurotransmitter release (Sudhof, 2000; Bonanomi et al., 2006). The second pathway 
is called kiss and run, where the vesicle is also retrieved after fusion pore opening, 
but it does not stay in the docked position (Valtorta et al., 2001; Rodal and Littleton, 
2008; Zhang et al., 2009). The third pathway involves full fusion of the vesicle with 
plasma membrane followed by clathrin-mediated endocytosis (Jarousse and Kelly, 
2001; Dickman et al., 2005; Cousin, 2009). Finally a bulk endocytosis of large 
membrane areas can also occur, which is a way of quickly retrieving vesicle 
membrane after fast repeated stimulations that other retrieval mechanisms do not 
have the capacity to deal with  (Matthews, 2004; Clayton et al., 2008; He et al., 
2009).  
 
1.7.1 Synaptic vesicle exocytosis 
Proteins that are involved directly in vesicle membrane fusion with the plasma 
membrane are called SNARE proteins (SNAP (Soluble NSF Attachment Protein) 
Receptors). There are three SNARE proteins, two of which are found in the plasma 
membrane (syntaxin and SNAP25) while the third one is a vesicular membrane 
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 protein (VAMP) (Chen et al., 2001; Jahn and Scheller, 2006; Sudhof and Rothman, 
2009). Syntaxin is a transmembrane protein, while SNAP-25 is a palmitoylated 
peripheral membrane protein. VAMP is a transmembrane protein (Bauerfeind et al., 
1996; Hu et al., 2002; Jahn and Scheller, 2006). Both syntaxin and VAMP have only 
one SNARE motif while SNAP-25 has two, and all of these SNARE motifs interact 
with each other to form the SNARE complex (Chen andScheller, 2001; Sudhof, 
2004). SNARE motifs consist of a homologus coiled-coil region of about 60 amino 
acids (Fasshauer, 2003). SNARE complex formation drives the vesicular and the 
plasma membranes to become closer to each other and the  fuse forming a fusion 
pore that allows neurotransmitter release (Figure 1.4) (Sritharan et al., 1998; Parpura 
and Mohideen, 2008).    
 
1.7.2 SNARE Proteins 
VAMP is a small synaptic vesicle membrane protein wth a molecular weight of 18 
kDa (Baumert et al., 1989). There are two isoforms of VAMP (VAMP1 and 2) which 
are both found in the central nervous system synaptic regions with an overlapping 
distribution, but VAMP 2 is the dominant isoform in most neurons (Raptis et al., 
2005). VAMP consists of three domains: the N-terminal SNARE motif, a trans-
membrane region, and a highly charged internal region (Trimble et al., 1988).  
SNAP 25 (synaptosome-associated protein of 25 kDa) is  25 kDa protein that is 
anchored to the cytoplasmic face of the plasma membrane via palmitoylation at 
several cysteine residues at the centre of the protein. SNAP 25 has two SNARE 
motifs that contribute to the SNARE complex for vesicle fusion (Hodel, 1998). There 
are two isoforms of SNAP 25 (SNAP 25 A and B), which both are present in 
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neurons. SNAP 25 binds to syntaxin in a 1:1 ratio and their SNARE motifs will form 
a 3 helical bundle and this bundle is the acceptor complex for the VAMP SNARE 
motif (Rizo and Rosenmund, 2008).  
Syntaxin 1 is found in the nerve terminal as a trans-membrane protein. There are 
three functional domains in syntaxin: the C-terminal tr ns-membrane domain, the 
SNARE motif and the N-terminal regulatory domain (Bennett et al., 1993). There are 
two conformations for syntaxin: the first is when the regulatory domain binds to the 
SNARE motif causing syntaxin to be in a restrained closed conformation that is not 
available for SNARE complex formation. This closed conformation binds to the 
protein Munc 18. The other is the open conformation where the regulatory domain 
and SNARE motif are freed, allowing the SNARE motif to bind other SNAREs 
(Rizo and Rosenmund, 2008).  
There are several other proteins which are involved in regulated exocytosis such as 
the synaptotagmins (the primary Ca2+ sensor) that couple Ca2+ entry into the nerve 
terminal with exocytosis (Yoon and Shin, 2009). There are two cytoplasmic C2 
domains in synaptotagmin that bind to Ca2+, The C2A binds to 3 Ca2+ ions, while 
C2B binds to 2 Ca2+ ions (Sudhof, 2004). Synaptotagmin binding to phoslipids is 
Ca2+ dependent, however the Ca2+-dependency of its binding to the SNARE complex 
is controversial (Sudhof, 2004). The SNARE complexes form a ring shape at the 
fusion area and synaptotagmin binding to phospholipids inside this ring results in 




other, which will facilitate and stabilize the pore opening in exocytosis (Sudhof, 
2004; Martens et al., 2007). 
 
1.7.3 Synaptic vesicle endocytosis 
Synaptic vesicles are endocytosed and locally recycl d after exocytosis, which is 
essential to maintain synaptic activity, and the recycled vesicles have to be identical 
to the originals to maintain the same function (Bonanomi et al., 2006; Schweizer and 
Ryan, 2006). After full fusion of a vesicle, a sorting process is needed to retrieve 
vesicle proteins (Sankaranarayanan and Ryan, 2001; Bonanomi et al., 2006; Rizzoli 
and Jahn, 2007). Clathrin mediated endocytosis performs this role (Figure 1.5 A) 
(Bonanomi et al., 2006; Granseth et al., 2007; Smith et al., 2008). The vesicle protein 
synaptotagmin attracts the cytosolic protein AP2 which initiates the recruitment of 
the endocytic machinery and clathrin cage formation (Bonanomi et al., 2006; Smith 
et al., 2008). After formation of the synaptic vesicle, the large GTPase dynamin 
fissions the vesicle from the plasma membrane (Slepnev and De Camilli, 2000; 
Bonanomi et al., 2006). The vesicle is then uncoated by removing the clathrin coat in 
an ATP dependent process. The vesicle is then reacidified and refilled with 
neurotransmitter ready to join the recycling vesicle pool (Bonanomi et al., 2006; 
Smith et al., 2008). 
 
1.7.3.1 Clathrin coat formation 
Clathrin cage formation involves several proteins. The adaptor protein complex 
(AP2) which is a tetrameric heterodimer consisting of two large subunits of about 




about 20 kDa (σ) (Edeling et al., 2006). There are two sequences to which AP2 binds 
(YXXФ and D/EXXXLL/I) (X is any amino acid and Ф is a large  hydrophobic 
residue) which are considered signals for endocytic membrane proteins (Edeling et 
al., 2006). AP2 also binds to phosphoinositides such as phosphoinositol-4, 5-
bisphosphate which are important signals for membrane identity to recruit AP2 
(Edeling et al., 2006). A direct interaction between AP2 and the cytosolic domain 
C2B of synaptotagmin triggers the assembly of the clathrin coated pit, which 
suggests that synaptotagmin might be a signalling protein for both exocytosis and 
endocytosis (Schmid, 1997; Bonanomi et al., 2006). Endocytic motifs enhance this 
interaction (Haucke and De Camilli, 1999). The other adaptor protein that is involved 
in synaptic vesicle endocytosis is the neuronal specific protein AP180 (about 90 
kDa) which also binds to phosphoinositides (Schmid, 1997; Bonanomi et al., 2006). 
AP180 binds to both AP2 and clathrin, which makes both AP2 and AP180 act as 
adaptors to assemble clathrin at the vesicle membrane (Cremona and De Camilli, 
1997; Kirchhausen, 2000).  
Clathrin assembly by these proteins triggers vesicl formation. The clathrin coat 
consists of triskelia and each triskelion consists of three clathrin heavy chains (about 
190 kDa) and three clathrin light chains (25-29 kDa) that form a stable oligomeric 
complex (Slepnev and De Camilli, 2000; Edeling et al., 2006).  
Two other proteins (endophillin and amphiphysin) which bind to inwardly curved 
membrane will be recruited to the curved vesicle membrane (Kirchhausen, 2000; 
Brett and Traub, 2006). They both have N-BAR (Bin-Amphiphysin-Rvs) domains 
which is an N-terminal amphipathic α-helix. These BAR domains are inserted into 
the membrane for optimal engagement while the core BAR domain stabilizes 
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vesiclular membrane curvature (Brett and Traub, 2006). Amphiphysin binds to both 
AP2 and clathrin making an adaptor for the assembled proteins (Slepnev et al., 1998; 
Farsad and De Camilli, 2002). Both endophillin and amphiphysin also contain SH3 
domains that bind to dynamin and synaptojanin proline rich domains (PRD) 
(Kirchhausen, 2000).  
Dynamin also binds to phosphoinositides through its PH domain and synaptojanin 
has a lipid modification activity as an inositol 5-phosphatase (Kirchhausen, 2000). 
Dynamin binding to the phosphoinositides promotes its oligomerization and 
assembly at the clathrin coated pit (Doherty and McMahon, 2009). In fact, dynamin 
assembly forms rings around the clathrin coated pit and membrane squeezing, by 
making the rings tighter, will cause the membrane to come in close proximity 
forming the vesicle neck. Further squeezing and twisting by dynamin causes vesicle 
fission and pinching off of the vesicle from the plasma membrane (Bonanomi et al., 
2006; Doherty and McMahon, 2009). Dynamin effects on membrane fission requires 
energy to cause fission of the lipid bilayer and energy is mainly provided by dynamin 
GTPase activity (Figure 1.5 B)  but also could involve the cytoskeleton (Doherty and 
McMahon, 2009). Phosphoinositide dephosphorylation decreases lipid binding 
proteins affinity to the lipid bilayer which acts as a signal for clathrin coat 
disassembly. Synaptojanin’s dual phosphatase activity results in phosphoinositide 
dephosphorylation and promotes clathrin coat disassembly (Ryan, 2006; Zanazzi and 
Matthews, 2007). In fact, deletion of either of the phosphatase domains from 
synaptojanin resulted in accumulation of coated vesicl s in the synaptic terminals 
suggesting a dual phosphatase activity of synaptojanin is required for vesicle 
uncoating (Ryan, 2006; Zanazzi and Matthews, 2007).  Auxilin is another protein 
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that binds to clathrin and is recruited to the coated vesicle (Edeling et al., 2006). The 
J domain of auxilin binds to the ATPase chaperone HSC70 and stimulates its ATPase 
activity (Edeling et al., 2006). HSC70 also binds to clathrin heavy chain and 
destabilize triskilions interactions, promoting triskilion release from the cage and 
initiating clathrin coat dissociation from the coated vesicle (Schmid, 1997; Edeling et 
al., 2006).    
 
1.7.4 Proteins involved in synaptic vesicle cycle that may interact with src or src 
substrates 
Src has previously been shown to either interact with or phosphorylate a number of 
nerve terminal proteins that are involved in synaptic vesicle recycling. These proteins 
have different functions across the vesicle life cycle from maintaing synaptic vesicle 
pools, vesicle docking and clathrin uncoating of the endocytosed vesicle. 
 
1.7.4.1 Synapsin 
The synapsins are peripheral vesicle proteins (Murthy, 2001; Fdez and Hilfiker, 
2006). They help in synapse formation and maintenance by maintaining the reserve 
vesicle pool (Murthy, 2001; Ferreira and Rapoport, 2002; Fdez and Hilfiker, 2006). 
There are five synapsin proteins expressed from three genes (synapsin Ia, Ib, IIa, IIb, 
and III) (Ferreira and Rapoport, 2002; Fdez and Hilfiker, 2006; Evergren et al., 
2007). SynapsinI and synapsinII are expressed in most nerve terminals, while 
synapsinIII is less abundant, but can be found either in the postsynaptic region or 
other parts of neuronal cells (Ferreira and Rapoport, 2002; Cousin et al., 2003; 
Evergren et al., 2007).  
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All synapsins have eight different domains (A-H), but have a similar structure in 
three domains: the N-terminal domain A, the central domain C, and the C-terminal 
domain E. The other domains however, display a diverse variation in structure across 
different species (Hosaka et al., 1999; Ferreira and Rapoport, 2002; Evergren et al., 
2007). Domain C interacts with synaptic vesicle phospholipids, actin filaments and 
ATP, and is a substrate for C-src (Evergren et al., 2007). The proline rich domain D 
is involved in synapsin interactions with many SH3 containing proteins including src 
(Evergren et al., 2007). Synapsins bind to the lipid surface of the synaptic vesicle via 
their N-terminal domain and middle portions (Ferreira and Rapoport, 2002).  
Synapsin I interacts with many SH3 containing proteins and it is a major binding 
partner of the C-src SH3 domain in the nerve terminals (Onofri et al., 1997; Onofri et 
al., 2000). In agreement the C-src SH3 domain has higher affinity to synapsin I than 
many SH3 domain containing proteins such as amphiphys n I and II, Crk, and 
phospholipase Cγ (Onofri et al., 2000).  
 
1.7.4.1.1 Synapsin phosphorylation 
Synapsin I can be phosphorylated by several kinases such as PKA (protein kinase A), 
CaMK I and II (Ca2+-calmodulin dependent kinases), MAP kinase and Cyclin-
dependent kinase 5 (CDK5) (Fdez and Hilfiker, 2006). Synapsin I phosphorylation at 
domain A by PKA or CaMK I and II causes a decrease in its affinity to synaptic 
vesicles which results in its dissociation from synaptic vesicle (Hosaka et al., 1999; 
Fdez and Hilfiker, 2006; Evergren et al., 2007). This phosphorylation also releases 
synapsin from actin filaments allowing the synaptic vesicle to be available for 
exocytosis. Synapsin I phosphorylation by MAP kinase does not affect its synaptic 
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vesicle association, but decreases its binding to ac in, which might play a role in 
recruiting recycled vesicles to the reserve pool (Fdez and Hilfiker, 2006). Synapsin is 
also phosphorylated by CDK5 at S551 and S553 (Figure 1.6A) and this 
phosphorylation does not seem to affect its affinity to actin (Matsubara et al., 1996). 
However CDK5 might play a role in synapsin clustering (Yamashita et al., 2007). 
 
1.7.4.1.2 Synapsin tyrosine phosphorylation 
Synapsin is also tyrosine phosphorylated by C-src at a single major site (Y301) in 
domain C (Figure 1.6A) that is conserved in all isoforms (Onofri et al., 1997; Onofri 
et al., 2007). Since the C domain is involved in syapsin interactions with synaptic 
vesicles, actin and dimerization, there is a possibility that synapsin phosphorylation 
by C-src regulates some aspects of the synapsin cycle or vesicle trafficking (Onofri et 
al., 2007).  C-src phosphorylation of synapsin I provides a binding site for the C-src 
SH2 domain. C-src binding to synapsin via both the SH3 and SH2 domains results in 
a several fold increase in C-src kinase activity in phosphorylating other substrates 
such as synaptophysin (Onofri et al., 1997; Onofri et al., 2007). Synapsin II may also 
interact with and activate C-src (Onofri et al., 1997). In fact, depletion of synapsin I 
results in a decrease in C-src kinase activity in sy aptic vesicles, suggesting that 
synapsin I might be a key src activator in the presynaptic region (Onofri et al., 1997; 
Onofri et al., 2007). In synapsin I KO mice, both src activity and tyrosine 
phosphorylation of synaptic vesicle proteins were depressed, even though src 
expression was not affected (Onofri et al., 2007). In addition, since synapsin serine 
phosphorylation regulates synapsin association withthe synaptic vesicle, it might 




substrates through synapsin association and dissociation from the vesicle membrane 
(Onofri et al., 2007).   
 
1.7.4.2 Synaptojanin 
Vertebrates express two genes for synaptojanin: synaptojanin 1 which is a 
neurospecific protein and synaptojanin 2 which is expr ssed ubiquitously (Rosivatz, 
2006). Synaptojanin 1 has two isoforms, a 145-kD protein that is enriched in the 
nerve terminal and a 170-kDa isoform only expressed in embryonic tissue (de 
Heuvel et al., 1997; Rosivatz, 2006). Synaptojanin co sists of 3 domains: two of 
which are lipid metabolizing domains known as the Sac 1 domain, the polyinositide 
phosphatase domain, and  the C-terminal proline rich domain (PRD) (Hopper and 
O'Connor, 2005; Mani et al., 2007). Synaptojanin I is required for clathrin mediated 
synaptic vesicle endocytosis and vesicle reavilabilty due to its role in synaptic 
vesicle uncoating (Cousin and Robinson, 2001; Kim et al., 2002; Mani et al., 2007). 
Synaptojanin KO neurons displayed a smaller functioal synaptic vesicle pool and a 
large fraction of the recycled membrane became trapped in functionally inert 
compartments after a prolonged stimulation (Kim et al., 2002). In fact, synaptojanin I 
KO resulted in accumulation of free clathrin coated v sicles in the synaptic area as 
well as deep invaginations (Kim et al., 2002; Mani et al., 2007).  
Endophillin is the major binding partner for synaptojanin 1 in nerve terminals 
(Micheva et al., 1997; Cestra et al., 1999; Rosivatz, 2006). Synapses that lack 
synaptojanin and endophillin show a defect in synaptic vesicle recycling (Dickman et 
al., 2005). Synaptojanin also interacts with the C-src SH3 domain, but the function of 
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C-src interaction with synaptojanin I is not known (Onofri et al., 1997; Onofri et al., 
2000). 
 
1.7.4.2.1 Synaptojanin phosphorylation 
Synaptojanin is one of the dephosphins that are dephosphorylated by calcineurin 
upon stimulation in a Ca2+-dependent manner (Cousin et al., 2001; Smillie and
Cousin, 2005), while it is rephosphorylated by cyclin-dependent kinase 5 (CDK5) 
under basal conditions (Lee et al., 2004; Smillie and Cousin, 2005). Synaptojanin 
phosphorylation by CDK5 at S1144 (Figure 1.6B) inhibits its interaction with 
endophillin (Lee et al., 2004). Minibrain kinase (MNB) also phosphorylates 
synaptojanin at multiple sites that are dephosphorylated by calcineurin (Adayev et 
al., 2006).  
 
1.7.4.2.2 Synaptojanin tyrosine phosphorylation 
Synaptojanin is tyrosine phosphorylated at multiple sites (Y1018, Y1059, and 
Y1172) on its PRD (Figure 1.6B) by the receptor tyrosine kinase ephrin B (EphB) 
receptor (Irie et al., 2005). Tyrosine phosphorylation of synaptojanin resulted in 
reduction of endophillin binding (Irie et al., 2005). Since endophillin binding is 
required for synaptojanin localization to synaptic vesicle (Schuske et al., 2003), 
reduction of endophillin binding decreases its recruitment to synaptic vesicles. 
Furthermore, tyrosine phosphorylation resulted in decreasing its phosphatase activity 
suggesting a regulatory role for synaptojanin phosprylation on its function (Irie et 
al., 2005). This was supported by the fact that EphB stimulation results in an increase 
in phosphoinositide levels within the cell and the lack of changes after EphB 
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stimulation when synaptojanin tyrosine residues were mutated (Irie et al., 2005). 
Similarly, since AMPA receptor internalization is clathrin mediated, synaptojanin 
tyrosine phosphorylation also regulated ligand induced AMPA receptor 
internalization (Irie et al., 2005). In support of this, the expression of both the kinase 
dead EphB and tyrosine mutated synaptojanin resulted in inhibited ligand induced 
AMPA receptor internalization (Irie et al., 2005). 
 
1.7.4.3 Synaptophysin 
Synaptophysin 1 (p38) is a 38 kD protein that is an integral synaptic vesicle protein 
with four intramembrane loops (De Camilli and Jahn, 1990; Bonanomi et al., 2007). 
Synaptophysin’s role in the synaptic vesicle life cycle is not clear since there are 
other isoforms such as synaptophysin 2 and synaptogyrin that might have 
overlapping roles. Synaptophysin KO mice showed no istinct phenotype suggesting 
that it has no distinct function in the synaptic region (Arthur and Stowell, 2007). 
However when both synaptophysin I and synaptogyrin I were deleted, short term and 
long term plasticity were affected (Janz et al., 1999). In synaptophysin KO mice 
retinal photoreceptor cells, which do not express synaptophysin II, showed a 
decrease in the number of synaptic vesicles, suggestin  an important role for 
synaptophysin in synaptic vesicle formation. Injection of the synaptophysin C-
terminus in the squid giant synapse showed a defect in synaptic vesicle endocytosis 
with an increase in clathrin coated vesicles, suggesting that synaptophysin might be 
involved in clathrin independent endocytosis (Spiwoks-Becker et al., 2001). In 
addition synaptophysin KO hippocampal neurones showed an impaired ability to 
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form synapses compared to wild type, suggesting a role of synaptophysin in synapse 
formation (Tarsa and Goda, 2002).  
 
1.7.4.3.1 Synaptophysin interactions 
 Synaptophysin is the major binding partner for cholesterol in synaptic vesicles, 
which might be involved in vesicle protein sorting in the plasma membrane before 
endocytosis, since partial depletion of cholesterol bl cks endocytosis, as well as 
causing membrane curvature that starts vesicle budding (Thiele et al., 2000). 
Synaptophysin I forms oligomers by binding to other synaptophysin I molecules via 
their transmembrane domains (Pennuto et al., 2003). Synaptophysin also binds to 
VAMP via its transmembrane domains in the synaptic vesicle membrane during 
basal conditions. Their complex dissociates upon stimulation, suggesting this binding 
might be important in the regulation of SNARE complex formation since VAMP can 
not participate in SNARE complex when bound to synaptophysin (Becher et al., 
1999; Pennuto et al., 2002; Yelamanchili et al., 2005). Synaptophysin binding to 
VAMP also plays an important role in VAMP targeting to the synaptic vesicle both 
from plasma membrane and intracellular compartments (Pennuto et al., 2003; 
Bonanomi et al., 2007). Synaptophysin binds to dynami  in a Ca2+ dependent manner 
at its C-terminus which is also negatively affected by synaptophysin binding to 
VAMP, suggesting that synaptophysin plays a role in dynamin targeting in 
endocytosis (Daly and Ziff, 2002).  
Synaptophysin co-precipitates with C-src suggesting a direct interaction between 
these two proteins (Barnekow et al., 1990; Linstedt et al., 1992; Zhao et al., 2000). In 
support of this, FRET studies showed that synaptophysin interacts with C-src via its 
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SH2 domain (Felkl and Leube, 2008). The C-terminal tyrosine residues of 
synaptophysin are thought to mediate binding to the C-src SH2 domain, because 
removing these residues abolishes their interaction (Felkl and Leube, 2008).  
 
1.7.4.3.2 Synaptophysin tyrosine phosphorylation 
The tyrosine rich C-terminus of synaptophysin with nine tyrosine residues (Figure 
1.7 A) forms a perfect target for tyrosine kinases, xplaining why it is the major 
tyrosine phosphoprotein on the synaptic vesicle membrane (Pang et al., 1988). 
Synaptophysin is tyrosine phosphorylated by C-src in vitro and also when C-src is 
over expressed in cells (Barnekow et al., 1990; Evans nd Cousin, 2005). 
Synaptophysin was also phosphorylated by either C-src or Fyn when coexpressed in 
COS cells, suggesting that synaptophysin is a substrate for these two members of the 
src family (Janz et al., 1999). There is no evidence of which of the nine tyrosine 
residues is phosphorylated in the synaptophysin C-terminus which might be due to 
the lack of a trypsin cleavage site, producing a large peptide that can not be analysed 
using mass spectrometry (Evans and Cousin, 2005).  There are most likely, however, 
to be multiple phosphorylation sites in the synaptophysin C-terminus which is 
common for src substrates (Evans and Cousin, 2005). There is no evidence for a 
stimulation dependent change in synaptophysin tyrosine phosphorylation, suggesting 
that synaptophysin tyrosine phosphorylation is not stimulation dependent (Onofri et 
al., 2007), however C-src interaction with synaptic proteins might be negatively 
regulated by intracellular Ca2+ and PKC activity (Zhao et al., 2000). Tyrosine 





that this event might be an important aspect in long term potentiation (Evans and 
Cousin, 2005). 
 
1.7.4.3.3 Synaptophysin serine phosphorylation 
Synaptophysin is serine phosphorylated in a Ca2+ dependent manner by CaM kinase 
II in vivo, in vitro and in purified synaptic vesicles even though none of the four 
serine residues in the synaptophysin C-terminus match the preferred sequence 
(RXXS) for CaM kinase II (Rubenstein et al., 1993). Synaptophysin is also serine 
phosphorylated by PKC on purified synaptic vesicles; however, synaptophysin 
phosphorylation by CaMK II is three times higher than that of PKC (Rubenstein et 
al., 1993). Furthermore CaMK II inhibitors decreased ynaptophysin phosphorylation 
in synaptosomes, suggesting that CaMK II is the main serine kinase for 
synaptophysin (Rubenstein et al., 1993). No important role of this phosphorylation 
has been shown. 
 
1.7.4.4 Munc 18 
Munc 18-1, also called n-sec1, plays an important role in the vesicle life cycle 
(Burgoyne et al., 2009). Munc18 KO mice showed normal brain development, and 
also neuromuscular junction formation that requires long axonal formation, including 
normal assembly of synapses and post synaptic function (Verhage et al., 2000). 
However, there was no neurotransmitter release observed even after strong electrical 
stimulation, suggesting that even though Munc 18 was not required for neuronal 
development, it was essential for neurotransmitter rel ase (Verhage et al., 2000).      
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Munc 18 forms a complex with syntaxin when syntaxin is in the closed conformation 
(Dulubova et al., 2007), and also plays a role in sy taxin and Munc 18 stabilization 
(Dulubova et al., 2005; Gerber et al., 2008). Munc 18 binding to closed syntaxin 
allows syntaxin’s passage from the endoplasmic retiulum to the plasma membrane 
without being engaged in ectopic SNARE complexes outside the nerve terminal 
(Rickman et al., 2007). This binding suggests that Munc 18 plays a regulatory role in 
SNARE complex formation (Dulubova et al., 1999; Carpp et al., 2006). However, 
Munc 18 also binds to the syntaxin N-terminus when it is in an open conformation or 
involved in the SNARE complex (Rizo and Rosenmund, 2008; Burgoyne et al., 
2009; Johnson et al., 2009). Munc 18 binding to the assembled SNARE complex is 
reduced by mutation at D214. The D214N mutant binds to open and closed syntaxin 
but has an impaired binding to the assembled SNARE complex (Graham et al., 
2009). This mutation slows the fusion kinetics and i creases the quantal size of the 
vesicles. In C. elegans this mutant reduces the ethanol excitatory (at low 
concentration) and sedatory (at high concentration) effect on locomotion suggesting 
that ethanol may act at the fusion stage (Graham et al., 2009).Munc 18 binding to the 
syntaxin N-terminus is essential for neurotransmitter release since Munc 18 mutation 
(F113R) that inhibits open syntaxin binding did not rescue neurotransmitter release 
from Munc 18 null mutants (Johnson et al., 2009).  
Munc 18 binding to open syntaxin mediates vesicle priming since mutations in Munc 
18 that inhibited its binding to open syntaxin disrupted synaptic vesicle priming 
(Deak et al., 2009). Synaptic vesicle docking might also be mediated by Munc 18 
and again involves Munc 18 binding to syntaxin (Okamoto and Sudhof, 1997). Munc 
18 binding to syntaxin in both its open and closed conformations might be two 
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aspects of the same function where Munc 18 prevents inappropriate SNARE 
complex formation and regulates SNARE complex formation to be in the right 
location and right time for regulated vesicle fusion (Burkhardt et al., 2008). This 
regulation involves Munc 18 mediated docking and subsequent SNARE motif 
interaction and vesicle tethering (Burkhardt et al., 2008).  Munc 18 may also regulate 
the readily releasable pool size and synaptic plasticity since an increase in the 
number of docked vesicles as well as an increase in the total number of vesicles was 
observed when Munc 18 was overexpressed (Weimer et al., 2003; Toonen et al., 
2006; Toonen and Verhage, 2007).  
 
1.7.4.4.1 Munc 18 phosphorylation 
Munc 18 is serine phosphorylated at S306 in vitro and S313 (Figure 1.7B) both in 
vitro and in vivo by PKC (Fujita et al., 1996; de Vries et al., 2000; Barclay et al., 
2003). PKC phosphorylation of Munc 18 in vivo is stimulation-dependent, where 
Ca2+ influx triggers this phosphorylation (de Vries et al., 2000). Munc 18 
phosphorylation by PKC decreases its interaction with syntaxin and enhances 
secretion in nerve terminals (de Vries et al., 2000). Munc 18 phosphorylation by 
PKC results in decreasing the release time and increases catecholamine release from 
adrenal chromaffin cells (Barclay et al., 2003). Munc 18 phosphorylation by PKC 
also potentiates vesicle pool replacement after depleting stimulation (Nili et al., 
2006). Munc 18 is also threonine phosphorylated by CDK5 in vitro at T574 (Fletcher 
et al., 1999), however CDK5 inhibitors had no effect on Munc 18 phosphorylation in 
vivo suggesting T574 phosphorylation by CDk5 does not occur in vivo since crystal 
structure shows that T574 is not accessible (de Vris et al., 2000).  In contrast PKC 
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inhibitors blocked Munc 18 phosphorylation suggesting that PKC is the major Munc 
18 kinase (de Vries et al., 2000).  
 
1.7.4.4.2 Munc 18 tyrosine phosphorylation 
Munc 18c (the nonneuronal form of Munc 18) is tyrosine phosphorylated in 
pancreatic β cells on four residues in the basal condition: Y66, Y103, Y218 and 
Y219 (Figure 1.7 C) (Oh and Thurmond, 2006). After glucose induced stimulation, 
only Y219 had an increased phosphorylation status, s ggesting that it is the primary 
glucose stimulation dependent phosphorylation site (Oh and Thurmond, 2006). 
Tyrosine phosphorylation resulted in a decreased bin ing affinity of Munc 18c to 
syntaxin 4, suggesting a regulatory role for tyrosine phosphorylation in Munc 18 
function in a similar way to serine phosphorylation (Oh and Thurmond, 2006). In 
fact, Y219 is not accessible to phosphorylation when Munc 18c is bound to syntaxin 
4 in its closed conformation but it becomes available when syntaxin 4 is in an open 
conformation (Jewell et al., 2008). Munc 18 tyrosine phosphorylation results in an 
increased affinity for Doc2β and a decreased affinity for syntaxin 4 which results in 
facilitating SNARE assembly and promotes exocytosis (Oh and Thurmond, 2006; 
Jewell et al., 2008). 
 
1.7.4.5 NSF  
N-ethylmaleimide sensitive factor (NSF) is a member of AAA family of ATPase 
proteins that uses ATP to alter the comformation of a protein (May et al., 2001; Dalal 
et al., 2004; Zhao et al., 2007; Malsam et al., 2008). NSF has three domains; an N 
domain which is required for αSNAP/SNARE binding, a D1 domain with ATPase 
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activity and a D2 domain that is involved in oligomerization (May et al., 2001; 
Morgan and Burgoyne, 2004). NSF utilizes ATP to disassemble the SNARE 
complex and thus allows SNARE protein sorting and recycling (Matsushita et al., 
2005; Zhao et al., 2007). NSF requires the adaptor r tein αSNAP (soluble NSF 
attachment protein) to bind to the SNARE complex. In fact NSF does not bind to 
αSNAP when αSNAP is not engaged in binding with the SNARE complex or when 
NSF is not oligomerized or not bound to ATP (Hanson et al., 1997; Malsam et al., 
2008). NSF ATPase activity is very low when it is alone but it is maximized when 
NSF is engaged with αSNAP/SNARE complex (Barnard et al., 1997; Haynes et al., 
1998; Zhao et al., 2007).  NSF also binds to a variety of proteins other than SNARE 
complex including receptor proteins such as GABA and glutamate receptors and 
cytosolic proteins such as Rab proteins (Nishimune et al., 1998; Hanley et al., 2002; 
Morgan and Burgoyne, 2004).  
 
1.7.4.5.1 NSF phosphorylation 
NSF is phosphorylated by PKC both in vivo and in vitro with S237 (Figure 1.8 A) in 
the catalytic D1 domain being the main phosphorylation site (Matveeva et al., 2001). 
Phosphorylation of NSF by PKC is Ca2+-dependent and decreases its association 
with the αSNAP/SNARE complex which suppresses its action in SNARE 
disassembly during exocytosis (Matveeva et al., 2001).  NSF is also phosphorylated 
by pictaire 1 (a CDK related kinase that is phosphorylated and activated by CDK5) at 
S569 in the D2 domain which decreases its ability for oligomerization, suggesting a 
regulatory role of S569 phosphorylation on NSF function (Liu et al., 2006).  
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1.7.4.5.2 NSF tyrosine phosphorylation 
NSF is tyrosine phosphorylated by the tyrosine kinase Fes at Y83 (Figure 1.8 A) 
which results in increased ATPase activity and decreased binding to αSNAP, 
suggesting a regulatory role for tyrosine phosphorylation in NSF function instead of 
constitutive activation (Huynh et al., 2004). Furthermore, NSF dephosphorylation by 
either PTP-MEG2 or PTP1B results in NSF activation a d SNARE complex 
disassembly (Huynh et al., 2004; Zarelli et al., 2009). Inhibition of NSF 
dephosphorylation or overexpression of aY83E phosphmimetic mutatnt resulted in 
accumulation of dead-end cis SNARE complexes and exocytosis inhibition (Huynh 
et al., 2004). PTP1B also dephophorylates NSF in sperm and this dephosphorylation 
results in NSF activation in disassembling SNARE complexes (Zarelli et al., 2009). 
Tyrosine phosphorylated NSF was unable to dissociate is SNARE complex and also 
inhibition of PTP1B resulted in inhibition of sperm exocytosis that could be rescued 
by using nonphosphorylated NSF (Zarelli et al., 2009). This suggests that NSF 
function is negatively regulated by tyrosine phosphorylation rather than being 
constitutively active (Zarelli et al., 2009).  Unlike neurons, SNARE proteins are 
assembled in cis complexes in sperm under resting condition and activ tion will 
result in their disassembly to be available for exocyt sis (Zarelli et al., 2009). 
 
1.7.4.6 Dynamin  
As membrane fusion between synaptic vesicles and the plasma membrane requires 
SNARE proteins, membrane fission of the recycled synaptic vesicle requires 
dynamin (Smillie and Cousin, 2005). The importance of dynamin in endocytosis was 




shown to cause a paralysis in Drosophila (Grigliatti et al., 1973; Poodry and Edgar, 
1979). There are three isoforms of dynamin: dynamin I is a brain specific isoform 
that is enriched in the pre-synaptic region, dynamin II s expressed in all tissues, and 
dynamin III is expressed in testis and brain, mainly i  the postsynaptic region 
(Rappoport, 2008). Dynamin is a 96 kDa protein (Figure 1.8 B) with a large GTPase 
domain (Praefcke and McMahon, 2004; Peplowska and Ugermann, 2005). GTPase 
activity can be stimulated by oligomerization (tetramers) of the protein that is 
mediated by the interaction between the GTPase domain, and the GTPase effector 
domain (GED) (Praefcke and McMahon, 2004; Smillie and Cousin, 2005). In 
addition to these domains, dynamin has a pleckstrin homology (PH) domain 
(Praefcke and McMahon, 2004) between the middle domain and the GED, and a 
proline rich (PRD) domain at its C- terminus (Praefck  and McMahon, 2004). The 
PRD plays an important role in protein-protein interactions and is also a site of 
splicing (Cao et al., 1998; Smillie and Cousin, 2005).  
Dynamin binds to negatively charged lipids, especially nositol phospholipids, with 
low affinity through its PH domain, but this binding becomes stronger after dynamin 
recruitment and oligomerization which controls dynamin action in membrane fission 
and GTPase activity (Takei et al., 2005; Konopka et l., 2006). Dynamin targeting to 
its site of action is mediated by its PRD binding to proteins containing SH3 domains 
such as amphiphysin and endophillin (Schmid et al., 1998; Praefcke and McMahon, 
2004). Dynamin is also associated with clathrin independent endocytosis such as 
caveolae-mediated endocytosis and RhoA dependent endocytosis. However, some 
endocytotic pathways are dynamin independent, such as fluid-phase uptake at the 
non-permissive temperature for Hela cells expressing the temperature sensitive 
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dynamin mutant (G273D) (Damke et al., 1995), and also Drosophila hemocytes 
expressing the temperature sensitive dynamin mutant (Guha et al., 2003). Even 
though there were several proposed models for dynamin mechanism in vesicle 
fission, the accepted model is that dynamin acts in a mechanochemical way to 
squeeze the vesicle’s neck until the vesicle pinches off (Praefcke and McMahon, 
2004; Bonanomi et al., 2006), whereas a new theory suggests that squeeze alone is 
not enough to cause fission. Therefore squeeze and pull are needed to create a 
membrane tension that causes membrane breakdown and vesicle fission (Roux et al., 
2006).  
 
1.7.4.6.1 Dynamin PRD 
The dynamin I PRD contains several PxxP sequences that are capable of binding to 
SH3 domain containing proteins. Among these proteins is amphiphysin 1, which is a 
125 kDa protein, essential for directing dynamin to coated pits by simultaneously 
binding to dynamin and the clathrin adaptor AP2 (Grabs et al., 1997; Solomaha et al., 
2005; Anggono and Robinson, 2007). Amphiphysin is another dephosphin that is 
dephosphorylated by calcineurin upon stimulation and its dephosphorylation is 
essential for its function since its phosphorylation at S376 and S285 by CDk5 
reduces its binding to AP2 and lipid membranes and ffects its recruitment to the 
coated pit (Liang et al., 2007; Craft et al., 2008). Endophillin, which is a 40 kDa 
protein that mediates lipid curvature and vesicle formation, is another protein that 
interacts with dynamin PRD via its SH3 domain (Solomaha et al., 2005; Anggono 
and Robinson, 2007; Graham et al., 2007). Both Amphiphysin and endophillin 
contain an N-BAR domain that binds to curved membranes and this might be 
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important for recruiting dynamin to the clathrin coated pit (Brett and Traub, 2006). 
Syndapin, which is a 52 kDa protein, is also a binding partner for the PRD via its 
SH3 domain in a phosphorylation dependent manner (Anggono and Robinson, 2007; 
Graham et al., 2007). Syndapin also binds to proteins involved in cytoskeletal 
assembly such as N-WASP where actin polymerization plays a role in linking 
endocytotic machinery with the cytoskeleton (Kessel and Qualmann, 2004).  
There are many other SH3 containing proteins that are known to bind dynamin PRD 
including cortactin, profillin, myosin 1E, Grb2, phospholipase Cγ (PLCγ) and Abp1 
(Orth and McNiven, 2003; Solomaha et al., 2005; Zhu et al., 2005; Konopka et al., 
2006; Krendel et al., 2007; Sandvig et al., 2008).  Intersectin, which binds to several 
other proteins through its other domains, SPIN90, which has an SH3 domain and 
three PRD,  and Nck, which is a scaffolding protein, are also binding partners of 
dynamin (Orth and McNiven, 2003; Kim et al., 2005; Solomaha et al., 2005; 
Konopka et al., 2006). 
 
1.7.4.6.2 Dynamin phosphorylation 
Dynamin is one of the dephosphins which is dephosphrylated upon nerve terminal 
stimulation by calcineurin. Dynamin dephosphorylation results in relocation from the 
cytosol to plasma membrane, which is an important regulator for its function (Smillie 
and Cousin, 2005; Ryan, 2006; Graham et al., 2007). Dynamin I is phosphorylated in
vivo on seven serine residues, two of which are found in the middle domain (S347 
close to GTPase domain and S512 close to PH domain) and the other five sites found 
in the PRD (Figure 1.8 B) (S774, S778, S822, S851, and S857) with S774 and S778 
being the major phosphorylation sites (Graham et al., 2007). CDK5 is the major 
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dynamin kinase (Tan et al., 2003), however, minibrain kinase (MNB) also 
phosphorylates dynamin at S857 in a stimulation independent manner, which 
negatively regulates amphiphysin binding (Huang et al., 2004). This phosphorylation 
also enhanced Grb2 binding, suggesting that it might regulate dynamin assembly to 
different protein clusters or locations (Huang et al., 2004). S857 phosphorylation 
represents about 12 % of the total dynamin phosphorylation and thus it might have a 
minor role in dynamin regulation (Graham et al., 2007). Dynamin is also 
phosphorylated by PKC at S795 (Powell et al., 2000); however, phosphorylation of 
this site does not occur in vivo (Graham et al., 2007). Dynamin phosphorylation at 
S774 and S778 regulate its function and inhibit syndapin binding (Tan et al., 2003; 
Anggono et al., 2006). Both S774 and S778 phosphorylation individually regulate 
dynamin’s interaction with syndapin suggesting a cooperative role for their 
phosphorylation on the dynamin and syndapin interacion (Anggono et al., 2006). 
Dynamin dephosphorylation by calcineurin is required for activity-dependent bulk 
endocytosis (ADBE) but not for clathrin mediated endocytosis (CME) (Clayton et 
al., 2009). The phosphorylation dependent dynamin interaction with syndapin is also 
essential for ADBE but not CME (Clayton et al., 2009). Furthermore expressing a 
peptide that encodes the binding region for syndapin (dynamin I 769-784) greatly 
interfered with ADBE but not CME supporting the suggestion that dynamin 
interaction with syndapin is required only for ADBE, which also supported by the 
fact that syndapin silencing using shRNA resulted in the same effect on ADBE  
(Clayton et al., 2009).  Thus even though dynamin is required for both types of 
endocytosis, dynamin dephosphorylation and syndapin binding are only required for 
ADBE (Andersson et al., 2008; Clayton et al., 2009).   
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1.7.4.6.3 Dynamin tyrosine phosphorylation 
C-src interacts with both the PRD of dynamin 1 and dynamin 2 (Solomaha et al., 
2005). This is a selective interaction since the SH3 domain of N1-src does not bind 
(Onofri et al., 1997; Foster-Barber and Bishop, 1998). C-src is suggested to have 
several binding sites (PxxP motifs 2, 6, and 8) on b th dynamin I and dynamin 2 
PRD (Solomaha et al., 2005). C-src phosphorylates dynamin 1 and 2 at Tyr597 in the 
PH domain, which results in an induction of it’s self-assembly and an increase in its 
GTPase activity (Ahn et al., 1999; Ahn et al., 2002). This suggests src may activate 
dynamin supported by the fact that in non neuronal tissues, C-src-mediated tyrosine 
phosphorylation of dynamin is required for its function in G protein-coupled clathrin 
mediated endocytosis of β2-adrenergic and M1 muscarinic acetylcholine receptors 
(Ahn et al., 1999; Ahn et al., 2002). In addition, dynamin, C-src, and Cb1 co-ordinate 
in formation of a signalling complex that affects oteoclast migration and adhesion 
suggesting a role of C-src in modulating dynamin fuction (Bruzzaniti et al., 2005). 
Dynamin I is phosphorylated at two sites (Figure 1.8 C) by src in non-neuronal cells. 
The first site is at Y231 in the GTPase domain which might be important in 
regulating its GTPase activity, and the second is at Y597 in the PH domain which 
might play a role in dynamin interaction with lipids (Ahn et al., 1999; Ahn et al., 
2002). When transfected into non-neuronal cells, dynamin I tyrosine phosphorylation 
regulates its self assembly and ligand induced endocytosis as well as β2 adrenergic 
receptor internalization, supporting the suggestion that dynamin tyrosine 
phosphorylation modulates its functions in non neuronal cells (Ahn et al., 1999; Ahn 
et al., 2002). Dynamin II is activated by tyrosine phosphorylation by C-src in 
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endothelial cells and increases its association with caveolin I suggesting that 
dynamin II phosphorylation by C-src is essential for its function in caveolae 
endocytosis (Shajahan et al., 2004). Dynamin I is phos horylated in the brain at three 
sites (Figure 1.8 C) Y80 and Y125 in the GTPase domain and Y354 in the middle 
domain (Ballif et al., 2008). These sites are different from the sites mapped 
previously, which suggests different function of tyrosine phosphorylation in neurons 
from that in the non-neuronal cells.  
 
1.8 Aims and hypothesis 
The src splice variants N1- and N2-src are neuron specific where as C-src is expressed 
ubiquitously. These splice variants are differentially spliced at their SH3 domains, 
therefore the hypothesis is that this splicing allows them to have different binding 
partners and perform different roles in neurons. The aim of this project is to identify new 
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2. Materials and methods 
2.1 Materials 
2.1.1 Chemicals 
Chemicals are listed below according to the manufact rers in alphabetical order. 
ABcam, Cambridge, UK 
Primary antibodies  
ABgene, Epsom, UK 
PCR tubes. 
Alphalaboratories, Hampshire, UK 
SDS-PAGE gel loading tips (1-200µl). 
Amersham Biosciences Ltd, Bucks, UK 
Glutathione beads, G25 spin columns, pGEX-T vectors. 
AMS Biotechnology, Abingdon, UK 
Primary antibodies (VAMP). 
BD Biosciences, Erembodegem, Belgium 
Quick clone rat brain cDNA library, Yeast Extract. 
Biolabs (NEB), Hertfordshire,UK 
Restriction enzymes (BglII, BbvCI). 
Bioline, London, UK 
Hyperladder I markers (200-10000 b). 
Bio-Rad, Hertfordshire, UK 
Transfer membrane (trans-blot) 0.45 µM and 0.2 µM. Precision plus protein markers 
(unstained and Kaleidoscope). 
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Calbiochem, San Diego,CA.USA 
Dioxan-free IPTG (isopropyl-beta-D-thiogalactopyranoside). 
Cogenic, Essex, UK 
Sequencing. 
Corning Incorporated, NY,USA 
Spin-X centrifuge tube filter. 
Fermentas, York, UK 
Restriction enzymes (BamHI, SalI, BstXI). 
Genscript Corporation, Piscataeay, NJ, USA 
Glutathione beads.  
Greiner bio-one, Stonehouse, UK 
Filter tips, Easy loading tips, Falcon tubes (15 ml and 50 ml), Eppendorfs (1.5 ml). 
Invitrogen, Strathclyde, UK 
TOPO PCR4 vector, Top10 bacteria, Agar, SYBR® safe. 
Merck KGaA, Darmstadt, Germany 
Tryptone. 
MWG biotech, London, UK. 
Primers. 
Novogen, Berkshire, UK 
pET-28a (+). 
Pechiney Plastic Packaging, Chicago, USA 
Pechiney Parafilm M. 
Pierce, Rockford, IL, USA 
ECL reagent, Colloidal Coomassie blue G-250 simplyblue safestain. 
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Promega Corporation UK, Southampton, UK 
Taq DNA polymerase, pfu DNA polymerase, DNA ligase, pGEM-T Easy, restriction 
enzymes (BamHI, SalI, BstXI, DpnI). 
Qiagen Ltd, Surrey, UK 
QIA quick extraction kit, Mini prep kit, pQE-30, Ni-NTA beads. 
Roche Diagnostics Ltd, East Sussex, UK 
Expand DNA polymerase, Complete Protease inhibitor c cktail tablets (4-(2-
aminoethyl) benzenesulfonyl fluoride (AEBSF), E-64, bestatin, leupeptin, aprotinin, 
and EDTA (sodium salt)). 
SantaCruz Technologies, inc. Heidelberg, Germany 
Primary antibodies 
Sigma-Aldrich Chemicals Company, Dorset, UK 
N2_Src kinase (human), IPTG, crystal violet, ampicillin, Dialysis tubing, Developer, 
Fixer, Kodak biomax film, leupeptin, PMSF (phenylmethanesulphonylfluoride), 
protease inhibitor cocktail (4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), 
pepstatinA, E-64, bestatin, leupeptin, and aprotinin), thrombin, all other basic 
chemicals. 
Stratagene, La Jolla, CA, USA 
Pfu turbo DNA polymerase, BL21 bacteria. 
Swan Morton, Sheffield, UK 
Surgical blades. 




VWR, Lutterworth, UK 
Latex gloves. 
2.1.2 Growth media and solutions 
All growth solutions were sterilized in the autoclave (20 min at 120 C°). 
LB media 
10 g NaCl, 10 g tryptone and 5 g yeast extract in a tot l volume of 1 litre of dH2O. 
The pH was adjusted to 7 using HCl. 
Super media 1 
Super media 1 was prepared by dissolving 25g yeast extract, 15g of tryptone, and 5g 
NaCl in one litre of dH2O. 
Super Media 2 
Super media 2 was prepared by dissolving 10g yeast extract, 15g tryptone, and 10g 
NaCl in one litre of dH2O. 
Polyacrylamide separating gels 
Polyacrylamide gels were prepared as shown (v/v) in the table below  
 7.5% 10% 12.5% 15% 16% Stacking 
30% bis-Acrylamide 25% 33.4% 41.6% 50% 53.3%% 15 % 
dH2O 50% 40.2% 31.8% 10% 0.667% 60 % 
0.5 M Tris pH 6.8 - - - - - 25% 
1.5 M Tris  25% 25% 25% 25% - - 
2.5 M Tris - - - - 40% - 
Glycerol - - - 15% - - 
10% SDS 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 
APS 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 




The following chart summarizes all the primary antibodies that are used. 
 Antibody Species Dilution Manufacturer 
1 Amphiphysin mouse 1:1000 Abcam 
2 Amphiphysin Goat 1:1000 Santa Cruz Biotechnology Inc 
3 Dynamin goat 1:1000 Santa Cruz Biotechnology Inc 
4 His mouse 1:1000 Sigma 
5 Endophillin goat 1:1000 Santa Cruz Biotechnology Inc 
6 Munc18 mouse 1:3000 BD Biosciences 
7 NSF rabbit 1:1000 Synaptic systems 
8 P-Dynamin 774 sheep 1:1000 Abcam 
9 P-Dynamin 778 sheep 1:1000 Abcam 
10 PY20 mouse 1:1000 Sigma 
11 RGS-His mouse 1:1000 Qiagen 
12 SRC mouse 1:100 Abcam 
13 SNAP25 mouse 1:1000 Sigma 
14 Syntaxin mouse 1:1000 Sigma 
15 Synapsin mouse 1:1000 Synaptic systems 
16 Synaptojanin goat 1:500 Santa Cruz Biotechnology Inc 
17 Synaptojanin rabbit 1:2000 Synaptic systems 
18 Synaptophysin rabbit 1:1000 Synaptic systems 
19 Syndapin mouse 1:2000 BD Biosciences 
20 VAMP rabbit 1:1000 Ams Biotechnology 
21 GST goat 1:2000 Amersham 
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The following chart summarizes the secondary antibodies that were used 
 Antibody Species Dilution Manufacturer 
1 Anti-Goat / Sheep Mouse 1:10000 Sigma 
2 Anti-Mouse (IgM) Goat 1:10000 Sigma 
3 Anti- Rabbit (IgM) Goat 1:10000 Sigma 
 
2.1.4 Vectors 
The following chart summarizes the vectors (Figure 2.1) that were used in this 
project 
 Vector Use Manufacturer 
1 pCR®4Blunt-TOPO Blunt ligation Invitrogen 
2 pGEM-T Easy T-A ligation Promega 
3 pGEX 4T-1 GST tag Amersham Biosciences 
4 pQE-30 His tag QIAGEN 
5 pET-28a(+) His tag Novogen 
 
TOPO vector and pGEM vector were used to amplify DNA, while pGEX was used 
to express GST tagged proteins, pQE30 and pET-28a were used to express the HIS 









Buffers that were used are shown below 
Lysis buffer: 1% triton X-100, 25 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1mM 
EGTA, 1 mM EDTA, 20 µg/ml leupeptin, 1 mM PMSF, complete protease inhibitor 
tablet.  
PBS 10X buffer pH 7.3: 1.37 M NaCl, 40 mM KCl, 200 mM Na2HPO4, adjust pH 
using NaH2PO4.H2O. 
Transfer buffer: 25 mM Tris, 192 mM Glycine, 20 % methanol. 
TBS 10X buffer: 12.15 mM Tris, 1.5 M NaCl. 
Upper electrode buffer pH 8.3: 250 mM Tris, 200 mM Glycine, 1 % SDS. 
Lower electrode buffer pH 8.3 : 54 mM Tris 
Stop solution (3X laemmli buffer): 40 ml of 0.5 M Tris pH 6.8, 28 ml Glycerol, 
228 mg EGTA, 6 g SDS, 70 mg bromophenol blue, 600 µl B-Mercaptoethanol, 19 
ml dH2O. 
Coomassie stain: 0.15 % (w/v) Coomassie Blue G-250, 20 % (v/v) methanol, and 
10% (v/v) acetic acid. 
SDS PAGE destain: 40 % Methanol, 10 % Acetic Acid Glacial, 50 % dH2O  
Ponceaus stain: 0.5 % ponceau S stain in 1 % acetic acid 
TFB1 buffer: 30 mM CH3CO2K, 10 mM CaCl2, 50 mM MnCl2, 100 mM RbCl, 15 
% v/v Glycerol, pH 5.8.  
TFB2 buffer: 10mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15 % v/v Glycerol, pH 
6.5. 
TBE buffer: 89 mM Tris, 89 mM Boric Acid, 2 mM EDTA. 
Binding buffer A: 20 mM HEPES, 100 mM NaCl, 1 mM EDTA, pH7.4 
 71 
Binding buffer B: 20 mM Tris, 100 mM NaCl, 1 mM EDTA, pH7.4 
Glutathione elution buffer: 10 mM reduced glutathione, 50 mM Tris, pH 8 
Bradford reagent:  0.02 g Brilliant blue G, 10 ml Methanol, 2 ml Orthophosphoric acid in 
a total volume of 200 ml (filter sterile before use) 
Breaking buffer: 100 mM HEPES, 500 mM KCl, 2 mM β-mercaptoethanol, pH 7 
Buffer A: 20 mM HEPES, 200 mM KCl, 50 mM imidazole, 2 mM β-mercaptoethanol, 10 
% v/v glycerol, 1 % v/v triton X 100, pH 7. 
STE buffer 
10 mM Tris, pH 8, 150 mM NaCl, 1 mM EDTA.  
His tag elution buffer: 20 mM HEPES, 200 mM KCl, 300 mM imidazole, 2 mM β-
mercaptoethanol, 10 % v/v glycerol, 1 % v/v triton X 100, pH 7 
Kinase reaction buffer: 100 mM Tris, 25 mM MgCl2.6H2O, 2 mM EGTA, 2mM 
DTT, 250 µM Na-VO4, pH 7.2, after pH adjusted add 5 mM MnCl2. 
Kinase storing buffer: 50 mM Tris, 1 mM NaCl, 0.05 mM EDTA, 1mM DDT, 10 
% glycerol, 1 mg/ml BSA,  0.05 % NP-40, pH 7.5. 
ECL solution 1: For 100 ml, 100 mM Tris, 45 mg of luminal dissolved in 1 ml 
DMSO, 440 µl of (37 mg of p-Coumaric acid dissolved in 2.5 ml DMSO) 
ECL solution 2: For 100 ml, 100 mM Tris, 60 µl H2O2 
 
2.1.6 Primers and primer design 
All primers were produced using the same protocol (figure 2.2). Usually primers had 
6 random bases in the beginning, followed by 6 bases for the restriction enzyme, and 
then complementary bases to adhere the primer to the template of the required DNA 




stop codon between the DNA sequence and the restriction site. DNA encoding full 
length srcs do not need this insertion, since they already have a stop codon in their 
DNA sequences. For site directed mutagenesis, primers w re designed identical to 
the template sequence except for mutagenic substitutions.  
All primers that are used for DNA cloning are summarized in the following table 
 Protein expressed Direction Sequence Restriction 
1 Src SH3 domains antisense CAC AGC GTC GAC TCA CTC CTC 
AGC CTG GAT GGA GTC GAA 
Sal I 
2 Src SH3 domains sense CCG CGT GGA TCC GGT GGG GTG 
ACT ACC TTT GTG GCC 
BamHI 
3 Full length src antisense CCG CGT GTC GAC CTA TAG GTT 
CTC CCC GGG CTG GTA CTG CGG 
Sal I 
4 Full length src sense CCG CGT GGA TCC ATG GGC AGC 
AAC AAG AGC AAG CCC AAG GAC 
BamHI 
5 Full length src repair 
primer 
antisense CCC AAA GTC GGC CAC TTT GCA 
CAC CAG GTT CTC GCC AAC 
- 
6 Full length src repair 
primer 
sense GTT GGC GAG AAC CTG GTG TGC 
AAA GTG GCC GAC TTT GGG 
- 
7 SDM to induce BglII 
restriction site 
antisense CCC TTT CTT GAA GGA CAG ATC 
TGT CTC TGT CCG TGA CTC 
BglII 
8 SDM to induce BglII 
restriction site 
sense GAG TCA CGG ACA GAG ACA GAT 
CTG TCC TTC AAG AAA GGG 
BglII 
9 ∆80 src antisense CCG CGT GTC GAC CTA TAG GTT 
CTC CCC GGG CTG GTA CTG CGG 
SalI 
10 ∆80 src sense CCG CGT GGA TCC GGT GGG GTG 
ACT ACC TTT GTG GCC 
BamHI 
11 Full length 
Synaptophysin 
antisense GTC GAC TTA CAT CTG ATT GGA 
GAA GGA GGT G 
SalI 
12 Full length 
Synaptophysin 
sense GGA TCC ATG GAC GTG GTG AAT 
CAG CTG GTG G 
BamHI 
13 SDM for Dynamin 
PRD S822A 
antisense GCC GAA AGG GTC AGG GGC AGC 
CCC CGG CCT GGA 
- 
14 SDM for Dynamin 
PRD S822A 
sense TCC AGG CCG GGG GCT GCC CCT 
GAC CCT TTC GGC  
- 
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15 SDM for Dynamin 
PRD S822E 
antisense GCC GAA AGG GTC AGG CTC AGC 
CCC CGG CCT GGA 
- 
16 SDM for Dynamin 
PRD S822E 
sense TCC AGG CCG GGG GCT GAG CCT 
GAC CCT TTC GGC 
- 
 
2.1.7 Protein expression plasmids 
All proteins that are used in this research were expressed in BL21 bacteria using 
either the pGEX-T, pET28a or pQE30 vector. The following table summarizes all the 
proteins that were expressed and used in this project 
 Name  Amino acids 
encoded 
Species  Vector From 
1 GST C src SH3 domain 81-142 rat pGEX This study 
2 His C src SH3 domain 81-142 rat pQE30 This study 
3 GST N1 src SH3 domain 81-148 rat pGEX This study 
4 His N1 src SH3 domain 81-148 rat pQE30 This study 
5 GST N2 src SH3 domain 81-159 rat pGEX This study 
6 His N2 src SH3 domain 81-159 rat pQE30 This study 
7 His ∆80 C src  81-533 rat pQE30 This study 
8 His ∆80 N1 src  81-539 rat pQE30 This study 
9 His ∆80 N2 src  81-550 rat pQE30 This study 
10 His Full length C src 1-533 rat pQE30 This study 
11 His Full length N1 src 1-539 rat pQE30 This study 
12 His Full length N2 src  1-550 rat pQE30 This study 
13 GST Dynamin PRD xa 751-864 rat pGEX P. Robinson 
14 GST Dynamin PRD xb 751-851 rat pGEX P. Robinson 
 75 
15 GST Dynamin PRD xa 2C 
(P786A) 
751-864 rat pGEX P. Robinson 
16 GST Dynamin PRD xa 3B 
(P793A) 
751-864 rat pGEX P. Robinson 
17 GST Dynamin PRD xa 9A 
(R838E) 
751-864 rat pGEX P. Robinson 
18 GST Dynamin PRD xa PB2 
(RR772/3EE) 
751-864 rat pGEX P. Robinson 
19 GST Dynamin PRD xa AA 
(SS774/8AA) 
751-864 rat pGEX P. Robinson 
20 GST Dynamin PRD xa EE 
(SS774/8EE) 
751-864 rat pGEX P. Robinson 
21 GST Dynamin PRD 3L 751-832 rat pGEX P. De Camilli 
22 GST Dynamin PRD xa 
(S822 E) 
751-864 rat pGEX This study 
23 GST Dynamin PRD xa 
(S822 A) 
751-864 rat pGEX This study 
24 GST Dynamin PRD B6A  
(S822 E) 
751-851 rat pGEX This study 
25 GST Dynamin PRD B6B 
(S822 A) 
751-851 rat pGEX This study 
26 GST  Syntaxin 1-288 rat pGEX A. Morgan 
27 GST Amphiphysin SH3 
domain 
596-683 rat pGEX P. De Camilli 
28 GST Synaptophysin C 
terminus 
224-308 mouse pGEX G. Evans 
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30 GST Synaptophysin C 
terminus AA (PP232/5AA)  
224-308 mouse pGEX G. Evans 
31 His Synaptophysin C 




32 His Full length 
Synaptophysin  
1-308 mouse pQE30 This study 
33 His Munc 18 1-593 rat pQE30 A. Morgan 
34 GST 1-239  pGEX Amersham 
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2.2 Methods  
2.2.1 PCR 
Polymerase Chain reaction (PCR) was used to clone different SRC SH3 domains, 
∆80 src and full length splice variants from a rat brain cDNA library. In addition it 
was used for site directed mutagenesis (SDM), cloning full length synaptophysin 
from various templates, and for colony screening.  
The following chart summarizes the DNA polymerases that were used in this project  
 
 DNA Polymerase Manufacturer Main use 
1 Taq DNA polymerase Fermentas 
Promega 
Colony screen, rat brain library, 
A-tailing 
2 Go-Taq DNA polymerase Promega Colony screen, A-tailing 
3 Pfu DNA polymerase Fermentas 
Stratagene 
Rat brain library, template 
4 Pfu turbo DNA polymerase Stratagene Rat brain library, template, SDM 
5 Pfu Ultra DNA polymerase Stratagene SDM 
6 Expand DNA polymerase Roche Template with A-tailing 
 
All PCRs were performed using a GeneAmp PCR system 9700 PCR machine 
(Applied Biosystems California, USA).  A standared PCR protocol is shown below:  
1- First melting time 95 °C for one minute  
2-  Cycles usually between 28-35 cycles (for site directed mutagenesis 18 cycles 
were used) 
a) Melting: 95°C for 30 seconds 
 78 
b) Annealing: 55 °C for 30 seconds 
c) Extension: 72°C for 1 min/1 kb for taq and 2 min/1 kb for pfu  
3- Extension time: 72 °C for 10 minutes 
4- End at 4°C  
The total volume of PCR reactions was 50 µl for all types of PCR reaction. PCR 
tubes were used, since these tubes have thin walls to conduct heat efficiently. The 
contents of the PCR reaction and their amounts are ummarized in the table below.  
 
 Components Normal PCR Colony screen 
1 dH2O make up volume to 50 µl make up volume to 50 µl 
2 10X buffer 5 µl 5 µl 
3 MgCl2 1M (for Taq only) 3 µl 3 µl 
4 dNTPs 100ng/µl 1 µl 1 µl 
5 anti-sense primer 100µM 0.5 µl 0.5 µl 
6 sense primer 100µM 0.5 µl 0.5 µl 
7 rat brain cDNA library or 
plasmid 1:10 diluted 
1-2 µl One colony from agar plate 
8 DNA polymerase 2.5U/µl 1 µl 1 µl 
 
The PCR tubes were kept on ice while the components were added to minimize the 
enzyme activity and to decrease the possibility of degradation.  
Colony screening was performed by adding all the comp nents apart from the 
templates and then a bacterial colony from a previous bacterial culture on agar plate 
was picked by a pipet tip emerged into the PCR reaction tube and then recultivitated 
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on a new agar plate. Dipping the the colony on pipet ti  inside the PCR reaction tube 
provides enough template for the PCR reaction. 
In certain cases, when PCR was performed with non-taq polymerases such as pfu, an 
A-tailing reaction was performed. A- tailing is a PCR reaction using Taq polymerase 
with only dATP and the PCR product (no primers). A-tailing adds A bases to the end 
of the PCR product which is essential for ligating the PCR product into the pGEM T 
easy vector (pGEM vector has T bases at both ends). The A-tailing reaction was 
performed in a total volume of 10.6 µl (PCR product 7µl, 10X buffer 1µl, MgCl2 




PCR products were separated using either 0.7 % (for PCR products of about 1kb or 
more) or 2 % (for PCR products of smaller than 1k) agarose gels with either 0.05% 
Crystal Violet, ethidium bromide, or SYBR® safe, to visualize DNA. 
Electrophoresis was run at 180V for 20 min. The bands were cut with a scalpel on a 
white light box for Crystal violet or on an ultra violet light box for either the SYBR® 
safe or ethidium bromide stained gels. The product was purified using a QIA quick 
extraction kit (Protocol followed according to the manufacturer’s instructions). The 
purified PCR product was then ligated into a TOPO vector using blunt-end ligation 
(4µl of purified PCR product, 1µl of 1M NaCl solution, 1µl of TOPO vector, and 4 
µl dH2O and incubation for 20 minutes at room temperature). TA ligation was used 
for pGEM T easy vector, where the PCR product has to be A-tailed (using a Taq 
polymerase) and then ligated to pGEM T easy vector (3µl of A-tailed PCR product, 
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5µl of 2X ligase buffer, 1µl of pGEM vector, and 1µl of ligase enzyme, incubated at 
room temperature for 1 hour or at 4 °C overnight). 
 
2.2.3 Agarose gel production 
DNA agarose gel was prepared by mixing 0.7 % (w/v) agarose powder with 1X TBE 
and heating until the agarose was desolved (the percentage of the agarose was varied 
according to the size of the DNA). The agarose was cooled before adding 0.5 µg/ml 
ethidium promide or SYBR® safe, poured into moulds and allowed to set at room 
temperature. 
 
2.2.4 Bacterial transformation 
 Ligated vectors were transformed into bacteria using the following protocol. 
Competent bacteria (100 µl) were thawed on ice (bacteria are stored at -70 °C) then 
either 2 µl of ligation product or 1 µl of mini pre was added, and incubated on ice 
for 30 minutes to allow binding of DNA to the cells. The cells were then heat 
shocked for 45 seconds at 42 °C to allow entry of DNA, and incubated on ice for a 
further 2 minutes. Bacteria were then added to 400 µl of LB media, incubated for 60 
minutes at 37 °C/ 200 rpm, and cultured on agar plate containing the appropriate 
antibiotic (100µg/ml ampicillin, 50µg/ml kanamycin or both). 
 
2.2.5 Restriction enzyme digestion 
Restriction enzymes digests were used for the following reasons  
1- Cutting a ligated vector to insure the insertion of the correct product before 
sequencing. 
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2- Transferring a DNA insert from one vector to another (such as from pGEM to 
pQE30 or from TOPO to pGEX). 
The restriction digestion reaction usually takes one hour at the temperature of the 
enzyme’s optimal activity (usually at 37 °C). If the two enzymes have different 
temperatures for optimal activities, the reaction will be incubated for one hour at the 
lower temperature and then another hour at the higher temperature. When a double 
digest was performed, combatable buffers were used according to the manufacturer’s 
recommendations. 
The table below summarizes the amounts of the components of the three digestion 
reactions. The test digestions were used to confirm that the conditions used are 
optimal on a small proportion of DNA before proceeding to digest the whole sample, 
reducing the loss of DNA samples.   
  
 Single digest test Double digest test Double digest 
dH2O Up to 20 µl Up to 30 µl Up to 60 µl 
10 X buffer 2 µl 3 µl 6 µl 
BSA (1mg/ml) 2 µl 3 µl 6 µl 
Enzyme 1 1 µl 1 µl 2 µl 
Enzyme 2 - 1 µl 2 µl 
DNA 2 µl 3 µl 40 µl 
 
2.2.6 Mini prep 
A mini prep is used to extract plasmid DNA from bacterial overnight cultures. To 
prepare the bacterial culture, 5 ml LB media with the appropriate antibiotic in a 30 
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ml culture tube was seeded with a single colony from transformed bacteria (or a 
scrape from a glycerol stock). The seeded 5 ml LB media was then incubated at 37 
°C, 200 rpm overnight. The overnight culture was spun down and the supernatant 
discarded. The bacteria were then minipreped according to the manufacturer's 
instructions (QIAgen) and the DNA plasmid eluted in a total volume of 50 µl dH2O. 
The plasmid concentration was estimated by running 5 µl of the mini prep on an 
agarose gel with SYBR® safe, and either visualized using ultraviolet light using 
known concentration on the marker, or by estimation of its optical density.  
 
2.2.7 Glycerol stocks 
One ml of the overnight culture was taken and mixed with one ml of 50% v/v 
glycerol and dH2O in a 2 ml tube. The tube was then labelled and stored at -70 C° to 
be used when needed. This mixture will allow the bacteria to freeze slowly which 
will not cause any damage to the bacteria and it stays active for several months. 
When needed, a scrape with the tip of a pipette tip is enough to seed an overnight 
culture. 
 
2.2.8 Preparation of competent cells  
A scrape of competent cells was taken using a sterile pipette tip, and added to 5ml 
sterile LB media (For competent cells already containing a chaperone, a bacterial 
colony grown on agar plate was added to 5 ml LB media with the appropriate 
antibiotic). The LB media was then incubated overnight at 37 °C, 200 rpm. 1 ml 
from this was then added to 100 ml of sterile LB media (for competent cells 
containing a chaperone, the appropriate antibiotic was added to this mix). Filter 
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sterile MgSO4 was added to a final concentration of 20 mM and incubated at 37 °C, 
200 rpm until the optical density was between 0.4 and 0.6 (measured using Biowave 
CO800 cell density meter (WPA, Cambridge UK)) at 600 nm. The bacterial culture 
was then poured in a sterile 250 ml container and centrifuged at 4648 g for 5 minutes 
at 4 °C. The supernatant was discarded and the pellt r suspended in 40 ml of ice 
cold filter sterile TFB1 buffer and transferred to 50 ml falcon tube. The bacteria were 
centrifuged at 4648 g for 5 minutes at 4 °C. The supernatant was discarded and the 
pellet resuspended in 4 ml ice cold filter sterile TFB2 buffer and incubated on ice for 
1 hour. The bacteria were then aliquoted into 100 ml aliquots in 1.5 ml eppendorf 
tubes and snap frozen by immersing them in a dry ice and isopropanol bath. The 
bacterial aliquots was then stored at -70 °C until use. 
 
2.2.9 Preparation of agar plates 
Agar stock was prepared by adding 1.5% agar to LB media in a total volume of 
either 250 ml or 500 ml followed by autoclaving and storage at room temperature 
until use. Agar stock was heated in a microwave for approximately 10 minutes until 
the agar was melted. After cooling, antibiotic was added (ampicillin 1:1000 of 100 
mg/ml or kanamycin 1:1000 of 50 mg/ml or both) in front of a Bunsen burner. The 
agar was then poured into plates (in front of Bunsen burner) until the bottom of the 
plate was covered. The Bunsen flame was moved over the agar surface to sterilize 
the surface and to remove any air bubbles. The plats were left to cool to allow the 
agar to solidify, and then the plates were labelled, s aled with Parafilm and stored at 
4 °C until use.  
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2.3 Protein Biochemistry 
2.3.1 SDS Polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE gels were prepared using a mini-protean III kit from Bio-Rad 
(Hertfordshire, UK). The percentage of gel poured was dependent on the molecular 
weight of the proteins analyzed. When proteins with low molecular weight (10 to 40 
kDa) were analysed, a 16 % SDS-PAGE gel was used while proteins with a mass of 
about 100 kDa were run on a 10 % SDS-PAGE gel allowing good separation. 
Recipes for stacking and separating buffers are displayed in section (2.1.2). Gels 
were run in a Tris/Glycine/SDS running buffer (upper electrode buffer) as defined in 
section (2.1.6) at 160 V for 60 minutes or until the front dye reached the bottom of 
the gel. For detection, protein gels were stained with Coomassie blue stain for 30 
minutes (section 2.1.6). Gels were destained using a MeOH/acetic acid destaining 
solution overnight with shaking (section 2.1.6). 
 
2.3.2 SDS-PAGE Large Gradient gel 
Large gradient gels were used to separate proteins for mass spectrometry analysis. 
The gradient gel was made using 15% and 7.5% polyacrylamide stock solutions 
(section 2.1.2). A gradient former (Bio-Rad) was used to pour the gel. Gels were run 
on a Protein II system (BioRad). The gel apparatus wa  assembled and the upper and 
lower electrodes were filled with their respective buffer. The gel was run overnight at 
100 Volts with cold water circulating in the surrounding water jacket. The gel was 
handled with extreme care minimizing keratin contamination. To ensure this, a face 
mask and nitrile gloves were used, all the equipment and instruments were cleaned 
with methanol and a new blade was used for each band. The gel was washed 3 times 
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with distilled water for 5 minutes to remove SDS and buffer salts from the gel (which 
interfere with dye binding to the proteins), and then stained using Colloidal 
Coomassie blue G-250 simplyblue safestain (Pierce) for one hour. The gel was 
destained with distilled water for one hour, and the bands of interest cutout with a 
new scalpel blade on top of a light box and stored in new eppendorf tubes. The bands 
were then sent for identification using MALDI-tof MS spectrometry in the laboratory 
of Prof. Phillip Robinson (CMRI, Sydney). 
 
2.3.3 Western Blotting 
For Western Blotting, SDS-PAGE was performed as described in section 2.3.1.   
After removal of the gel from the Protein III system, the gel was equilibrated in 
transfer buffer (section 2.1.5). The nitrocellulose m mbrane was soaked in water and 
transfer buffer for 10 minutes each. Transfer was performed in a mini trans blot cell 
(BioRad). The apparatus was assembled according to the manufacturer's manual (the 
gel and the nitrocellulose membrane were surrounded by whatman 3 MM paper and 
fiber pads and then assembled in a holder cassette and then placed in the transfer tank 
with an ice pack to prevent overheating). Transfer was typically performed for 2 
hours at 100 volts on ice or alternatively overnight at 30 Volts. After transfer, 
membrane was stained with Ponceaus stain (section 2.1.5) to assess the transfer 
efficiency, and then destained with water. The membrane was incubated for 30 
minutes in blocking buffer (PBS, 5% low fat milk powder, 0.5% PVP-40) to stop 
non-specific binding. The membrane was then incubated for 1-2 hours in primary 
antibody (diluted as in 2.1.3. in PBS + 0.5% PVP-40). The membrane was then 
washed 3 times with PBS for 5 minutes, followed by incubation for 30-60 minutes in 
 86 
the secondary antibody (diluted as in 2.1.3 in PBS + 0.5% PVP-40). The membrane 
was then washed 3 times with PBS for 10 minutes and then incubated in ECL-
substrate solution for 1-2 minutes. The membrane was pl ced between two filter 
papers to remove excess ECL, covered with cling film, and secured in an X-ray 
cassette. The membrane was exposed to X-Ray film in the dark room for an adequate 
time to allow bands to be visualized. The film was then incubated in developer 
(Sigma) for about 30 seconds, washed with water, incubated in fixer (Sigma) for 
about 30 seconds and washed with water again.  
 
2.3.4 Expression of recombinant proteins  
To express large quantities of recombinant proteins, a culture tube containing 5 ml 
LB media was seeded with a small scrape of bacteria from a glycerol stock. The 
appropriate antibiotic was used, and the culture was incubated at 37 ºC 200 rpm over 
night. The next day the 5 ml culture was seeded into o e litre of super media (super 
media 1 is used usually unless otherwise is mentioned) in a 2.5 L flask containing the 
appropriate antibiotic (100 mg/L for ampicillin, and 50mg/L for kanamycin). The 
one liter culture was incubated at 37 ºC 200 rpm until the optical density was 
between 0.6 and 1.2 (usually after 2.5 – 3 hours). IPTG was then added to a final 
concentration of 1 mM to induce protein synthesis, and the culture was incubated 
again for 3 hours at 37 ºC 200 rpm or overnight at 16 ºC 200 rpm (dependent on 
which conditions gave higher protein expression). The culture was then centrifuged 
at 4648 g, the supernatant was discarded and the pellet was resuspended in a 50 ml 
falcon tube in a total volume of 40 ml of either STE buffer (section 2.1.5) for GST-
tagged proteins or breaking buffer (section 2.1.5) for His-tagged proteins. The tube 
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was then centrifuged at 4648 g, the supernatant was discarded and the dry pellet 
stored at -70 ºC until use. 
 
2.3.5 Preparation of GST and His tagged fusion proteins 
The bacterial pellet was thawed on ice and resuspended in a total volume of 40 ml 
STE buffer for GST-tagged proteins and 40 ml of buffer A for His-tagged proteins. 
After resuspension, PMSF (a serine protease inhibitor final concentration 1mM) and 
either a protease inhibitor cocktail tablet or 50 µl of protease inhibitor cocktail 
solution were added. Lysozyme (final concentration 5.7 µM) and DTT (final 
concentration 5 µM for GST tagged proteins only) were added and the suspension 
was mixed and incubated on ice for 30 minutes. During this incubation, Glutathione 
beads (Amersham or Genscript) for GST-tagged proteins or Ni-NTA agarose beads 
(Qiagen), for His-tagged proteins, were prepared by washing with PBS for 
glutathione beads and buffer A for the Ni-NTA beads, and centrifuging at 64 g for 5 
minutes. The supernatant was removed by aspiration nd washing was repeated 3 
times. Beads were then stored at 4 ºC until use. After 30 minutes, Triton X-100 was 
added to the bacterial suspension to a final concentration of 1 % (Triton X-100 will 
solubilise the membrane lipids). The suspension was sonicated on ice 6 times at 10 
MHz for 30 seconds with 30 seconds interval between the sonications to prevent 
overheating (sonication will break down the bacteria). The suspension (bacterial 
lysate) was centrifuged at 17400 g for 30 minutes a 4 ºC. The supernatant was then 
added to the prepared beads and incubated at 4 ºC for 1-2 hours with rotation. The 
beads were pelleted by centrifuging at 64 g for 5 minutes, and the supernatant was 
removed by aspiration. Beads were washed 5 times in 30 ml PBS then once with 
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PBS + 1.2 M NaCl, and finally the PBS wash was repeated 2 more times (for Ni-
NTA beads Buffer A was used instead of PBS). The beads were then resuspended in 
PBS (buffer A for Ni beads) to make a 50 % slurry. The 50 % slurry was then 
resuspended in 7 ml PBS (buffer A for Ni beads) and 7 ml of glycerol was added and 
mixed well. The suspension was then stored at -20 ºC until use. 
 
2.3.6 Eluting GST-tagged and His-tagged proteins from beads 
For binding assays, GST-tagged and His-tagged recombinant proteins had to be 
separated from beads. To perform this, 1 ml of the 50% bead slurry was put in a 1.5 
ml eppendorf tube, centrifuged at 28 g at 4 ºC for 5 minutes, after which the 
supernatant was aspirated. The beads were resuspended in 500 µl glutathione elution 
buffer (section 2.1.5) for GST-tagged proteins and His-tagged elution buffer for His-
tagged proteins. After 2 minutes the beads were centrifuged again and the 
supernatant removed and collected. This procedure was repeated 4 more times, and 
each time the supernatant was stored separately. All the supernatants were tested for 
eluted protein by mixing 10 µl of each elution with 5 µl 3X sample buffer and then 
10 µl of this was run on SDS-PAGE gel and then coomassie stained and visualized 
for their protein contents. 
Elution was also performed in Spin-X centrifuge tube filter instead of eppendorf 
tubes, where the 1 ml of 50% beads slurry was applied into a Spin-X centrifuge tube 
filter and centrifuged at 870 g at 4 ºC for 5 minutes. The flow through was discarded 
and the beads were resuspended in 500 ml glutathione elution buffer for GST-tagged 
proteins and His-tagged elution buffer for His-tagged proteins, kept for 2 minutes 
and then centrifuged again at 870 g at 4 ºC for 5 minutes. The flow through samples 
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were collected and the same procedure was repeated again 4 more times and each 
flow through was stored separately. All the flow through were tested for eluted 
protein on SDS PAGE gels. 
 
2.4 Protein Assay 
Protein concentrations were estimated using a Bradfo d assay (Bradford, 1976) 
where 0 – 10 µl of 1 mg/ml BSA (bovine serum albumin) were added into 1 ml of 
Bradford reagent and 1, 2 and 5 µl of the test protein were also added to into 1 ml of 
Bradford reagent, mixed and left for 5 min to set. The samples were read on 
spectrophotometer at 595 nm. The BSA samples were us d to generate a 
concentration curve and draw a line of best fit, which was used to determine the 
concentration of the test protein. The other way to estimate protein concentration is 
by running the proteins against different concentrations of BSA on SDS-PAGE. If 
the protein samples are impure due to breakdown or other proteins such as chaperons 
are co-purified with the protein samples, a Bradfor assay will give missleading 
results since it will calculate the total protein con entration including the 
contamination. In this case running the proteins against different concentrations of 
BSA will produce more acurate results. 
 
2.4.1 Pull down assay using synaptosomal lysate 
Pull-down assays involve coupling a protein of interest to beads to serve as an 
affinity resin. Proteins that bind to this protein can then be isolated from the lysate. 
Synaptosome lysates (prepared from rat forebrain by colleagues) were used for pull-
down assays. Typically, 50 µg of protein on beads wa used in a pull down assay. 
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Beads were applied to pre-washed G25 spin columns, spun at 870 g for 1 minute, and 
washed with lysis buffer (see 2.1.5) twice. 175 µl of rat brain synaptosomal lysate 
were applied to the G25 spin columns with beads and then incubated with rotation 
for 60 minutes at 4 °C.  Columns were then placed in 2 ml Eppendorf tubes and spun 
at 870 g for 1 minute with the flow through being discarded. Beads were then 
washed with lysis buffer 3 times, lysis buffer with 500 mM NaCl once, lysis buffer 
twice, and finally Tris buffer (20 mM Tris pH 7.4) to remove any non-specific 
binding. After washes, samples were eluted from the beads using a 50 µl Laemmli 
stop solution (see 2.1.5) followed by boiling for 5 minutes and finally centrifugation 
for 10 minutes at 18890 g. Samples were then analysed by SDS PAGE. 
 
2.4.2 Pull down Assay using bacterial lysate 
This assay is very similar to the pull down assay for synaptosomal lysate; it tests the 
binding affinity of recombinant proteins in bacterial lysate. His-tagged proteins were 
expressed in BL21 bacteria, and the bacteria were lys d as described previously 
(section 2.3.4 and 2.3.5) using binding buffer B (section 2.1.5). Equal amounts of 
GST-tagged proteins on beads in glycerol were added to 15 ml falcon tubes 
containing 10 ml binding buffer B. The tubes were spun at 64 g for 5 minutes and the 
supernatant carefully aspirated. The beads were washed 2 more times and then the 
bacterial lysate containing His-tagged proteins wasdivided equally between the 15 
ml falcon tubes containing the GST-tagged protein bads. Tubes were then incubated 
for 1-2 hours at 4 ºC with rotation. After the incubation, the tubes were spun at 64 g 
for 5 minutes and the supernatant aspirated and discar ed. The beads with the 
remaining bacterial lysate were transferred to pre-washed G25 spin columns. The 
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columns were spun at 870 g in a chilled centrifuge for 1 minute and the flow through 
discarded. The beads in the columns were washed 3 times with binding buffer B, 
once with binding buffer B + 500 mM NaCl, and 2 times with binding buffer B. 
After washes, 40 µl of Laemmli stop solution was added to the column, incubated for 
5 minutes, and then spun at 18890 g for 10 minutes collecting the flow through.  
 
2.4.3 Binding assay 
This assay was used to compare the affinity of GST-tagged recombinant proteins 
with His-tagged recombinant proteins. The main difference between this assay and 
the pull down from bacterial lysate is that the exact amounts of both the GST-tagged 
and His-tagged proteins are known. GST-tagged proteins 20 µl of 50 % slurry of 
glutathione beads, and His tagged protein were mixed in 1.5 ml eppendorf tube and 
binding buffer A was added to make a total volume of 200 µl (the final 
concentrations of the GST-tagged and the His-tagged proteins were 200 nM). The 
tubes were incubated at 4 ºC with rotation for 60 min. The tubes were then spun at 
870 g for 30 seconds and their contents transferred to pre-washed G25 spin columns 
and centrifuged at 870 g for 30 seconds. The columns were then washed 3 times with 
binding buffer A, once with binding buffer A + 500 mM NaCl and twice with 
binding buffer A. GST tagged proteins (and associated His tagged proteins) were 
eluted from the beads using 40 µl of Laemmli buffer, incubated for 5 minutes and 
centrifuged for 10 minutes at 18890 g. The flow through was collected in 1.5 ml 




2.4.4 Kinase assay 
Kinase assay was performed using commercial N2-src (Sigma) to define the extent 
of tyrosine phosphorylation of proteins. The kinase reaction was performed in either 
the presence or absence of substrate and also in the presence or absence of ATP to 
have two independent negative controls. The ATP solution (final concentration of 
250 µM) was added last to start the reaction. The components were warmed to 30 ºC 
in a water bath before adding the ATP, and the tubes w re incubated in the water 
bath at 30 ºC for one hour. For time course of 0, 10, 30 and 60 min were used. 
Reactions were stoped by addition of laemmli stop slution. Protein tyrosine 
phosphorylation was detected using western blot with phosphotyrosine antibody.  
The chart below summarises the amounts added from each component of the reaction 
in different conditions 
 
 No substrate reaction No ATP reaction Normal reaction 
Kinase reaction buffer 29 µl 29 µl 19 µl 
N2-src kinase  1 µl 1 µl 1 µl 
ATP solution 10 µl - 10 µl 
Substrate - 10 µl 10 µl 
total 40 µl 40 µl 40 µl 
 
When the src splice variants that were produced in our lap or from G. Evans were 
used, 10 µl of src kinases were used in each reaction and the kinase reaction buffer was 
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3. Producing different constructs of src splice variants 
3.1 Introduction 
Producing the tools needed for research experiments is a necessary part of any 
research, and in this chapter making src proteins for identification of new protein 
interactions and substrates will be discussed.  Recombinant protein over-expression 
is widely used by scientists to study the structure and function of proteins, to produce 
antibodies or to prepare proteins for other uses. Protein over-expression is usually 
performed either in eukaryotic cells such as insect c lls (Geisse et al., 1996; Karlsson 
et al., 2000; Wang et al., 2008), or prokaryotic cells such as E. coli bacteria 
(Schumann and Ferreira, 2004; Hou et al., 2006; Liu et al., 2007). Protein over-
expression in E. coli is usually preferred for it is easy to perform and regulate, and 
also because the resulting proteins are easily purified and harvested in good 
quantities. In this project, all the recombinant proteins were expressed in an E. coli 
bacterial system and purified as described in the methods section. 
In this study constructs for src splice variant SH3 domains, full length, and truncated 
proteins needed to be made. The flow chart in figure 3.1 describes the strategy that 
was adopted for producing C-, N1-, and N2-src splice variant SH3 domains or full 
length proteins.  
 
3.2 SH3 domains of src splice variants 
All three splice variants of src (C-src, N1-src, and N2-src) share the same structure 
and the same amino acid composition with the exception of  extra amino acids 
inserted in the SH3 domain of both of the neuronal forms of src (N1-src and  
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N2-src). The C-src SH3 domain has 67 amino acids (81-147), N1-src SH3 domain 
has 6 extra amino acids inserted after residue T116 of the full length protein (36 of 
SH3 domain), and N2-src SH3 domain has a further 11 amino acids inserted after 
residue V122 of full length N1-src as shown in figure 3.2. Since the differences 
between the three splice variants of src are found only in the SH3 domains, and to 
reduce the binding interference of the other src domains, the SH3 domains were first 
selected for expression studies to investigate their binding partners.  
  
3.2.1 Cloning splice variant SH3 domains DNA 
To amplify C-, N1-, N2-src splice variant SH3 domains, primers were designed. 
Since the splice variants vary in the central region, ne set of primers that 
complemented the ends of the C-src SH3 domain is adequate to perform PCR for all 
the SH3 domains. PCR was performed using Pfu polymerase enzyme and a rat brain 
cDNA library. All three splice variants were amplified in the same PCR reaction 
(Figure 3.3 A). The PCR product bands showed different intensities, with N1-src 
SH3 domain having the highest intensity and C-src SH3 domain the lowest intensity 
(Figure 3.3 A). In multiple PCR reactions, there was  fourth band repeatedly 
observed of approximate 300 bases (which we called N3?), which had the same 
relative abundance as the C-src SH3 band. 
 
3.2.2 Ligation of SH3 domain DNA into TOPO vector 
Ligation of PCR products into plasmids is an essential procedure to transform the 




one of the vectors that are used for this purpose. All three splice variants were ligated 
into TOPO vector (Figure 2.1) and then transformed into top 10 bacteria. Colony 
screening was then performed to determine which vector had which SH3 domain. 
More than 50% of the screened colonies contained th N1-src SH3 domain while less 
colonies contained the C-src or N2-src SH3 domains. Some colonies showed 
multiple bands. Colonies containing only a single band of one of the three src splice 
variant SH3 domains were re-cultured (marked with arrows in figure 3.3 B). This 
method allowed us to isolate and purify DNA encoding the three src SH3 domains. 
None of the colonies had the fourth band which we named N3. In an attempt to 
isolate it, the fourth band was gel purified and ligated to TOPO vector, but colony 
screens only showed multiple bands in all selected olonies similar to those in figure 
3.3.B. The isolated src SH3 domains were sequenced and were identical to the SH3 
domains of rat src.  
 
3.2.3 Insertion of SH3 domain DNA into pGEX vectors 
The pGEX-4T-1 vector (see 2.1.4 and also Figure 2.1) is used for GST-tagging of 
proteins to facilitate protein expression and purification. The vector has an inducible 
promoter for protein expression and cloning sites for different restriction enzymes, 
and also ampicillin antibiotic. The three src SH3 domains in TOPO vector were 
miniprepped (see 2.2.5) from TOP 10 bacteria, and double digested using the 
restriction enzymes BamH1 and Sal1, the restriction enzyme recognition sequence 
were introduced into the SH3 domain PCR product sequence when the primers were 
designed. The pGEX vector was also double digested using the same restriction 
enzymes and all the four restriction products were gel purified (Figure 3.3 C). The 
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SH3 domains were ligated into pGEX vector and transformed into TOP 10 bacteria. 
A colony was selected from each splice variant and used to miniprep the pGEX 
vector with the SH3 domain insert. The miniprepped DNA was tested for 
incorporation by double digesting (see 2.2.4) with BamH1 and Sal1 restriction 
enzymes (Figure 3.4 A).  
 
3.2.4 Protein expression for GST-tagged SH3 domains 
GST tagging is used to purify expressed proteins from bacteria, since GST can be 
bound to glutathione beads and then purified from the bacterial lysate via 
centrifugation of the beads. The pGEX vectors containing SH3 domains were 
transformed into BL21 bacteria for protein expression. Expression of GST-tagged src 
splice variant SH3 domains was then induced by addition of IPTG followed by their 
purification on glutathione beads. GST-tagged C-src and N1-src SH3 domains had a 
similar expression whereas the N2-src SH3 domain had a much lower expression 
compared to them (figure 3.4 B) under the following conditions (500 ml of super 
media 1 (see 2.1.2) with 3 hours incubation at 37 °C.  
 
3.2.5 Insertion of src SH3 domains into the pQE30 vector 
The src SH3 domains were also tagged with His to allow binding assays or pull down 
assays to be performed in conjunction with GST-tagged proteins. The pQE30 vector 
(see 2.1.4 and also figure 2.1) adds 6 histidine amino acid residues to either the N 
terminus or C terminus of a protein, which allows purification of the protein on Ni+2 




only a very small addition in the size of the SH3 domains compared to GST (about 
220 amino acids). pGEX plasmids containing SH3 domain inserts were double 
digested using BamH1 and Sal1 restriction enzymes to release the src splice variant 
SH3 domain DNA (Figure 3.5 A). The SH3 inserts were then ligated to either pGEM 
or pQE30 vectors and transformed into XL 10 gold bacteria. Both pGEM and pQE30 
vectors were miniprepped and tested for the presenc of the insert by double digest 
using BamH1 and Sal1 restriction enzymes (figure 3.5 B). The pQE30 vectors 
containing the src splice variant SH3 inserts were th n transformed into BL21 
bacteria for protein expression. His-tagged SH3 domains were then expressed using 
super media 2 (see 2.1.2) with a 16 °C overnight induction with IPTG and purified 
on Ni+2 beads (figure 3.5 C). N2- src SH3 domain was expressed using double the 
volume and purified using half the amount of beads. Good expression was observed 
for all three His-tagged splice variants. 
 
3.3 Full length src splice variants 
Investigating protein interactions of isolated domains can produce misleading results 
since other regions of the protein may either enhance or inhibit binding. For this 








3.3.1 Cloning full length src splice variant DNA 
To amplify full length C-, N1-, N2-src splice variants, the same set of primers were 
designed for all three splice variants. Cloning theree src splice variants was 
attempted from rat brain cDNA library. PCR was performed using either Pfu or Taq  
polymerase enzymes, however, no PCR products were detected. The PCR reaction 
was performed again with alterations (figure 3.6 A). Doubling the amount of rat 
brain cDNA library (the substrate) and doubling both the amount of rat brain cDNA 
library and taq polymerase (the enzyme) in the PCR reaction produced a detectable 
PCR product. Doubling the amount of rat cDNA library, the Taq enzyme, and 
reaction buffer did not produce any detectable amount. However, since the src PCR 
reactions produced a small amount of PCR product, the PCR products from these 
PCR reactions (PCR1 and PCR2 from figure 3.6 A) were used as a template for 
another round of PCR using taq polymerase enzyme. This approach gave a good 
amount of PCR product (figure 3.6 B). A similar approach using PCR products from 
PCR1 and PCR2 (figure 3.6 A) as templates but using Pfu turbo polymerase enzyme, 
or PCR2 as a template using expand polymerase enzyme were also performed (figure 
3.6 C). In this case only when PCR2 was used as a template with Pfu turbo 
polymerase was a PCR product observed. It was impossible to determine whether all 
3 src splice variants had been amplified due to the small difference in base number 
compared to the whole DNA product. 
 
3.3.2 Ligation of FL src DNA into the pGEM vector 
Once the PCR product (PCR2b in figure 3.6 C) had been generated, it was TA 





Gold bacteria (see 2.2.3). Colony screening was performed using SH3 domain 
primers to determine which splice variants were in which colony. Colony screening 
showed that only 7 out of 12 colonies had a possible src insert (figure 3.7 A). The 
colonies that were expected to have the C-src insert were 10 and 12, the colonies that 
were expected to have the N1-src insert were 1, 5, and 8, and the colonies that were 
expected to have the N2-src insert were 4 and 7. All 7 colonies were miniprepped, 
and the miniprep was used as a template for a PCR reaction using full length src 
primers. PCR products were only seen from colonies 1 and 8 (with N1-src insert) and 
from colony 12 (with C-src insert) (Figure 3.7 B). When the DNA from these 
colonies were compared to the src splice variant sequences several mutations were 
found in full length C-src and two point mutations were found in full length N1-src at 
base-pair 1224 (C to T) and 1228 (T to C).  
 
3.3.3 Producing the full length C-src and N2-src 
The presence of multiple mutations in full length C- and N1-src presented a problem, 
however this could be solved using SH3 domain DNA. A strategy was formed to 
ligate the SH3 domains of C- and N2-src into the full length N1-src pGEM vector. 
This would produce full length versions of all 3 src plice variants. The strategy that 
was formulated to achieve this is described in figure 3.8. First, two restriction 
enzymes were needed that could cut src SH3 DNA at poin s flanking the N1-src and 
N2-src insertions. These enzymes also could not cut the full length src or pGEM 
vector. After database searching, several enzymes were found that could cut the SH3 
domain after the N1-src and N2-src insertions, but no enzymes were found that could 




create a restriction site in the area before N1- and N2-src. This strategy was adopted 
and the restriction enzyme BglII selected. The sequence from 286-291 (TGACCT) 
was selected for mutagenesis (AGATCT) (figure 3.8 B). The other enzyme that was 
selected to cut after the N1-src and N2-src insertion was BbvCI which cuts the 
sequence (CCTCAGC (432-439)). The cut sequence has about 150 base pairs, which 
makes it large enough to be separated on a 2 % agarose gel and purified, but also 
small enough to show differences between the three splice variants (figure 3.8 C). 
SDM was performed for both C-src and N2-src SH3 domains in pGEX, and also for 
full length N1-src in pGEM. All SDM PCR products were transformed into XL 10 
Gold bacteria (see 2.2.3) and miniprepped. The vectors were then digested using both 
BglII and BbvCI restriction enzymes (see 2.2.4), and the inserts separated on agarose 
gels (figure 3.9 A). Both of the inserts from C-src and N2-src SH3 domains were 
purified and ligated to the purified FL N1-src digest d pGEM vector, and then 
transformed into XL 10 Gold bacteria. A colony screen was performed using SH3 
domain primers for 10 colonies from each ligation as shown in figure 3.9 B. Purified 
C-src, N1-src, and N2-src SH3 domains were used as controls. Most of the colonies 
contained N1-src which may have been due to the full length N1-src plasmid having 
only partially digested and resealing without taking the C-src or N2 src inserts. Two 
colonies from C-src and two colonies from N2-src were selected and were 
miniprepped (marked with arrows in figure 3.9 B). 
 
3.3.4 Ligation of full length src DNA to pQE30 vector 
After generation of the three full length src splice variants DNA, the pGEM vectors 




when the primers were designed (see 2.1.6)), along with the pQE30 vector (Figure 
3.10 A). Two colonies from C-src and N2-src and onecolony from the original N1-
src vector were selected for overnight culture, miniprep, and then double digestion 
using BamHI and SalI restriction enzymes. All three full length src splice variant 
inserts were then ligated to pQE30 vector and transformed into XL 10 Gold bacteria. 
Two colonies from each splice variant were minipreped and tested for the insert 
using double digestion with BamH1 and Sal1 enzymes (Figure 3.10 B). The full 
length src splice variants in pQE30 were sequenced to insure that there were no extra 
mutations inserted during the SDM. 
 
3.3.5 Expression of His-tagged full length src splice variants 
The three full length splice variants in pQE30 vectors were then transformed into 
BL21 bacteria for protein expression. Several attempts were made before finding the 
best expression conditions including using super media 1 and 2, varying expression 
temperatures and the time of induction. Finally a Gro-ESL chaperone in a separate 
vector (pREP4-Gro-ES-Gro-EL) was co-expressed with the src splice variants in the 
same bacteria in order to help protein folding and e hance expression (Lee et al., 
2002b; Yanase et al., 2002). All three splice variants of src were co-expressed with 
Gro-ESL using two litres of super media 2 (see 2.1.2) at 16 °C overnight (see 2.3.4). 
The proteins were then purified on Ni+2 beads, and separated on SDS PAGE gels 
(figure 3.11 A). The Gro-ESL chaperone was also purified with src splice variants on 
Ni+2 beads, resulting in the presence of several bands  thus it was not possible to 
confirm the presence of the src splice variants by Coomassie staining alone. To 





western blot analysis (Figure 3.11 B). A His-tag antibody blot showed that all the src 
splice variants had similar expression levels. However a src antibody blot displayed a 
very faint N2-src band sized compared to C-src and N1-src splice variants. This 
could be due to N2-src SH3 domain contains insertion that might reduce the antibody 
recognition since the antibody was produced against C-src SH3 domain.  
 
3.4 The ∆80 src splice variants 
3.4.1 Cloning ∆80 src splice variant DNA 
Multiple studies have observed increased expression of src levels if the N-terminal 
80 amino acids are removed. Therefore src splice variants were produced lacking this 
region (∆80). To amplify ∆80 src from full length src splice variant templates, the 
forward primer of the SH3 domain and reverse primer of full length src were used.  
All three splice variants were amplified using pfu turbo polymerase enzyme (Figure 
3.12 B). The PCR products were separated from template DNA on agarose gels and 
gel purified. The purified ∆80 src splice variant DNA were ligated into pGEM and 
transformed into XL 10 Gold bacteria. Colony screening of five colonies for each 
splice variant was performed (Figure 3.12 C). Two colonies (marked with arrows) 
were picked from each splice variant to be minipreped; each miniprep was tested by 
double digestion using BamH1 and Sal1 restriction enzymes and compared to the 
uncut vector (Figure 3.12 D). 
 
3.4.2 Ligation of ∆80 src splice variant DNA into pQE30 and protein expression 
∆80 src splice variants in pGEM were double digested using BamH1 and Sal1 





vector and transformed into XL 10 Gold bacteria. Five colonies from each splice 
variant were screened and all showed positive results (figure 3.13 B). One colony 
from each splice variant was miniprepped and tested for inserts using BamH1 and 
Sal1 restriction enzymes (Figure 3.13 C). The ∆80 src splice variants in pQE30 were 
then transformed into BL21 bacteria for protein expr ssion. A Gro-ESL chaperone 
was also transformed into the same bacteria. All three splice variants of src were co-
expressed with Gro-ESL using two litres of super media 2 (see 2.1.2) at 16 °C 
overnight induction (see 2.3.4). The proteins were then purified on Ni+2 beads, and 
separated on an SDS PAGE gel (Figure 3.14 A). The Gro-ESL chaperone was 
purified with src splice variants on Ni+2 beads, resulting in the presence of several 
bands of approximately 50 kDa. To confirm that src proteins were expressed, a series 
of western blots were performed using both src and His antibodies (figure 3.14 B). 
All the three splice variants were expressed, and there seem to be some break down 
products. 
 
3.5 Producing the active kinases of ∆80 src splice variant  
The full length and the ∆80 src splice variants that were produced were tested and 
shown to be inactive kinases due to a mutation in the catalytic domain (using Taq to 
perform the first PCR generated two point mutations and one of them is not 
conservative where Lysine was mutated to Glutamic ac d (amino acid 410) for full 
length N1 src at BP 1228 (see 3.3.2)). Therefore, a str tegy that was adopted to 
produce active forms of ∆80 src splice variants by correcting their mutations (Figure 
3.15). The first step was to correct the mutation in full length N1-src (Figure 3.15 A 
and B). The second step was to replace the mutated region in ∆80 src with fixed full 
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length N1-src. The enzymes selected were BstX1 (which will cut the DNA at (1185-
1189)) and Sal1 which will cut at the end of the coding reagion (this restriction site 
was induced with the primers) (Figure 3.15 C and D). 
 
3.5.1 Production of active ∆80 src splice variant DNA 
The mutations in full length N1-src in pGEM were corrected. All ∆80 src splice 
variants in pQE30 and full length N1-src in pGEM were double digested using 
BstX1 and Sal1 restriction enzymes (figure 3.16 A). The insert from full length N1-
src and the cut vectors from ∆80 src splice variants were separated on an agarose gel 
and purified (figure 3.16 A). Some of the ∆80 src splice variant vectors were only 
partially digested with one enzyme, resulting in two bands on the agarose gel; 
therefore the two bands were separated using a low percentage agarose gel and 
longer separation time. The lower band represents the double digested fragment 
(Figure 3.16 B). The ∆80 src splice variant vectors and the insert from the corrected 
full length N1-src were tested on agarose gels (Figure 3.16 C) and ligated to produce 
the active ∆80 src splice variants in pQE30. 
 
3.5.2 Production of active ∆80 src splice variant protein 
The corrected ∆80 src splice variants in pQE30 were then transformed into BL21 
bacteria for protein expression. A Gro-ESL chaperon i  a separate vector was 
inserted into the same bacteria as the ∆80 src splice variants. All three splice variants 
of src were co-expressed with Gro-ESL using two litres of super media 2 (see 2.1.2) 
at 16 °C overnight induction (see 2.3.4). The proteins were then purified on Ni+2 






proteins were expressed, proteins were subjected to western blot with a His antibody 
(Figure 3.17 B). All three of the corrected ∆80 src splice variants were expressed 
under these conditions.  
3.5.3 Testing the activity of ∆80 src splice variant protein 
To test the activity of the ∆80 src, a kinase assay was performed (see 2.4.4). The 
amount of kinase was estimated according to a His blot (figure 3.17 B), and GST-
synaptophysin C-terminus was used as a substrate (Synaptophysin is tyrosine 
phosphorylated by C-src (Barnekow et al., 1990)). The reaction was performed at 37 
°C for 60 minutes. Kinase assays were tested by western blotting for His to 
determine the amount of kinase used, PY20 phospho-tyrosine antibody was used to 
determine the extent of tyrosine phosphorylated synaptophysin, and synaptophysin 
antibody was used to determine the amount of substrate (figure 3.17 C). This 
experiment confirmed that all three ∆80 src splice variant proteins were active and 




In this chapter, all the methods and strategies used for cloning and expressing the src 
splice variants were summarized. Firstly all the three src splice variant SH3 domains 
were cloned and amplified from a rat brain cDNA library. The amplified SH3 
domains were ligated to different vectors for different reasons. All three src splice 
variant SH3 domains were expressed either as GST-tagged or as His-tagged 
recombinant proteins in E. coli expression systems. Full length src splice variants 
were also cloned from a rat brain cDNA library. Site directed mutagenesis was used 
to produce both C-src and N2-src splice variants and ll the full length src splice 
variants were produced as His-tagged proteins with the help of Gro-ESL chaperone 
co-expression. Truncated versions of src splice variants (∆80 src) were produced to 
enhance their expression by removing the first 80 amino acids. These truncated 
forms were co-expressed with a Gro-ESL chaperone as His-tagged proteins. 
Mutations in the kinase domain resulted in producing i active forms of src splice 
variants but improved the expression at the same ti. The active forms of truncated 
src were produced using site directed mutagenesis and restriction enzymes. These 
corrected truncated forms were co-expressed with a Gro-ESL chaperone as His-
tagged recombinant proteins and proven to be active kinases. 
 
3.6.1 SH3 domains 
The SH3 domains of all three src splice variants were cloned successfully from rat 
brain cDNA library. The cloning of src SH3 domain DNA from the rat brain cDNA 
library resulted in four PCR products. A similar result was observed by Pyper and 
Bolen when they cloned src SH3 domains from adult hman brain DNA (Pyper and 
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Bolen, 1990). Several attempts were made to clone the fourth band (N3) including 
gel purification and ligation, but colony screening always showed multiple bands 
even when single colonies were picked. This is abnormal since bacteria should only 
accept one plasmid. After multiple attempts, no furthe  investigation was performed 
leaving the identity of the N3 band still undetermined. 
When the GST-tagged SH3 domains were expressed, C-src and N1-src SH3 domains 
expressed well but there was poor expression of N2-src SH3 domain. The expression 
conditions were altered in many ways including using all three types of media 
described in 2.1.2, using different expression tempratures including (37°C, 19°C, 
and 16°C), using different expression times including (3 hrs, 5 hrs, and 14 hrs 
(overnight)), and using larger volumes of media. The optimal conditions (larger 
volumes at 16°C overnight) were adopted and adequat amounts of protein were 
produced as shown in the next chapter. A larger bacteri l pellet was observed when 
expression of the N2-src SH3 domain was induced compared against the other splice 
variants. This suggested that the N2-src SH3 domain y be toxic to the bacteria.  
All His-tagged SH3 domains expressed well, several higher molecular weight bands 
were also purified on the Ni+2 beads with one protein band running at about 60 KDa 
(figure 3.5 C). These bands may be bacterial chaperones which are often seen during 
recombinant protein expression in bacteria. Attempts to purify the His-tagged src 
SH3 domains from the contaminating proteins failed, ven using a 30 KDa cut off 
membrane. One noticeable feature was that His-tagging enhanced N2-src SH3 
domain expression compared to GST-tagging (even thoug  twice the bacterial 
volume was used compared to C- and N1-src splice variant SH3 domains). 
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3.6.2 Full length src 
Full length srcs were much more difficult to clone from the rat brain cDNA library. 
Several attempts were made using different polymerases and different annealing 
temperatures, but the result was always negative. A PCR product was obtained when 
taq polymerase enzyme was used in addition to more rat brain cDNA library (figure 
3.6 A). The downside was that taq polymerase enzyme does not have proof reading, 
which makes the possibility of cloning errors higher. Since the amount of PCR 
product was low, another PCR reaction was performed using the previous PCR 
product as a template (figure 3.6 C). The absence of a full length N2-src clone was a 
surprise, since the previous amplification of SH3 domains showed that N2-was 
abundant (figure 3.3 A). All PCR products had errors in their sequences which was 
no surprise since taq DNA polymerase was used for the initial cloning step. Since it 
was so difficult to obtain PCR products from rat brain cDNA library, an alternative 
strategy was employed to generate full length C- and N2-src from N1-src. Full length 
N1-src had only two mutations at bases 1224 (C to T) and 1228 (T to C), The first 
mutation was a conservative mutation for valine (amino acid 408) but the second one 
was not conservative and it mutated Lysine to Glutamic acid (amino acid 410).  
Since PCR from rat cDNA library was performed several times before and it was not 
easy to have successful cloning of src splice variants, the alternative method was to 
replace the area that is different from N1-src with its equivalents from C-src and N2-
src. The only difference among the three splice variants is in the SH3 domains which 
were cloned previously, and swapping the equivalent areas only required finding the 
suitable digestion enzymes that are able to singularly cut SH3 domains in the right 
place (one enzyme before the insertion of N1-src and N2-src and another enzyme 
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after). These enzymes should not be able to cut the pGEX vector (which has the SH3 
domains inserted) or pQE30 vector (which has the full length N1-src inserted). This 
mutant swaped the DNA sequences from both C- and N2-src into the full length full 
length N1-src. SDM was required to introduce a conservative mutation that created a 
restriction site for the BglII enzyme. After double digestion with BglII and BbvCI 
which flanked the SH3 domain inserts, the ligation with full length N1-src was 
successful resulting in the three full length src splice variants in pQE30 vector. 
The full length src splice variants could not be expr ssed in bacteria until the Gro-
ESL chaperone was also inserted into the same bacteria. The ability of full length src 
to be expressed at all may result from the point mutation (K410 to E) in the original 
N1-src in the kinase domain. Such a dramatic substit tion (basic to acidic) may have 
severe consequence for kinase activity and induced th se kinase were found to have 
no activity. The inactivity of src and thus relationship to their expression has been 
examined previously.  Kemble and colleagues co-expressed src (83-533) with Gro-
ES-EL chaperone and compared two mutants with the wild type. They found that the 
more the src activity is impaired the better the expr ssion. While the wild type had a 
very poor expression and extensive degradation, src car ying a mutation that inhibits 
its kinase activity (K295M) is expressed nicely (Kemble et al., 2006). On the other 
hand a different src mutant (N391D) expressed to almost the same level as the kinase 
dead mutant still had a very low kinase activity (about 1:1000 compared to the wild 
type). In conclusion they suggested that the activity of the kinase is inversely related 




3.6.3 ∆80 src  
A truncated form of src was also produced since sevral groups had shown this 
enhances expression. However deletion of amino acids after residue 89 severely 
affects src kinase activity (Nemeth et al., 1989). Saya and colleagues ligated 
truncated C-src, where amino acids 15-225 were deleted, to Staphylococcus protein 
A (Staphylococcus protein A is a 40-60 kDa surface protein originally found in the 
cell wall of the bacteria Staphylococcus aureus). This ligation resulted in enhanced 
expression of active C-src, which is able to phosphrylate other substrates and also 
auto-phosphorylate (Saya et al., 1993). Seeliger and collegues co-expressed truncated 
C-src from amino acid 251-533 with YopH phosphatase in two different plasmids in 
bacteria and they found that when they expressed src alone most of the product was 
insoluble, but with the phosphatase co-expression they were able to express and 
purify active src in a bacterial system (Seeliger et al., 2005). Weijland and colleagues 
expressed truncated C-src starting from amino acid 81 until the end of the protein. 
They co-expressed it with CSK in a yeast expression ystem in order to cause 
phosphorylation of Y527, which will result in binding of this residue to the SH2 
domain and keep the kinase in a closed conformation form, reducing its kinase 
activity (kinase activity of src phosphorylated at Y527 is 20 times less than the non-
phosphorylated).  They found that co-expressing src with CSK resulted in producing 
good amounts of the kinase (Weijland et al., 1996; Weijland et al., 1997). Wang and 
colleagues co-expressed truncated inactive C-src (K295M) from amino acid 83-533 
with GroSL/EL chaperones in separate plasmids in an E. coli bacterial system, or 
from 86 to 533 co-expressed with PTPIB phosphatase in the same plasmid, and they 
had nice expression in both cases (Wang et al., 2006). Xu and colleagues expressed 
human src residues 86-536 (equivalent to residues 83-533 in chicken src) in insect 
cells and used this construct for crystallisation (Xu et al., 1997).  
 
3.6.4 Active ∆80 src 
All the ∆80 src splice variants were dead kinases (same as the full length src) when 
they were tested for their kinase activity using synaptophysin C-terminus as a 
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substrate. For this reason active ∆80 src proteins were made. Only one splice variant 
was mutated using SDM to correct the point mutations at bases 1224 (C to T) and 
1228 (T to C). The original full length N1-src was u ed for this and then the mutated 
areas from ∆80 src splice variants were replaced with the correted equivalent region 
from full length N1-src. Expressing the active form was much harder than expressing 
the mutant form. Even using two litres of bacteria for each src splice variant at the 
optimized expression conditions only a small amount of His-tagged active ∆80 src 
splice variants was produced, however this was sufficient for kinase assay.  The 
activity of these active src splice variant constructs was tested using synaptophysin 
C-terminus as a substrate; synaptophysin C-terminus s known to be tyrosine 
phosphorylated by src (Evans and Cousin, 2005). The results showed that all three 
src splice variants are able to phosphorylate synaptophysin C-terminus (figure 3.17 
C). Because active src is so hard to express, different strategies had to be employed. 
Weijland and colleagues found that co-expressing the PTP-PEST tyrosine 
phosphatase with the src kinase domain alone (258-533) overcame the toxicity of src 
in a yeast expression system; this resulted in the production of a significant amount 
of the kinase domain. However they also found that expressing wild type src in the 
same expression system did not produce any significa t amounts of protein 








Novel binding partners of N2-src SH3 domain 
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4. Novel binding partners of N2-src SH3 domain 
4.1 Introduction 
There is a huge range of SH3 containing proteins. SH3 domains consist of 50-70 
amino acids and they are used for protein-protein interactions, where they bind to 
proline rich domains (Kay et al., 2000; Kolafa et al., 2000; Macias et al., 2002; 
Camara-Artigas et al., 2009). The typical structure of the binding site for SH3 
domains is PxxP which will adopt a left hand helix with an arginine residue adjacent 
to the PxxP motif (Feng et al., 1994; Rickles et al., 1994; Alexandropoulos et al., 
1995; Weng et al., 1995; Bedford et al., 2000; Macias et al., 2002). The C-src SH3 
domain has been reported to bind to dynamin I (Gout et al., 1993; Okamoto et al., 
1997; Foster-Barber and Bishop, 1998; Onofri et al., 2000; Solomaha et al., 2005). 
Dynamin I is also tyrosine phosphorylated by C-src both in vivo and in vitro (Ahn et 
al., 1999; Ahn et al., 2002). C-src is also known to bind synapsin I (Onofri et al., 
1997; Foster-Barber and Bishop, 1998; Onofri et al., 2000; Onofri et al., 2007). 
Synapsin I is tyrosine phosphorylated by C-src and this interaction results in further 
activation of C-src kinase activity (Onofri et al., 1997; Onofri et al., 2007). C-src is 
also known to bind synaptojanin (Onofri et al., 1997; Onofri et al., 2000).  
There is not much known about the interactions of the neuron specific splice 
variants, N1- and N2-src, apart from that N1-src does not bind to dynamin I and 
synapsin I (Gout et al., 1993; Foster-Barber and Bishop, 1998). However, since N1- 
and N2-src splice variants are expressed only in neurons, they are expected to have a 
role in neuronal function. Since the only differenc between these splice variants is 
in their SH3 domains (Figure 3.2), an obvious hypothesis is that these SH3 domains 
would have different binding partners that determine their neuron-specific functions. 
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The aim of this chapter is therefore to investigate the binding partners for all the src 
splice variant SH3 domains in nerve terminals with particular emphasis on N1- and 
N2-src SH3 domains. The hypothesis is that by identfyi g novel interacting partners, 
new functions for both N1- and N2-src will be revealed.  
To achieve this aim a general strategy was adopted (Figure 4.1). GST-pull downs 
from rat nerve terminal lysates were performed using GST-tagged src splice variant 
SH3 domains. The specific interacting proteins were th n identified by using 
MALDI-tof mass spectrometry. Proteins that are know to bind to C-src, such as 
dynamin I, were not included in this identification process since they were expected 
to bind. Novel binding partners were then confirmed by western blotting. In vitro 
interaction assays were used to determine whether the binding is direct. At this stage 
the binding partners were examined for their ability to act as src substrates by using 
kinase assays and the src binding site on these prot ins identified using sequence 
analysis and site directed mutagenesis. 
  
 4.2. SH3 domain interactions with proteins from synaptosomal lysates 
GST, and GST-tagged C-, N1-, N2-src SH3 domains were used to perform pull 
downs from rat brain synaptosomal lysates (basal and stimulated). Basal and 
stimulated lysates were both used to investigate if any src splice variant displays 
stimulation-dependent binding. Proteins that were bound to these GST fusion 




colloidal Coomassie stain (Figure 4.2). A number of proteins were extracted from 
nerve terminal lysates by the C-src SH3 domain (major bands seen at 145 kDa, 96 
kDa, 85 kDa, and 55 kDa). No stimulation-dependency was seen for these 
interactions. N1-src SH3 domain exhibited much less binding compared to C-src, 
with very few bands observed with N1-src either at b sal conditions or after 
stimulation. One noticeable difference was an increase in the binding of N1-src to a 
protein at approximately 100 kDa in stimulated lysate  compared to basal (Figure 4.2 
marked with stars). The N2-src SH3 domain displayed a completely different set of 
interacting partners, with major bands observed at 80 kDa, 67 kDa and 50 kDa.  
   
4.2.1. Identification of proteins bound to SH3 domains 
To identify which proteins from the GST-pull downs were extracted by the different 
SH3 domains, MALDI-tof MS analysis was performed. Since the majority of bands 
from the two splice variants were from N2-src SH3 domain pull downs compared to 
the N1-src SH3 domain, most of the bands sent for ident fication were selected from 
N2-src pull downs (Figure 4.2). Known binding partners for C-src such as 
synaptojanin (145 kDa), dynamin (96 kDa), and synapsin (85 kDa) were not selected 
for MALDI-tof MS analysis. N2-src SH3 domain binding partners that were 
identified included dynamin I (96 kDa), N-ethylmaleimide sensitive fusion protein 
(NSF) (80 kDa), and Munc18 (67 kDa). Synapsin 2 (50 kDa) was identified as a C-
src pull down binding partner (Table 4.1). 
 
4.2.2. Confirmation of SH3 domain interactions with nerve terminal proteins 




suggested which proteins bound to src splice variant SH3 domains. To confirm the 
identity of these proteins, pull downs from resting rat brain synaptosomal lysates 
were repeated using GST and GST-tagged C-, N1-, and N2-src splice variant SH3 
domains. Western blot analysis was then used to confirm the binding partners of 
different src splice variant SH3 domains. 
 
4.2.2.1. SH3 domain binding to dynamin, synapsin I, and synaptojanin 
C-src SH3 domain has a well identified interaction with synaptojanin, dynamin I, and 
synapsin I (Gout et al., 1993; Okamoto et al., 1997; Onofri et al., 1997; Foster-
Barber and Bishop, 1998; Onofri et al., 2000; Solomaha et al., 2005; Onofri et al., 
2007). To confirm these proteins were the major bands observed in the GST-pull 
downs, western blot analysis was performed (Figure 4.3). These blots show that 
dynamin I bound to the C-src SH3 domain with little binding observed with both N1- 
and N2-src, in agreement with previous studies showing that C-src is the main 
binding splice variant for dynamin I (Gout et al., 1993; Onofri et al., 1997; Foster-
Barber and Bishop, 1998; Onofri et al., 2000). Both synapsin I and synaptojanin 
bound only to C-src, and no binding was detected with N1- or N2-src, again 
confirming C-src is the major interacting partner fo these proteins out of the splice 
variants (Onofri et al., 1997; Foster-Barber and Bishop, 1998; Onofri et al., 2000). 
 
4.2.2.2 N2-src SH3 domain binding to NSF, synaptophysin, and Munc 18 
MALDI-tof MS analysis suggests a specific interaction of both NSF and Munc 18 to 
N2-src. To confirm this, western blot analysis was performed on GST pull down 
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 samples from resting nerve terminal lysates (Figure 4.3). When NSF binding was 
examined, it was found that NSF bound only to N2-src SH3 domain, but not C-src 
and N1-src. A similar pattern of binding was also seen for Munc 18, however some 
binding was also observed to the C-src SH3 domain. Sy aptophysin is the major 
tyrosine phospho-protein in nerve terminals (Onofri et al., 1997; Evans and Cousin, 
2005; Onofri et al., 2007), and is known to interact with src in nerve terminals 
(Barnekow et al., 1990; Linstedt et al., 1992; Zhao et al., 2000). Therefore we also 
determined the binding specificity of synaptophysin for the different SH3 domains. 
There was a selective interaction of N2-src with synaptophysin, with no binding 
observed to N1-src and C-src. This suggests that N2-src is the main binding splice 
variant for NSF, synaptophysin and Munc 18, all proteins with postulated roles in the 
synaptic vesicle life cycle. 
 
4.2.2.3 Different SH3 domain binding to dynamin I, Munc 18, NSF, and 
synaptophysin 
To determine whether the binding of Munc 18, NSF, and synaptophysin to N2-src 
SH3 domain was specific, or was shared across otherSH3 domains, binding to other 
GST-SH3 domains from different proteins were screened. GST pull downs from 
synaptosomal lysates were performed using GST and GST-tagged C-, N1-, and N2-
src splice variants, plus syndapin I, P85, endophilin I and II, and amphiphysin I and 
II SH3 domains (Figure 4.4). As expected dynamin I bound to all SH3 domains with 
the exception of N1- and N2-src. In contrast Munc 18, NSF and synaptophysin 
binding displayed a high degree of variation between different SH3 domains. Munc 
18 bound to C-src, N2-src, syndapin I, P85, and amphiphysin I and II, with little 
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binding to endophillin I and II, and N1-src (Figure 4.4). A similar pattern of binding 
was observed for synaptophysin, the only difference being a lack of interaction with 
the C-src SH3 domain. In contrast NSF bound to N2-src, P85, and endophillin I and 
II, while no binding was observed to the other SH3 domains. Thus binding of these 
proteins to N2-src SH3 domain is not specific and the SH3 domains bound may 
provide clues to identify binding sites.  
 
4.2.2.4 SH3 domain binding to SNARE proteins 
N2-src SH3 domain bound to both Munc 18 and NSF, proteins that also interact with 
the SNARE proteins. To test whether NSF and Munc 18 bind N2-src indirectly via 
either syntaxin, VAMP, or SNAP 25, GST alone and GST-tagged src splice variant 
SH3 domains plus amphiphysin SH3 domain were used to perform pull downs from 
resting rat brain synaptosomal lysates (Figure 4.5). Munc 18 bound to N2-src SH3 
domain, with some binding to C-src and amphiphysin I SH3 domains as seen 
previously (Figure 4.4). In contrast neither syntaxin, VAMP, or SNAP25 bound to 
any of these SH3 domains. This suggests the SNARE proteins do not bind any src 




4.3 SH3 domain binding to recombinant proteins 
4.3.1 SH3 domain binding to recombinant Munc 18 
To determine whether Munc 18 interacts directly with N2-src, in vitro interaction 
assays were performed. In these experiments His-tagged full length Munc 18 was 
expressed in bacteria and either the bacterial lysates were used directly for pull 
downs using GST-tagged src splice variant SH3 domains, or purified Munc 18 was 
used for binding assays with GST-tagged src splice variant SH3 domains. GST-
tagged syntaxin, which is the major Munc 18 binding partner (Dulubova et al., 1999; 
Ciufo et al., 2005b; Rickman et al., 2007), was used as a positive control. 
GST and GST-tagged C-src, N1-src, N2-src, and syntaxin were used to perform pull 
downs from bacterial lysates expressing His-tagged Munc 18 (Figure 4.6 A). Munc 
18 bound only to syntaxin, whereas no binding was detected with any of the src 
splice variant SH3 domains. This suggests that recombinant Munc 18 expressed in 
bacteria does not bind to src splice variant SH3 domains.  
Next, GST and GST-tagged C-src, N1-src, N2-src, andsyntaxin were used to 
perform binding assays with Munc 18 purified from bacterial lysates (Figure 4.6 B). 
Once again no specific binding was observed with any src SH3 domain. Therefore 
bacterially expressed Munc 18 does not bind to any src SH3 domain, questioning 
whether the interaction observed in nerve terminals is direct.  
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4.3.2 SH3 domain binding to recombinant synaptophysin C-terminus 
To determine whether synaptophysin binding is direct, the cytoplasmic 
synaptophysin C-terminus (His-tagged) was expressed in bacteria and purified for 
binding assays or used for pull downs from bacterial lysates. 
GST and GST-tagged C-src, N1-src, and N2-src SH3 domains were used to perform 
pull downs from bacterial lysates expressing His-tagged synaptophysin C-terminus 
(Figure 4.7 A). As with Munc 18, no binding was detected with any of the src splice 
variant SH3 domains, suggesting that recombinant synaptophysin C-terminus 
expressed in bacteria does not bind to src splice variant SH3 domains.  
Next, GST and GST-tagged C-src, N1-src, and N2-src SH3 domains were used to 
perform binding assays with His-tagged synaptophysin C-terminus purified from 
bacteria (Figure 4.7 B). No binding was detected with any of the src splice variant 
SH3 domains, confirming the suggestion that recombinant synaptophysin C-terminus 
expressed in bacteria does not bind to src splice variant SH3 domains. Therefore as 
with Munc 18, this raises a doubt as to whether these interactions are direct in nerve 
terminals.  
 
4.3.2 Phosphorylation of Munc 18 and synaptophysin C-terminus 
Since both Munc 18 and synaptophysin bound to N2-src in nerve terminal lysates, it 
is possible that they could be substrates for its kinase activity. To test this possibility 
recombinant full length N2-src was used to perform kinase assays using both purified 
full length His-tagged Munc 18 and GST-tagged synaptophysin C-terminus as 
substrates (Figure 4.8). The synaptophysin C-terminus was phosphorylated, in 





(Barnekow et al., 1990; Linstedt et al., 1992; Onofri et al., 1997; Zhao et al., 2000; 
Evans and Cousin, 2005; Onofri et al., 2007). However no phosphorylation was 
observed with Munc 18. This suggests that Munc 18 cannot bind to N2-src directly 
or be phosphorylated by it, therefore its identificat on as a possible N2-src interaction 
partner is still open to question. 
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4.4 Discussion 
The aim of this chapter was to identify novel interacting partners for the different src 
splice variant SH3 domains to identify proteins that might indicate a possible role for 
N1- and N2-src in neuronal function. It was found that the N2-src splice variant had 
binding partners different from the C-src splice variant. C-src, the most common 
splice variant, bound to dynamin I, synaptojanin, ad synapsin I. N1-src had little 
binding to any nerve terminal protein but may have a stimulation-dependent 
interaction with dynamin I. In contrast N2-src specifically bound three proteins, 
which are NSF, Munc 18 and synaptophysin, all proteins involved in the synaptic 
vesicle life cycle.  
 
4.4.1 C-src binding partners 
Both N1- and N2-src splice variants are expressed only in neurons, whereas C-src is 
expressed in all cell types (Brugge et al., 1987; Levy et al., 1987; Martinez et al., 
1987; Levy and Brugge, 1989; Pyper and Bolen, 1989; Raulf et al., 1989; Pyper and 
Bolen, 1990; Dorai et al., 1991). In this study, the investigation was focused on 
proteins that are found in the nerve terminals and their specific interactions to the 
SH3 domains of src splice variants. Thus C-src SH3 domain was treated as the 
reference for the neuronal specific splice variants, N1- and N2- src SH3 domains. 
Binding was compared in nerve terminal lysates plus and minus stimulation, which 
initiates synaptic vesicle turnover. Stimulation also causes the phosphorylation or 
dephosphorylation of proteins which can alter protein-protein interactions. For 
example, dephosphins such as dynamin I and synaptojanin are dephosphorylated 
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after stimulation (Cousin and Robinson, 2001; Cousin et al., 2001; Clayton et al., 
2007; Evans and Cousin, 2007). 
Synapsin I was observed to bind C-src but not N1- or N2-src splice variant SH3 
domains, in agreement with previous studies (Onofri et al., 1997; Foster-Barber and 
Bishop, 1998; Onofri et al., 2000; Zhao et al., 2000; Onofri et al., 2007). 
Synaptojanin also bound only to C-src. It has been r ported that synaptojanin binds 
to several other SH3 containing proteins including amphiphysin I and II, endophillin 
I and II, syndapin, and Grb2 (Bauerfeind et al., 1997; de Heuvel et al., 1997; 
Micheva et al., 1997; Onofri et al., 1997; Cestra et al., 1999; Hill et al., 2001; 
Zucconi et al., 2001; Schuske et al., 2003; Verstreken et al., 2003). This shows that 
even though synaptojanin has several binding partners containing SH3 domains, it 
binds specifically to C-src but not the neuronal splice variants suggesting that both 
N1-src and N2-src are not involved in synaptojanin i teractions. 
Dynamin I binds specifically to the C-src SH3 domain with little binding to N1- and 
N2-src SH3 domains, in agreement with previous studies showing that C-src 
interacts with dynamin I (Gout et al., 1993; Grabs et al., 1997; Okamoto et al., 1997; 
Foster-Barber and Bishop, 1998; Solomaha et al., 2005). This is also supported by 
previous findings where both synapsin I and dynamin I were shown to bind to C-src 
but not N1-src (Onofri et al., 1997; Foster-Barber and Bishop, 1998).  
The N1-src splice variant SH3 domain bound very few n rve terminal proteins. It did 
bind to dynamin I, although binding was much lower when compared to the C-src 
SH3 domain. Interestingly an increase in dynamin I binding to N1-src SH3 domain 
was seen after stimulation (marked with stars in Figure 4.2) suggesting a possible 
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phosphorylation-dependent interaction. This stimulation dependent dynamin- N1-src 
interaction will be investigated in the next chapter.  
 
4.4.1.1 N2-src binding partners 
The N2-src splice variant displayed a completely different pattern of binding 
compared to C- and N1-src SH3 domains with interactions identified for Munc 18, 
NSF and synaptophysin. This is the first identification of N2-specific binding 
partners. In an effort to determine whether binding was specific for the N2-src SH3 
domain, binding was compared across SH3 domains. When t is was performed, 
Munc18 and synaptophysin displayed a very similar binding pattern across different 
SH3 domains, suggesting similarity in their binding sites. This might suggest that 
Munc 18 and synaptophysin have similar functions and they may compete for 
binding partners in nerve terminals. 
 
4.4.1.2 Synaptophysin  
In previous studies, synaptophysin was shown to co-precipitate with C-src using 
immunoprecipitation, co-localize with C-src using immunofluoresce and, interact 
with C-src SH2 domain using FRET (Barnekow et al., 1990; Linstedt et al., 1992; 
Zhao et al., 2000; Felkl and Leube, 2008).  However, none of these studies showed a 
direct interaction between C-src SH3 domain.  
Synaptophysin bound to the SH3 domain of the N2-src splice variant, while C-src 
had little binding to synaptophysin, suggesting the putative synaptophysin and C-src 
interaction is not via the C-src SH3 domain. N2-src SH3 domain interaction with 
synaptophysin may be direct, since it contains a classical type I PxxP motif 
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(228RAPPGAP235) which is accessible for binding since it is in the cytoplasmic C-
terminus, not the trans-membrane region (Figure 4.9 A). 
However, in vitro experiments failed to show a direct interaction betwe n 
synaptophysin C-terminus and N2-src in pull downs from bacterial lysates or 
recombinant proteins, casting doubt on a direct interaction. There are several 
possibilities explaining the lack of binding. The first possibility is that binding of N2-
src might also require amino acid residues of the cytosolic loop of the trans-
membrane domain of synaptophysin, with the C-terminus alone not sufficient for 
binding to the N2-src SH3 domain. To test this possibility several attempts were 
made to produce full length synaptophysin in bacteria and use it for pull downs. 
However, it was not easy to express probably due to synaptophysin being a trans-
membrane protein. The great majority of protein was tr pped in detergent-insoluble 
structures and was therefore unavailable for binding. Different expression systems 
such as eukaryotic cells like yeast or insect cells might improve expression and allow 
the investigation of binding to full length synaptohysin. 
The other possibility is that the synaptophysin C-terminus needs to be 
phosphorylated to bind to N2-src. Synaptophysin is phosphorylated in a Ca2+-
dependent manner by both CaM kinase II (Ca2+/ calmodulin-dependent protein 
kinase II) at two serine residues (Pang et al., 1988; Greengard et al., 1993; 
Rubenstein et al., 1993; Braun and Schulman, 1995; Evans and Cousin, 2005) and by 
src on multiple residues (Barnekow et al., 1990; Onofri et al., 1997; Zhao et al., 
2000; Evans and Cousin, 2005; Onofri et al., 2007). If the synaptophysin C-terminus 
was subjected to phosphorylation by either CaM kinase II or src, and then used in 




phosphorylation can modulate protein interactions (Chung et al., 1997; Viollet et al., 
1997; Pitcher et al., 1999; Mazurek et al., 2000; Ma et al., 2001). 
Another possibility is that the synaptophysin/N2-src binding is indirect and occurs 
via other proteins. The major synaptophysin interacting partner in nerve terminal is 
VAMP 2 (Calakos and Scheller, 1994; Edelmann et al., 1995; Washbourne et al., 
1995; Khvotchev and Sudhof, 2004; Felkl and Leube, 2008) suggesting that VAMP 
2 may mediate the interaction. However, our data showed that none of the SNARE 
proteins including VAMP 2 bound to the N2-src SH3 domain, suggesting that the 
synaptophysin-N2-src interaction is not through this protein. Further investigation is 
needed to identify the protein, if any, that is mediating synaptophysin-N2-src 
binding.  
Synaptophysin is phosphorylated at multiple tyrosine residues on its C-terminus 
(Evans and Cousin, 2005) with previous studies showing that C-src can 
phosphorylate synaptophysin i  vivo and in vitro (Barnekow et al., 1990; Linstedt et 
al., 1992; Onofri et al., 1997; Zhao et al., 2000; Evans and Cousin, 2005; Onofri et 
al., 2007). Our data showed that synaptophysin C-terminus was phosphorylated in
vitro by all src splice variants as seen in figure 3.17 C and figure 4.8.  
Since synaptophysin binds more to N2-src SH3 domain tha  C-src SH3 domain (as it 
was seen in the pulldowns from synaptosomal lysates figure 4.3), it is expected that 
N2-src would have a lower Km than C- and N1-src and thus be more efficient in 
synaptophysin phosphorylation if tests were performed. This hypothesis would fit 
with the fact that N2-src is expressed only in neuronal cells where faster or specific 
responses might be essential. Since SH2 domains in all src splice variants are 
identical and they would bind to the phospho-tyrosine, there might be a 
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compensatory role for the SH2 domain in maintaining the interaction of C- and N1-
src with synaptophysin, even if the initial binding between the SH3 domain and 
synaptophysin is not strong.  
 
4.4.1.3 Munc 18  
Munc 18 is known to be involved in regulating exocyt sis through its binding to 
syntaxin, which is not an SH3 domain containing protein (Dulubova et al., 1999; 
Ciufo et al., 2005a; Schutz et al., 2005; Yerrapureddy et al., 2005; Dulubova et al., 
2007; Rickman et al., 2007). Munc 18 had three modes of binding to syntaxin 1) 
when syntaxin is in the closed conformation 2) to the N-terminus of syntaxin when it 
is in an open conformation and 3) to syntaxin in the SNARE complex (Dulubova et 
al., 1999; Dulubova et al., 2007; Rickman et al., 2007; Shen et al., 2007; Burgoyne et 
al., 2009).  
Munc 18 bound specifically to the N2-src SH3 domain w th little binding to C-src 
and no binding to N1-src. The lack of binding to C- and N1-src is surprising since 
Munc 18 bound to most of the other screened SH3 domains. Thus Munc 18 interacts 
with a wide range of the SH3 domains, which might either suggest multiple roles of 
Munc 18 in the nerve terminal or that many proteins can regulate or modulate Munc 
18 function.  
Munc 18a, the neuronal isoform, contains only one PxxP motif (239PSSP242) which is 
a prospective binding site for N2-src SH3 domain (Figure 4.9 B). However, this 
PxxP motif may not be accessible when the crystal structure is examined, suggesting 
N2-src may not bind at this motif. Other possibilities exist such as a conformational 
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change when Munc 18 is phosphorylated, resulting in exposure of the PxxP motif to 
N2-src binding. In support of this, Munc 18 binding to syntaxin is regulated by 
phosphorylation. For example, Munc 18 serine phosphrylation by protein kinase C 
resulted in decreased binding affinity to syntaxin (de Vries et al., 2000; Barclay et 
al., 2003). Furthermore, in glucose-stimulated insuli  secretion, stimulation resulted 
in a change in the Munc18c structure and tyrosine phos horylation (Y219) of Munc 
18c. This reduced binding to syntaxin 4 in pancreatic β cells, and increased binding 
to Doc2 β instead (Oh and Thurmond, 2006; Jewell et al., 2008). Munc 18c, a non-
neuronal form, does not have the PxxP motif while both Munc 18a and b contain a 
PxxP motif (Oh and Thurmond, 2006). Since Munc 18 binding to syntaxin is 
regulated by tyrosine phosphorylation in other systems, it suggests a possible role for 
N2-src binding to Munc 18, whereby it might regulate Munc 18 binding to syntaxin. 
On the other hand, tyrosine phosphorylation might result in N2-src binding to Munc 
18 and thus induce further phosphorylation for Munc 18 since Munc 18 has four 
possible tyrosine phosphorylation sites (Oh and Thurmond, 2006). Since N2-src did 
not bind to any of the SNARE proteins, there is a possibility that N2-src binds to free 
Munc 18 only and modulates its function via binding or phosphorylation or both. 
The in vitro experiments failed to show any direct interaction between Munc 18 and 
N2-src in pull downs from bacterial lysates or as recombinant proteins in binding 
assays. This might be due to the fact that Munc 18 aggregated when purified. This 
aggregation caused false results in the binding assays ince the aggregated Munc 18 
could not pass through the spin columns during sample washes, resulting in apparent 
binding to all GST fusion proteins. This problem was overcome by performing pull 
downs direct from bacterial lysates, however no binding was observed. This leaves 
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the possibility that there might be phosphorylation needed in order to expose the N2-
src SH3 domain binding site and facilitate binding. Another possibility is that Munc 
18 binding is mediated by syntaxin or the other SNARE complex. However none of 
the SNARE complex proteins bound to N2-src, suggesting that Munc 18 is not 
binding to N2-src via these proteins. 
Munc 18 aggregation in fact might explain the lack of specific binding as well as the 
lack of phosphorylation in the kinase assay. The same kinase assay showed tyrosine 
phosphorylation for synaptophysin C-terminus it failed to show any phosphorylation 
for Munc 18. The question of whether Munc 18 is phosphorylated by N2-src is still 
not answered, and if Munc 18 is immunoprecipitated from nerve terminal (if it does 
not aggregate) and then used as a substrate for N2-src it might be phosphorylated. 
Expressing Munc 18 in a baculovirus expression system might reduce the 
aggregation problem too (Hu et al., 2003). Thus the ability of Munc 18 to either bind 
or be a substrate for N2-src is still open to question. 
 
4.4.1.4 NSF  
NSF bound to N2-src SH3 domain but not to C- or N1-src SH3 domains. Among the 
SH3 domains that were screened, only N2-src, P85, and endophillin I and II SH3 
domains bound NSF, suggesting a more specific interac ion. NSF contains one PxxP 
motif (613PIGP616), which is a prospective N2-src SH3 domain binding site (Figure 
4.9 C). There is no crystal structure of NSF to confirm if this motif is available for 
binding, similar to synaptophysin, or whether a conformation change is needed to 
make it available (similar to Munc 18). N2-src did not bind to the SNARE proteins 
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suggesting that it might have a direct binding to NSF rather than indirect interaction 
through SNARE proteins.  
NSF has an ATPase activity and its role in disassembling SNARE complex allows 
SNARE proteins to recycle (Matveeva and Whiteheart, 1998; Matveeva et al., 2002; 
Whiteheart and Matveeva, 2004). NSF binding to the SNARE complex stimulates its 
ATPase activity (Haynes et al., 1998; Matveeva and Whiteheart, 1998). NSF is 
phosphorylated at S237 by protein kinase C, and this p osphorylation prevents NSF 
binding to SNARE complexes (Matveeva et al., 2001). NSF is also phosphorylated at 
S569 by Pctaire I, and this phosphorylation regulates NSF oligomerization (Liu et al., 
2006). In support of a direct role for src binding, NSF is also tyrosine phosphorylated 
at Y83 and is dephosphorylated by the tyrosine phosatase PTP-MEG2, resulting in 
an increase in its ATPase activity (Huynh et al., 2004). Thus, there is a possibility 
that N2-src phosphorylates NSF and regulates its ATPase activity. Whether the N2-
src SH3 domain binds to NSF directly or NSF serine phosphorylation is required 
before N2-src binds is still to be investigated. In addition, further investigations still 
have to be performed in order to confirm the role of N2-src binding and 
phosphorylation in regulating NSF activity.  
 
4.4.2 Limitations of this approach  
There are advantages and disadvantages of the strategy that were used. The 
advantages of this strategy include 1) Proteins are tak n from brain directly, not from 
cell lines, which would reflect the same structure and status that the proteins have in 
neurons, and 2) these are only from the synaptic region highlighting possible 
interactions in synaptic vesicle recycling. Other advantages include 3) protein 
 159 
binding can be tested in basal or stimulated conditions to reflect the effect of the 
mechanism that controls synaptic vesicle release on pr tein interactions, and 4) 
Proteins are phosphorylated endogenously. Another advantage is 5) the interference 
of other src domains was eliminated by using only SH3 domains and any difference 
in binding would be related to the splicing differenc  of the SH3 domains alone. The 
flip side of this advantage however is that these SH3 domains might not act the same 
way if the whole protein was used, where the other src domains might facilitate or 
inhibit the SH3 domain interactions with other proteins. 
Other disadvantages include 1) N2-src might not be found in the synaptic region and 
thus it might not encounter these proteins in live neurones. It is not clear whether N2-
src is expressed in all neuronal cells or it is specific for some cell types or specific 
regions. There is no N2-src specific antibody available and C-src SH3 domain 
antibodies do not recognize all the splice variants equally. We twice attempted to 
produce N2-src specific antibodies, however these studies met with no success.  
Further disadvantages also include the fact that 2) using lysates would destroy the 
structure of the nerve terminal causing proteins to be disorganised. This means 
proteins that bound to N2-src may not normally encou ter each other in intact 
neurones. 3) the in vitro assay does not reflect the real interaction in nerve terminals 
where other proteins might interfere by inhibiting or facilitating interactions. Other 
disadvantages of this method are 4) that some proteins are hard to express and purify, 
especially if these proteins are toxic to the host sy tem (such as src and full length 
synaptophysin), and also 5) some proteins are degrad rapidly or they aggregate 










5. Phosphorylation-dependent dynamin I interaction with N1-src 
5.1 Introduction 
Dynamin I is an important protein in vesicle recycling where it causes the 
internalization of the vesicle by wrapping itself around the vesicle’s neck and 
causing it to be separated from the membrane (Takei et al., 1995; Takei et al., 1996; 
Lu et al., 2008). Many SH3 domain containing proteins are known to bind to the 
dynamin I PRD including syndapin I, endophilin I & II, amphiphysin I & II, Grb2, 
PLCγ (Phospholipase Cγ), LYN, P85, and intersectin (Gout et al., 1993; Seedorf et 
al., 1994; Grabs et al., 1997; Okamoto et al., 1997; Solomaha et al., 2005; Anggono 
et al., 2006; Elhamdani et al., 2006; Anggono and Robinson, 2007). Several proteins 
seem to modulate dynamin I function either by direct binding such as amphiphysin 
which results in stimulation of dynamin I GTPase activity (Yoshida et al., 2004), or 
by phosphorylation such as CDK5 which phosphorylates dynamin on multiple sites 
and reduces dynamin I recruitment to the membrane (Tan et al., 2003; Smillie and 
Cousin, 2005).  
The protein tyrosine kinase, C-src, has been identifi d as a binding partner for 
dynamin I and II in neurones and other non neuronal cells (Foster-Barber and 
Bishop, 1998; Bruzzaniti et al., 2005), and can tyrosine phosphorylate dynamin I in 
non neuronal cells (Ahn et al., 1999; Ahn et al., 200 ; Shajahan et al., 2004). The src 
SH3 domain and dynamin I PRD domain were the main interaction points between 
these two proteins (Gout et al., 1993; Solomaha et l., 2005). However, N1-src did 
not show any interaction with dynamin I (Gout et al., 1993; Foster-Barber and 
Bishop, 1998).  
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The aim of these experiments is to compare serine phosphorylation of dynamin I 
PRD on both C- and N1-src binding, and also to determine whether C- and N1-src 
bind to the dynamin I PRD.  All experiments involving full length src constructs 
within this chapter were performed using kinase dead v riants, the merits of which 
are discussed in the general discussion. The previous chapter demonstrated that 
dynamin I binds to N1-src in a stimulation dependent manner, therefore the 
hypothesis is that N1-src but not C-src binds to dynamin I in a phosphorylation 
dependent manner, and that they would have distinct binding sites with N1-src 
binding being regulated by serine phosphorylation. 
 
5.2 Effect of dynamin I phosphorylation on its interaction with N1-src 
Protein phosphorylation regulates a number of protein-protein interactions, including 
those of dynamin I. It was therefore tested whether  previously observed lack of 
N1-src binding was due to dynamin I phosphorylation. To test this hypothesis, pull 
downs from resting rat brain synaptosomal lysates wre performed using GST-
tagged C-, N1-, N2-src SH3 domains. Dynamin I was ob erved to bind to the C-src 
SH3 domain (Figure 5.1 A). This finding agrees with the previous finding from 
chapter 4 (Figure 4.2) and others (Gout et al., 1993; Foster-Barber and Bishop, 
1998). Phosphorylated dynamin I was bound to C-src, but not N1-src or N2-src 
(Figure 5.1 A), suggesting dynamin I phosphorylation may play a role in regulating 
N1-src and N2-src interactions. Since dynamin I phos rylation is controlled by 
stimulation, its binding to C-src and N1-src SH3 domains was examined in resting 
and stimulated nerve terminal lysates. Synaptosomal lys tes were treated with 10 µM 




calcineurin (Faulds et al., 1993; Jorgensen et al., 2003). C-src SH3 domain showed 
no noticeable difference in total dynamin I binding between the stimulated and non-
stimulated conditions either in the presence or absence of cyclosporin A (Figure 
5.1B). This suggests that C-src binds to dynamin I in a phosphorylation-independent 
manner. However, more dynamin I bound to N1-src after s imulation (when dynamin 
I is dephosphorylated) supporting the hypothesis that N1-src binds to dynamin I in a 
phosphorylation-dependent manner (Figure 5.1B). No increase in dynamin I binding 
was observed in stimulated synaptosomal lysates with cyclosporin A. To confirm the 
phosphorylation dependency of this interaction, a phos ho-dynamin I 774 antibody 
was used on the same samples. The amount of phospho-dynamin I bound to C-src in 
stimulated conditions was increased in samples treated with cyclosporin A, in 
contrast to the similar extent of total dynamin I binding. This confirms that C-src 
binding to dynamin I is phosphorylation-independent. No phospho-dynamin I was 
detected bound to N1-src in any condition. These findings suggest that C-src binding 
to dynamin I is phosphorylation-independent, while N1-src only binds to dynamin I 
in its dephosphorylated state.   
 
5.3.1 Effect of dynamin I PRD mutations at S774/778 
Dynamin I is phosphorylated at two major sites in nerve terminals, S774 and S778 
(Tan et al., 2003; Smillie and Cousin, 2005; Graham et al., 2007). To determine 
whether these sites are important in the regulation of N1-src binding, two mutations 
(Figure 5.2) of the PRD were used. These mutations were a double phospho-null 
mutation, where both serine residues were mutated to alanine (DynIdmA-PRD), and a  
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 double phosphomimetic mutation where both serine residues were mutated to 
glutamate (DynIdmE-PRD). Previous studies have shown that phosphomimetic, but 
not phospho-null mutants, inhibit the binding of the endocytosis protein syndapin I 
(Anggono et al., 2006).   
To investigate the effect of these phosphorylation sites on C- and N1-src interactions  
GST-tagged PRD wild type, GST-tagged DyndmA-PRD, and GST-tagged DyndmE-
PRD were used to pull down His-tagged C- and N1-src SH3 domains from bacterial 
lysates (Figure 5.3). These experiments failed to sh w any significant effect of 
mutagenesis of the S774/778 sites on the dynamin I PRD interaction with C- or N1-
src SH3 domains, suggesting that phosphorylation of S774 and S778 do not play a 
role in the regulation of binding to either C- or N1-src SH3 domains.  
To confirm the lack of effect of either S774 or S778 in regulating src binding, these 
experiments were repeated using kinase dead full length His-tagged src. This was 
because it has previously been observed that syndapin I SH3 domain itself showed 
no phosphorylation dependency in its binding to dynamin I, whereas the whole 
protein bound in a phosphorylation dependent manner (Anggono et al., 2006).  
Therefore, to determine whether full length C- and N1-src splice variant binding 
could be regulated by mutagenesis of S774 and S778, a new series of pull downs 
were performed (Figure 5.4).  Neither mutation of the dynamin I PRD had any effect 
on full length C-src binding, confirming the lack of role for these sites. Similarly 
there was no significant effect of both mutations o full length N1-src binding. Thus 
the phosphorylation-dependent regulation of the dynami  I-N1-src interaction is not 





5.3.2 Effect of dynamin I PRD mutations at S774/778 on syndapin I, endophilin, 
and amphiphysin binding 
To confirm that the DynIdmA-PRD and DynIdmE-PRD mutations were acting in a 
similar manner to previous publications, syndapin I, endophilin, and amphiphysin 
binding was examined. Previous experiments showed that the DynIdmE-PRD mutant 
inhibited binding of syndapin I and endophilin, while amphiphysin binding was 
unaffected (Anggono et al., 2006).  
The experiments were performed using GST-tagged dynamin I PRD, DyndmA-PRD, 
DyndmE-PRD to pull down binding proteins from rat brain synaptosomal lysates 
(Figures 5.5 and 5.6). Western blots showed that endophilin binding to both DyndmA-
PRD and DyndmE-PRD was reduced by more than 50 %, while syndapin I a d 
amphiphysin binding was unaffected. These results are contrary to those observed by 
Anggono and coleagues where they observed inhibition of syndapin I binding in 
addition to endophilin (Anggono et al., 2006).   
 
5.3.3 Dynamin I PRD mutations (2C, 3B, 9A, and PB2)  
The lack of effect of DyndmA-PRD and DyndmE-PRD mutations, suggested that 
neither C- or N1-src bound near the phosphobox region of dynamin I, which includes 
S774 and S778 (Figure 5.2). To confirm this, dynamin I PRD mutants were 
employed that disrupt the binding of syndapin I, endophilin and  amphiphysin 
(Anggono and Robinson, 2007). Both endophilin and syndapin I bind to PxxP motifs 
2 and 3 of dynamin I PRD. In addition syndapin I interacts with the whole 





to PxxP motif 2 (Figure 5.2). Amphiphysin binds to a different site, PxxP 9, near the 
C-terminus (Grabs et al., 1997; Anggono and Robinson, 2007).  
GST-tagged PRD (2C, 3B, 9A, and PB2) binding site mutants were used to perform  
pull downs for full length C- and N1-src splice variants from bacterial lysates (see 
figure 5.2 for details).  Full length C-src binding to the dynamin I PRD was not 
affected by any of these mutants, suggesting C-src did not bind to any of these sites. 
N1-src binding to the dynamin I PRD was not affected by the 2C and 3B mutations, 
but binding to the 9A and PB2 mutants was greatly affected, with an approximate 80 
% decrease in binding to the 9A mutant and more than 90 % decrease in binding to 
the PB2 mutant (figure 5.7). The results suggest that neither PxxP motifs 2 and 3 are 
binding sites for N1-src. In contrast, N1-src binding s affected by the PB2 mutation, 
suggesting that arginine residues R772, R773 may form part of the N1-src binding 
site. The ablation of N1-src binding with the 9A mutant suggests that N1-src may 
have more than one interaction site on the dynamin I PRD. 
 
5.3.4 Effect of dynamin I PRD mutations (2C, 3B, 9A, and PB2) on endophilin, 
syndapin I, and amphiphysin binding 
To confirm that the dynamin I PRD mutants were acting as previously published, 
these experiments were repeated using rat brain synaptosomal lysates (Figures 5.8 
and 5.9). None of the mutants had any effect on syndapi  I binding. Endophilin 
binding to the 2C mutant was unaffected, but its binding to the other mutants was 
reduced by at least 50 % (Figure 5.9). Amphiphysin binding was only affected by the 
9A mutation. These results were not expected for a number of reasons. Syndapin I 







significant decrease in syndapin I binding to the dynamin I PRD when used 
previously (Anggono and Robinson, 2007). Endophilin showed the expected results 
in binding to 3B and 9A, however the PB2 mutation was not expected to affect its 
binding to the PRD, while the 2C mutant was expected to reduce it’s binding to the 
PRD. Amphiphysin binding occurred as expected and was only affected by the 9A 
mutation.  
 
5.3.5 Dynamin I PRD mutations (S822A and S822E) 
Since mutations at either S774, S778 or sites 2 and 3 had no effect on the N1-src 
interaction, the role of another phosphorylation site was investigated. The binding of 
N1-src at sites 8 and 9 was also investigated. These sites are adjacent to S822 which 
is a minor phosphorylation site on the dynamin I PRD (Graham et al., 2007). The 3L 
mutant was used to determine whether the C-terminal region of dynamin I PRD 
starting from PxxP motif 8 was essential for N1-src binding to dynamin I. Since the 
deletion of the C-terminal region of the dynamin I PRD after V832 blocked 
amphiphysin binding (Grabs et al., 1997), it may also affect N1-src binding to 
dynamin I, since N1-src binding to the dynamin I PRD was affected by the 9A 
mutation (Figure 5.7). To test this hypothesis, this mutant was used with the wild 
type PRD to perform pull downs for full length C- and N1-src splice variants from 
bacterial lysates. C-src binding to the dynamin I PRD was not affected by this 3L 
mutant. On the other hand, N1-src binding to the dynamin I PRD was greatly 
affected, with an approximate 90 % decrease in binding observed (figure 5.10). This 
suggests that the C-src binding site might be before PxxP motif 8, and the N1-src 
binding after this motif. To narrow down the region which N1-src could be 
 177 
 178 
binding to, a dynamin I PRD splice variant (WT xb) was used. Dynamin I xb PRD is 
similar to the dynamin I xa PRD up to PxxP motif 10, but has no PxxP motifs after 
this point (Figure 5.2). C-src binding to the xb PRD was not different compared to 
the xa PRD (Figure 5.10). On the other hand, N1-src binding to this splice variant 
was reduced by approximately 75 % (Figure 5.10). This decrease could mean that 
N1-src needs the C-terminal PxxP motifs 11, 12, and 13 for its binding to dynamin I 
PRD, suggesting differential binding of N1-src to xa and xb dynamin I.
Serine residue 822 of dynamin I is phosphorylated during basal conditions and 
dephosphorylated during stimulation (Graham et al., 2007). S822 is adjacent to site 8 
and 9 suggesting potential regulation of N1-src binding by phosphorylation. To test 
this hypothesis phospho-null (S822A) and phosphomimetic (S822E) mutations were 
used with wild type xa dynamin I PRD to perform pull downs for full length C- and 
N1-src splice variants from bacterial lysates. C-src binding to the xa PRD was not 
affect by these mutants. On the other hand N1-src binding to the PRD was decreased 
about 50 % by the phospho-null mutant S822A and about 60 % by the 
phosphomimetic mutant S822E (Figure 5.11). These findings suggest that S822 
phosphorylation might regulate N1-src binding to dynamin I. Furthermore, this 
serine residue might be part of the N1-src binding site since even the phospho-null 
mutation resulted in binding inhibition.  
 
5.3.6 Effect of dynamin I PRD mutants (S822A, S822E and 3L) and wt xb on 
syndapinI, endophilin, and amphiphysin binding 
The effect of the S822A, S822E, and 3L mutants, and WT xb were also investigated 
in pull downs from synaptosomal lysates to test their effects on known interaction  
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partners. When syndapin I binding was investigated, no change in binding was 
observed for any PRD protein (Figures 5.12 and 5.13). Endophilin binding to the 
S822A mutant, the S822E mutant and the WT xb splice variant was greatly reduced, 
while the 3L mutant had no effect. Amphiphysin showed a huge decrease in binding 
to the 3L mutant while with other proteins no significant decrease was observed 
(Figure 5.12 and 5.13). When coomassie gels were studied an extra band was 
identified at about 60 kDa in WT xb pull downs that was not found with the WT xa 
or other mutants (Figure 5.12A). Further investigation is needed in order to identify 
this band and why it binds only with the WT xb splice variant. 
 
5.3.7 Dynamin I PRD mutations P830A and P836A  
Since the S822 mutation beside PxxP motifs 8 and 9 affected N1-src binding to 
dynamin I PRD, it is possible that one of these motifs is the main site for N1-src 
binding. To investigate which motif is more important for N1-src binding or if both 
of these motifs are required, these PxxP motifs were mutated. Two mutants were 
made, a P830A mutation which will only affect PxxP motif 8, and P836A which 
should only affect PxxP motif 9 (Figure 5.2). These mutants were used to perform 
pull downs for full length C- and N1-src splice variants from bacterial lysates. There 
was a small non-significant reduction in binding of C-src to the P830A mutant while 
N1-src was not affected. The P836A mutant also had no significant effect on either 
C- or N1-src binding, (althogh was decreased by about 35 %) (figure 5.14), this 







5.3.8 Effect of dynamin I PRD mutations P830A and P836A on syndapin I, 
endophilin, amphiphysin and Grb2 binding 
Sites 8 and 9 have been shown to be the major sites for both amphiphysin and Grb2 
binding (Grabs et al., 1997; Anggono and Robinson, 2007). The binding to these 
mutants plus other nerve terminal proteins was therefore investigated using 
synaptosomal lysates. Syndapin I binding was unaffected by either PRD mutant 
(Figures 5.15 and 5.16). Endophilin binding to P830A was not affected, however its 
binding to the P836A mutant was reduced by about 40 %. Amphiphysin on the other 
hand showed a decrease of about 60 % binding to the P830A mutant while there was 
no effect on binding to the P836A mutant, suggesting s te 8 is the major amphiphysin 
binding site, contrary to published data (Grabs et al., 1997).  
Since Grb2 binding was reported to bind in the area of sites 8 and 9, its binding to 
P830A, P836A, 3L, and 9A was investigated (Figures 5.17 and 5.18). The S830A 
and 3L mutants reduced Grb2 binding by almost 60 % compared to the wild type; 
however, the S836A and 9A mutants had no significant effect. The data suggests that 
PxxP motif 8 might be an important binding site forG b2 as previously reported 
(Grabs et al., 1997), but it is not the only binding site.  
 
5.4 Effect of dynamin I PRD presence on the kinase activity of the ∆80 C- and N1-
src splice variants  
One unaddressed question for the N1-src dynamin I interaction is what function does 
it perform? One possibility is that dynamin I bindig may regulate src activity, 
possibly by disrupting its clamp position (Young et al., 2001). In agreement, 








activity (Onofri et al., 1997; Onofri et al., 2007). To test the effect of dynamin I PRD 
binding on ∆80 C- and N1-src kinase activity, a kinase assay was performed (see 
chapter 2.4.4). A time course of synaptophysin C-terminus phosphorylation was 
performed to establish a time point where phosphorylation is strong enough for 
detection on a western blot but not saturated, enabling further substrate 
phosphorylation (Figure 5.19 A). A 30 minute time point was selected to be optimal 
for this kinase reaction.  The WT dynamin I PRD was added to the kinase reaction 
for both ∆80 C- and N1-src with synaptophysin C-terminus as a substrate (figure 
5.19B). In the absence of synaptophysin C-terminus, no dynamin I PRD 
phosphorylation was observed, confirming that the dynamin I PRD is not a src 
substrate. However, there were also no obvious differences in the phosphorylation of 
the synaptophysin C-terminus in the presence of dynami  PRD either when the ∆80 
C-src or N1-src was used for the kinase reaction. This experiment suggests that 
dynamin I PRD binding does not have any effect on ∆80 C- and N1-src activity.  
 
5.5 Tyrosine phosphorylation of dynamin I in neurons 
Another possible role for the dynamin I/src interaction is to phosphorylate another 
part of dynamin I. Previous studies have produced confli ting data on whether 
dynamin I is tyrosine phosphorylated in nerve terminals (Graham et al., 2007; Ballif 
et al., 2008). To address this and to determine whether there is a stimulation-
dependent tyrosine phosphorylation of dynamin I; we examined its phosphorylation 




synaptosomal lysates were performed using GST-tagged C-src SH3 domain, no 
dynamin I tyrosine phosphorylation was observed either in the presence or absence 
of sodium vanadate (Figure 5.20 A). In addition, no phosphorylation of dynamin I 
was also observed following dynamin I immunoprecipitation from stimulated and 
resting synaptosomal lysates in the absence of sodium vanadate.  However, dynamin 
I was tyrosine phosphorylated in both basal and stimulated conditions in the presence 
of sodium vanadate, but there was no obvious difference in the level of dynamin I 
tyrosine phosphorylation between these conditions (Figure 5.20 B). Since sodium 
vanadate was added before stimulation in the stimulated samples, one would expect 
that if dynamin I is tyrosine phosphorylated during basal conditions and 
dephosphorylated after stimulation, it would not be se n since dephosphorylation is 
blocked by sodium vanadate. The other possibility is that dynamin I phosphorylation 
is not stimulation-dependent or other signals such as Ca2+ influx are required for its 




In summary, I have shown N1- src binding to dynamin I PRD is phosphorylation 
dependent, and S822 is a key regulator in this dependency. The binding site for N1-
src is likely to be at PxxP motifs 8 and 9 and the regions C-terminal to this site. C-src 
binding to dynamin I is not phosphorylation dependent and the major binding site is 
still to be determined.  
 
5.6.1 Dynamin I PRD mutations used in these experiments 
In this study 10 mutations were used in order to investigate their effect on N1-src 
binding to dynamin I. These mutants can be divided into two major regions. The first 
region is at PxxP motifs 2 and 3, while the second region is at PxxP motifs 8 and 9. 
For each region, the two PxxP motifs were mutated (2C and 3B for the first region, 
and P930A and P836A for the second region). Serine phosphorylation sites flanking 
these sites were also tested (S774/778 for first region and S822 for second region) in 
addition to arginine residues (PB2 for first region and 9A for second region). Finally 
two shorter C-terminal versions were used, the 3L mutant starting from PxxP motif 8 
and the xb splice variant that has no PxxP motifs after 10.  
The reason for choosing these two regions is that mny SH3 domain containing 
proteins have been mapped to bind to one of these rgions. Syndapin I and 
endophillin I were mapped to bind to the first region, where as amphiphysin I and 
Grb2 were mapped to bind to the second region (Anggo o and Robinson, 2007). In 
addition these were flanked by serine residues S774/7 8 in the first region and S822 
in the second region which have been reported to be phosphorylated (Graham et al., 
2007).  
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5.6.2 N1-src and C-src binding to dynamin I 
5.6.2.1 N1-src binding to dynamin I is phosphorylation dependent  
Dynamin I is one of the dephosphins that are dephosphorylated upon stimulation by 
calcineurin in a Ca2+ dependent manner (Liu et al., 1994; Cousin and Robins n, 
2001; Cousin et al., 2001). N1-src was observed to bind to dynamin I in stimulated 
synaptosomal lysates, suggesting dephosphorylation of dynamin I is central for the 
interaction. This was confirmed by blocking the stimulation-dependent interaction 
using the calcineurin inhibitor cyclosporin A. In contrast, the C-src dynamin I 
interaction is not affected by phosphorylation, which suggests that C-src association 
with dynaminI is not related to stimulation. 
Previous data has shown that the C-src, but not the N1-src SH3 domain, binds to 
dynamin I (Gout et al., 1993; Foster-Barber and Bishop, 1998). Gout and colleagues 
(1993) used the dynamin I WT xb splice variant which did not bind much to N1-src 
in this study suggesting why they did not observe any binding (Gout et al., 1993).  
The other reason for the lack of binding is that they used resting bovine brain lysates 
where dynamin I is most likely to be phosphorylated while N1-src showed binding to 
dephosphorylated dynamin I.  
 
5.6.2.2 S822 is the phosphorylation site that affects N1-src 
Serine residues 774 and 778 are the main serine phosphorylation sites for dynamin I, 
being phosphorylated by CDK5 both in nerve terminals and in vitro (Tan et al., 2003; 
Graham et al., 2007).  Anggono and colleagues (2006) showed that syndapin I 
binding to dynamin I is regulated by phosphorylation of these serines (Anggono et 
al., 2006). Both C-src and N1-src SH3 domains did not show any difference in 
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binding to these mutants. This is consistent with previous studies showing that full 
length syndapin I but not the SH3 domain shows phosrylation dependent binding 
to dynamin I (Anggono et al., 2006). However, in contrast to syndapin I neither full 
length N1-src or C-src binding was affected by mutations of these sites.  
S822 is a minor phosphorylation site in dynamin I with less than 5 % of the total 
phosphorylation (Graham et al., 2007). Phosphomimetic and phospho-null mutations 
of this site significantly reduced binding between N1-src and the dynamin I PRD. 
The fact that even the phospho-null mutant caused a significant decrease in N1-src 
binding suggests that the presence of a serine residu  itself is important for N1-src 
binding and not just phosphorylation status of this residue. Two other 
phosphorylation sites are present in the dynamin I PRD: S851 and S857. These 
account for 12 % of the total phosphorylation (Graham et al., 2007). These are the 
likely sites regulating N1-src binding since the 3L mutant and WT xb (which do not 
have them) abolish binding. In support, mutation of S857 regulates amphiphysin 
binding (Huang et al., 2004). Since N1-src binding is similar to amphiphysin, this 
suggests that S857 may be the key phospho-regulated site. Further experiments using 
phospho-null and phosphomimetic mutants should confirm this hypothesis.  
 
5.6.2.3 Binding site for N1-src starts from PxxP motif 8. 
It was expected that the N1-src binding site would be adjacent to its phosphorylation 
regulating site, therefore as expected neither the 2C or 3B mutants affected N1-src 
binding, since the S774 and S778 mutants had no effect on the interaction. The lack 
of binding of the PRD 3L mutant indicated that the N1-src binding site was from 
PxxP site 8 onwards.  
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Furthermore, the majority of N1-src binding is still retained with the PxxP 8 and 9 
mutations, suggesting that the major binding site i further C-terminal to these sites. 
This is supported further by the xb splice variant, which has no PxxP motifs past the 
splice site at PxxP motif 10. Dynamin I xa (WT xa) h s 684 amino acids (considered 
as the wild type in these experiments) and dynamin I xb (WT xb) has 851 amino 
acids (Robinson et al., 1993; Urrutia et al., 1997). Dynamin I xa seems to have a 
higher affinity than dynamin I xb for several SH3 domain containing proteins 
including Grb2, fyn, lyn, and P85, while they have the same affinity for PLCγ 
(Okamoto et al., 1997). The WT xb splice variant of dynamin I does not contain 
PxxP motifs 11, 12, and 13 and lacks the phosphorylated serines 851 and 857 instead 
it has 7 additional amino acids (Figure 5.2). Since the WT xb splice variant exhibited 
little binding to N1-src, it suggests PxxP motifs 11- 3 are the major binding site. 
Further experiments mutating this region will need to be performed to confirm this. 
 
5.6.2.5 Arginine residues are essential for N1-src binding  
Arginine residues form part of the SH3 domain binding sites, and are adjacent to the 
PxxP motifs. The arginine residues are essential for SH3 domains to bind to PxxP 
motifs (Alexandropoulos et al., 1995). The PB2 (RR772/3EE) mutation affected 
syndapin I binding to the dynamin I PRD, where as the 9A (R838A) mutant affected 
amphiphysin and endophilin binding to the dynamin I PRD (Anggono and Robinson, 
2007). Both of these mutations showed a huge effect on N1-src, but not C-src, 
binding to the dynamin I PRD, suggesting that either arginine residues in both sites 
are important for N1-src binding or that changing the positive charge of the arginine 
to a negative charge (PB2) or no charge (9A) would affect the ability of the SH3 
 197 
domains to bind to the PxxP motifs. The fact that C-src binding to the dynamin I 
PRD was not affected with these mutations supports the first possibility.    
 
5.6.2.6 C-src binding to dynamin I 
The C-src binding site is still unidentified, because none of the mutations tested had 
any significant effect on binding to the dynamin I PRD. There is a possibility that C-
src has multiple binding sites and any one single mutation would not show a 
significant reduction on its binding. Previous studies suggested that the C-terminal 
region including PxxP motif 2 need to be truncated b fore any significant effect on 
binding can be observed; in fact the presence of PxxP motifs 2 and 3 was able to 
retain about 70 % of the binding (Okamoto et al., 1997). The multiple binding sites 
for C-src were suggested to be at PxxP motifs 2, 6,and 8 (Solomaha et al., 2005). 
 
5.6.3 Syndapin I, endophilin, and amphiphysin binding to dynamin I 
Syndapin I, endophilin I, and amphiphysin I are themajor interacting proteins of 
dynamin I (Qualmann et al., 1999; Simpson et al., 1999; Takei et al., 1999; Hill et 
al., 2001; Solomaha et al., 2005; Anggono et al., 2006; Elhamdani et al., 2006; 
Anggono and Robinson, 2007; Graham et al., 2007; Andersson et al., 2008). Their 
binding to the dynamin I PRD mutants was used to corrob rate effects seen with src 
binding. The data observed conflicted with some published results and as such the 





5.6.3.1 Effect of the PRD mutants on amphiphysin binding 
Amphiphysin I is known to bind to dynamin I in a phosphorylation independent 
manner (Graham et al., 2007) and it is suggested to bind to PxxP motif 9 (Anggono 
et al., 2006; Anggono and Robinson, 2007). However, it was reported that mutation 
of serine residue 857 (S857E) resulted in inhibition of amphiphysin binding to the 
dynamin I PRD and thus phosphorylation of this site by the protein kinase 
Mnb/Dyrk1A inhibits amphiphysin binding (Huang et al., 2004).  These findings are 
conflicting, but since phosphorylation of this site is about 6 % of the total 
phosphorylation, this could explain the reason why this phosphorylation effect on 
amphiphysin binding was not observed by other groups.  
In the experiments in this thesis amphiphysin binding to the dynamin I PRD was 
significantly affected by mutations in the area of PxxP motifs 8 and 9 as expected. 
Deletion of this binding site (3L) and mutation of R838 (9A) both resulted in a huge 
reduction of amphiphysin binding, while using the xb PRD did not affect its binding 
confirming that the amphiphysin binding site lies within this region (PxxP motifs 8 
and 9) agreeing with previous studies (Grabs et al., 1997; Okamoto et al., 1997; 
Solomaha et al., 2005; Anggono and Robinson, 2007). However, PxxP motif 9 has 
been suggested to be the main binding site for amphiphysin rather than PxxP motif 8  
(Solomaha et al., 2005; Anggono and Robinson, 2007), which does not agree with 
the findings presented here. The fact that none of these previous studies used 
mutations in PxxP motif 8 or 9 makes this study a uniq e approach, since Anggono 
and Robinson made their suggestion about the binding site according to 9A mutation 
results (which is similar to results in this study) and not according to PxxP motifs 
mutations (Anggono and Robinson, 2007). The fact tha mutation of site 8 did not 
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have a total block on amphiphysin binding (about 60 % reduction) while 3L 
abolished the binding (about 95 % reduction) suggests that site 9 might have a role in 
the binding of amphiphysin. This agrees with Grabs et al (1997) where they found 
that deleting the N-terminal region up to PxxP motif 8 resulted in loss of some of the 
binding while using the 3L mutant resulted in total loss of binding (Grabs et al., 
1997). All other mutations did not affect amphiphysin binding, suggesting that the 
amphiphysin binding site is most likely to be at Pxx  motifs 8 and 9. 
 
5.6.3.2 Effect of the mutants on endophilin binding 
Endophilin binding sites were suggested to be at PxxP motifs 2 and 3 and PxxP 
motifs 8 and 9 (Solomaha et al., 2005; Anggono and Robinson, 2007). In this study 
only PxxP motif 3 seemed to be the main binding site. However the effect of 
mutation of the phosphorylation sites S774, S778 and S822 suggested that these 
serine residues have a role in endophilin binding. Also, arginine residues 772, 773 
and 838 seem to be essential parts of the binding site. The fact that the 3L mutant has 
no effect on endophilin binding suggests for sites 8 and 9 play little role in 
endophilin binding, where as the effect seen with the splice variant xb suggests that 
splicing might mediate differential binding binding of proteins between the two 
isoforms. Some of these findings conflict with Anggono and Robinson (2007), where 
they suggested that PxxP motif 2 is part of the endophilin binding site, while my 
findings suggested that this site is not important for endophilin binding. Furthermore, 
the two arginine residues in the phosphobox (RR772/3) were suggested not to be part 
of the endophilin binding site, while in this study these two residues seem to be part 
of endophilin binding site. The finding that PxxP motif 3 and R838 both are 
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important for endophilin binding agrees with their findings (Anggono and Robinson, 
2007). The finding that the 3L mutation does not affect endophilin binding does not 
agree with Solomaha et al where they suggested that endophilin binds to both PxxP 
motifs 8 and 9 (Solomaha et al., 2005). The fact tha e S774/8 and S822 mutations 
affected endophilin binding implies that these residues themselves are important for 
endophilin binding as well as phosphorylation effect. The phosphorylation effect on 
endophilin binding agrees with Anggono et al (2006) where they found that 
endophilin binding to dynamin I is significantly affected by S774/778 DyndmE-PRD, 
suggesting phosphorylation dependent binding, Analysis of the single mutants 
showed that S778 may be the key phosphorylation site involved in endophillin 
binding (Anggono et al., 2006). 
 
5.6.3.3 Effect of the mutants on syndapin I binding 
Syndapin I was shown to bind in phosphorylation dependent manner to the PxxP 
motifs 2 and 3 on dynamin I (Anggono et al., 2006; Anggono and Robinson, 2007). 
In the experiments in this thesis syndapin I was not affected by any of the mutations 
tested or the splice variant WT xb. This was not expected since the 2C, 3B, and PB2 
mutations are in this region. These findings do not agree with previous studies where 
syndapin I was shown to be affected by phosphorylation of S774/8 and 
phosphomimetic mutations of these sites. The mutation of RR772/3 and PxxP motifs 
2 and 3 also affect its binding (Anggono et al., 2006; Anggono and Robinson, 2007). 
This difference observed could be due to using synaptosomal lysates (this thesis) 
which has different population of proteins from thewhole brain lysates (Anggono et 
al), or they have the same proteins which may have diff rent phosphorylation states.  
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5.6.3.4 Effect of the mutants on Grb2 binding  
Grb2 was suggested to bind to dynamin I at PxxP motifs 8 and 9 (Okamoto et al., 
1997). It was also suggested that there were three binding sites for Grb2 at PxxP 
motifs 2, 8, and 10 (Solomaha et al., 2005). In the experiments in this thesis Grb2 
binding to dynamin I was examined only with mutations within the region of PxxP 
motifs 8 and 9. The only mutation that significantly affected Grb2 binding was the 
3L mutation. The P830A mutant shows a trend towards a decrease in binding 
suggesting that PxxP motifs 8 and 9 might be a binding site for Grb2. It seems this is 
not the only binding site, which does not agree with previous studies which have 
suggested that truncation of the C-terminal area of the dynamin I PRD starting from 
PxxP motif 8 resulted in a total block of Grb2 binding (Grabs et al., 1997; Okamoto 
et al., 1997). However, other studies suggested that Grb2 binding might include two 
sites at PxxP motif 2 and 3 and at PxxP motifs 8 and 9 (Solomaha et al., 2005; 
Anggono and Robinson, 2007), agreeing with the findings in this chapter. 
  
5.6.4 Effect of the dynamin I PRD presence on the kinase activity of the ∆80 C- 
and N1-src splice variants  
C-src interaction with the PRD containing protein, synapsin I, resulted in an increase 
in src kinase activity, and this activation was antagonized by the presence of the src 
SH3 domain (Onofri et al., 1997; Onofri et al., 2007). The ability of the src-dynamin 
I interaction to increase src kinase activity was therefore investigated. Tyrosine 
phosphorylation of synapsin also activates src kinase activity, which might be related 
to src SH2 domain binding to phospho-tyrosine of synapsin (Onofri et al., 1997). 
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HIV-1 Nef is also able to activate src and other src family members which have been 
inactivated with C-terminal Src kinase (Csk) by direct interaction with their SH3 
domain through its PxxP motif (Trible et al., 2006). All of the above findings 
suggested that src could be activated by direct binding to other proteins either 
through its SH2 or SH3 domains.  
The dynamin I PRD is not a src substrate since it con ains no tyrosine residues. The 
PRD had no effect on src activity in the kinase assay. There are several possibilities 
that might explain this. The first possibility is that dynamin I binding does not affect 
src kinase activity. The second possibility is that t e whole dynamin I protein and not 
just the PRD domain is needed to achieve the requird effect. Thirdly, the binding 
protein may need to be tyrosine phosphorylated, and thus both SH3 and SH2 
domains need to bind to further activate src. The fourth possibility is that this effect 
can not be seen with synaptophysin as a substrate and it still can be achieved with 
other substrates. The fifth possibility is that srci  already fully active and can not be 
activated further. In this case src might need to be deactivated by Csk before the 
experiment is performed. Finally it may have been auto-phosphorylated which 
resulted in its desensitization to further activation which has been suggested by Sun 
et al (2002).  Further experiments are required in order to address these possibilities 
(Sun et al., 2002).    
 
5.6.5 Tyrosine phosphorylation of dynamin I in neurons 
One role of the N1-src dynamin I interaction could be to phosphorylate dynamin I; 
however tyrosine phosphorylation of dynamin I in neurones is controversial. 
Previous studies using 32P to radioactively label dynamin I showed no incorporation 
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of radioactivity on tyrosine residues (Graham et al., 2007), but phosphorylation of 
tyrosine sites was found when using vanadate in the buffer (Ballif et al., 2008). In 
non-neuronal cells, exogenous dynamin I is phosphorylated by src at site Y231 in 
vivo, at site Y352 in vitro and at site Y597 both in vivo and in vitro (Ahn et al., 1999; 
Ahn et al., 2002). Dynamin I tyrosine phosphorylation seems to be important in 
dynamin I self assembly and ligand induced endocytosis for epidermal growth factor 
receptor in COS-7 cells transfected with dynamin I (Ahn et al., 2002), and β2 
adrenergic receptor internalization in HEK cells (Ahn et al., 1999). In endothelial 
cells, src phosphorylation activates dynamin II and i creases its association with 
caveolin I, suggesting that tyrosine phosphorylation may activate dynamin II 
(Shajahan et al., 2004).  
Dynamin I has been shown to be phosphorylated in mouse brain lysates at three sites, 
Y80 and Y125 in the GTPase domain and Y354 in the middle domain (Ballif et al., 
2008), which are all different from the sites mapped previously. The fact that 
dynamin I is tyrosine phosphorylated in brain suggests a regulatory role for tyrosine 
phosphorylation similar to other tissues. A dynamin I IP in the presence of vanadate 
showed that dynamin I was tyrosine phosphorylated both under basal and stimulated 
conditions. There was no difference in the level of tyrosine phosphorylation between 
basal and stimulated conditions, suggesting dynamin I can be phosphorylated under 


























6 General discussion 
In this study, the neuronal specific splice variants of src were compared to the non 
neuronal form (C-src). Differences in src occur dueto alternative splicing of the SH3 
domain which is a protein- protein interaction domain. Therefore the hypothesis was 
that this splicing modulates src interactions with neuronal proteins. Since the three 
splice variants of src are expressed in the brain, it is expected that the neuronal splice 
variants (N1- and N2-src) will have some distinct functions from C-src that will 
result in more efficient or more specific function in neurones.  
 
6.1 C-src interactions 
The isolated SH3 domains were a useful starting point for the study since they 
eliminate the possibility that protein-protein interactions of src splice variants is 
through other src domains. This is especially true for the SH2 domain which is 
known to bind to phosphorylated tyrosine residues, or tyrosine residues such as Y416 
and Y527, that might be binding sites for SH2 domain containing proteins. On the 
other hand, the down side is that there might be important modulatory effects of 
other src domains on SH3 domain interactions that can not be observed when only 
the SH3 domains were used.  
Pull downs from rat brain synaptosomal lysates using GST tagged SH3 domains of 
src splice variants revealed different binding partners as confirmed by MALDI-tof 
analysis and western blot. The C-src SH3 domain main binding partners were 
dynamin I, synapsin I and synaptojanin, which had been described before (Onofri et 
al., 1997; Foster-Barber and Bishop, 1998). No stimulation dependency was 
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observed in C-src interactions with these proteins, suggesting that C-src binding to 
these three proteins is stimulation independent.  
 
6.2 N2-src interactions 
The N2-src SH3 domain seemed to have many binding partners in synaptosomal 
lysate. Novel N2-src SH3 domain binding partners were identified including 
Munc18, NSF, and synaptophysin suggesting a different role in neurones from C-src. 
The lack of stimulation dependency in N2-src interactions with these proteins 
suggests that N2-src function is constitutively active rather than being regulated by 
neuronal activity.  There is a possibility that these proteins are not always available 
for N2-src binding such as Munc 18-1 which might bind to N2-src when it binds to 
syntaxin at the closed conformation or open conformation only. NSF also might only 
bind to N2-src when it is free or engaged in binding with the SNARE complex. 
However, this possibility is not supported by the pull down results and further 
investigation is needed to clarify these interactions. The fact that both Munc18 and 
NSF are binding to N2-src splice variant SH3 domain suggests that N2-src might 
play a role in exocytosis. This could occur either by having these proteins as 
substrates, since both of them are tyrosine phosphorylated (Huynh et al., 2004; Oh 
and Thurmond, 2006), or by providing access for N2-src to phosphorylate binding 
partners for these proteins. The fact that none of the SNARE proteins bound to N2-
src proved that they do not interact directly with its SH3 domain, but whether N2-src 
gains access to these proteins through its binding to Munc18 or NSF is not clear. The 
same idea has been suggested for C-src phosphorylati n to synaptic vesicle proteins 
via its binding to synapsin (Onofri et al., 1997; Onofri et al., 2007).  
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The in vitro binding experiments failed to prove direct interactions between N2-src 
and the synaptophysin C-terminus or Munc 18-1. For the synaptophysin interaction, 
there is a possibility that the trans-membrane loops play a role in its binding to the 
N2-src SH3 domain and since it was not possible to express and purify the full length 
synaptophysin in bacteria, this hypothesis was not tested any further. On the other 
hand, all the src splice variants were able to phosrylate synaptophysin C-terminus 
in vitro, suggesting that binding was not necessary for its tyrosine phosphorylation.  
In vitro binding experiments failed to prove a direct interaction between Munc 18-1 
and the N2-src SH3 domain, suggesting that this interac ion might not be direct, 
especially given that the 3D structure of Munc 18-1 suggested that the only PxxP 
motif in Munc 18-1 was not accessible for binding. This does not eliminate the 
possibility that other Munc 18-1 interactions or phosphorylation could result in 
conformational changes that make this binding site accessible and thus N2-src could 
be recruited to Munc 18. Since Munc 18-1 has several binding modes to syntaxin, 
there is a possibility that one or more of these binding modes results in allowing N2-
src binding to Munc 18-1. This could result in syntaxin dissociation from Munc 18-1, 
since no syntaxin was found in the N2-src pull downs. No tyrosine phosphorylation 
of Munc 18 was observed for N2-src kinase activity, suggesting that either Munc18-1 
is not a substrate for N2-src or N2-src may need to bind to Munc 18 prior to using it 
as a kinase substrate since the recombinant Munc 18-1 did not bind to N2-src in the 
in vitro experements.  
The distribution of the src splice variants could be a key factor in understanding the 
function of src splice variants in neurones, with each splice variant being found in 
specific neuronal subtypes or intracellular locations. Two attempts were made to 
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produce an N2-src specific antibody in rabbit with no success. This might be due to 
the fact that the only difference between N2-src and other splice variants is the extra 
amino acids that are inserted in N2-src SH3 domain. These inserted amino acids are 
very hydrophobic, which might cause them to fold in a way that makes them 
inaccessible for antibodies. This might also be the reason for an N2-src specific 
antibody not being available commercially even though it has been known for almost 
20 years (Pyper and Bolen, 1990). Since the production of N2-src specific antibody 
failed, N2-src distribution within the brain was not tested. Not knowing the N2-src 
distribution within neurons made it difficult to suggest a specific role for the N2-src 
splice variant in certain areas in the brain or specific locations.  
 
6.3 N1-src interactions 
The N1-src SH3 domain showed a very specific binding with pull downs from rat 
brain synaptosomal lysates revealing very few binding partners. The N1-src SH3 
domain had a stimulation dependent binding to dynami  I that is related to dynamin I 
dephosphorylation, since cyclosporine A prevented is binding to dynamin I in nerve 
terminals. The phosphorylation dependent interaction was shown not to be regulated 
by the two main phosphorylation sites on dynamin (S774 and S778) which regulate 
syndapin binding (Anggono et al., 2006). Mutation at the S822 phosphorylation site 
affected N1-src binding where both phosphomimetic and phosphonull decreased N1-
src binding to the dynamin PRD. Since this site represents only a small amount of the 
total phosphorylation in vivo (Graham et al., 2007), there is a possibility that 
phosphorylation sites S851 and S857 are the main sites that regulate N1-src binding 
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to dynamin. In support of this hypothesis, the binding of other proteins such as 
amphiphysin is regulated by phosphorylation of S857 (Huang et al., 2004).  
The binding site for dynamin was also investigated. N1-src binding was not affected 
by mutations in PxxP motifs 2 and 3. However, a truncated version of dynamin I 
lacking the C-terminus up to PxxP 8 (3L) eliminated its binding, suggesting that the 
N1-src binding site is after the 3L truncation site (PxxP motifs 8-13). Mutations in 
PxxP motifs 8 and 9 decreased N1-src binding but did not totally block it, suggesting 
that even if these two sites are involved in N1-src binding there is another binding 
site. The lack of binding of N1-src to the short tailed splice variant of dynamin I 
(dynamin I xb) which contains up to PxxP motif ten suggested that the main binding 
site for N1-src is at PxxP motifs 11-13 at the end of the dynamin PRD, which 
supports the suggestion that the phosphorylation site controlling N1-src binding is 
most likely to be S851 and S857. The lack of binding of N1-src to dynamin PRD 
when the arginine residues RR772/3 or R838 were mutated suggested that these 
arginine residues play a role in N1-src binding. These mutations are preventing 
binding and not causing a conformational change in the dynamin PRD, since not all 
protein binding was affected by these mutations, especially C-src, which did not 
show any decrease in binding with any of the mutations that were used. 
No data is available about the distribution or distinct functions of dynamin I with 
long C-terminus tail (xa) or and the short C-terminus tail (xb). Since N1-src is 
associated only with dynamin I xa, there is a possibility that this association has a 
unique function. There might be a regulatory role for N1-src in dynamin I xa 
function in a stimulation dependent manner where N1-src will have a very specific 
function either by phosphorylating dynamin I xa or gaining access to other proteins 
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such as endophillin. The first possibility is supported by the fact that dynamin I is 
tyrosine phosphorylated in the brain at multiple sit s (Y80, Y125 and Y354) (Ballif 
et al., 2008). This tyrosine phosphorylation might be of importance in modulating 
dynamin activity, especially after repeated stimulation which will result in greater 
dynamin serine dephosphorylation (Clayton et al., 2009) allowing more N1-src 
interaction and activity. The second suggestion is supported by the fact that 
endophilin A2 phosphorylation at Y315 by src is mediated by the endophillin SH3 
domain interaction with FAK PRD (Wu et al., 2005). The repeated stimulation also 
will result in more N1-src interaction with dynamin and thus being closer to its 
substrates. In this manner the phosphorylation dependent interaction of N1-src with 
dynamin might act as mechanism of activating an extra pathway for endocytosis after 
extensive stimulation whereas its function in normal conditions is minimal. 
The fact that there are different distribution patterns for src splice variants suggests 
that the neuronal specific splice variants are not required in all neuronal cell types or 
locations, but instead they are expressed only where they are needed. Both C-src and 
N1-src are found in the synaptic region suggesting that both of these isoforms are 
needed there. C-src is enriched on synaptic vesicles which might be related to C-src 
binding to synapsin. N1-src is more specifically located to the plasma membrane 
suggesting different roles there (Onofri et al., 2007). These distinct locations and the 
distinct binding interactions could provide specificity for src splice variant to 





6.4 Experimental issues 
The first issue is the use of the kinase dead src spli e variants in this project. The 
dynamin PRD is expected to interact only with the SH3 domain of src which has no 
mutations. However, there could be some effects from the other src domains on SH3 
domain interactions, including the kinase domain. This could lead to a different 
effects from the mutated kinase domain compared to the active kinase domain on the 
SH3 domain interactions. However, the active kinase src is very hard to express in 
bacteria which make it very difficult to express in adequate amounts for pull down 
experiments. The kinase domain however is not generally considred to be involved in 
protein protein interactions, which makes this single mutation in this domain unlikely 
to affect the SH3 domain interactions. Furthermore, th  effect of the kinase domain 
mutation would be equal on all PRD constructs including the wild type which is used 
in this project as a standard and all the mutants interactions were compared to it. 
The other issue is coexpressing the Gro-ESL chaperone with the full length src splice 
variants. The presence of Gro-ESL chaperone in the bacterial lysates might affect the 
dynamin PRD interactions with the full length src splice variants. However, Gro-ESL 
chaperone is expected to bind only to unfolded protein and dissociates from the 
protein when it is folded properly (Wang et al 1999; Falke et al 2001). Furthermore, 
if the presence of Gro-ESL chaperone would affect the dynamin PRD interactions 
with src splice variants, its effected is expected to be equal on all PRD construct 
including the wild type. This means that its effect is elemintated since wild type PRD 
is used as a standard.  
The other issue is using the phosphomemetic mutations. Phosphomimetic mutants 
mimic both the bulky structure of the phosphate group and the negative charge but it 
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is not exactly the same as real phosphorylation. In some cases, phosphomemetic 
mutations would have a similar effect as the true phos horylation on the protein 
protein interactions (Barclay et al 2003). On the other hand, both phosphomimetic 
and phosphonull mutations might affect protein protein interactions as it was seen 
with S822A/E mutations where both affected the  dynamin PRD intractions with N1-
src leading to the expectation that this residue is important as is in this interaction 
instead of the effect of the charge and or the bulky structure. This however does not 
elemenate the possibility that phosphorylation of this residue would cause a decrease 
in the PRD interaction since phosphorylation would cause a change in charge and 
bulky structure that could affect its interaction. 
The other issue is the protein concentrations that are used in these experiments. In 
these experiments high concentrations of proteins were used to make sure that any 
protein protein interactions will be picked up even if it is at a low affinity. Any 
protein protein interactions that are not seen mean ither they have a very low 
affinity or need some other conditions such as the presence of some other proteins or 
phosphorylation conditions alterated. On the other and, there might be some 
differences in affinity that can not be seen at high concentrations and lower 
concentrations of the protein would show these differences. May be a series of 
descending concentrations in the binding and pull down assays would help in 
assessing these differences that can not be seen in the high protein concentrations.  
 
6.5 Model for src splice variant function 
From this study a general model can be proposed for src splice variant function in 
nerve terminals. C-src functions as the major src in all non neuronal cells and its 
 213 
expression is adequate for normal cellular functions. Neuronal cells are known for 
their high activity levels, stimulation and firing rates, which might require extra src 
roles to maintain their functions. Indeed there are several neuronal specific proteins 
and protein isoforms that have structures that only recognize the neuronal splice 
variants to accommodate these differences (Chih et al., 2006).  
For the N2-src splice variant the extra amino acids in its SH3 domain cause a shift in 
it’s binding from synapsin, synaptojanin and dynamin I (the classical binding 
partners for C-src) to a new group of proteins including Munc 18, NSF and 
synaptophysin. All of these proteins are tyrosine phosphorylated and they are 
involved in vesicle cycling at different stages. This suggests that N2-src might be 
involved in regulating exocytosis, where both Munc 18 and NSF play essential roles. 
The possible role for N2-src in the synaptic area includes regulation of these proteins 
function or changing the phosphorylation status during different patterns of neuronal 
activity (Figure 6.1).  
N1-src function on the other hand might be very specific for synaptic vesicle 
endocytosis specifically in regulating dynamin I activity, which might include some 
vesicle recycling routes that require only the dynamin I xa splice variant but not the 
short version. These routes will also be activated fter repeated stimulation since that 
will result in more dynamin I being serine dephosphorylated thus increasing binding 
to N1-src. This might be a key function for understanding activation of various 
different routes of synaptic vesicle recycling. Since dynamin PRD alone is not a src 
substrate, it is possible that N1-src function may be to phosphorylate both dynamin I 
xa and dynamin I xb since dynamin forms a ring around vesicles neck. Therefore, the 




 to dynamin acts as a bridge for N1-src to phosphorylate substrates that specifically 
interact with dynamin xa such as endophillin. 
 
6.4 Further experiments  
There are still many aspects of src splice variants that need to be inspected in more 
detail. These include using the full length or the runcated ∆80 src splice variants to 
perform pull down assays from both whole brain and synaptosomal lysates to 
compare differences in their bindings in the presence of other domains besides the 
SH3 domain. These splice variants could then be co xpressed with these proteins in 
eukaryotic cells, such as PC12 cells or neurones to inspect their co localization and 
see whether there is a direct interaction between th m as well as any changes in their 
phosphorylation status.  
It would be useful to mutate the PxxP motifs in Munc 18, NSF and synaptophysin 
and co express them with N2-src to investigate if N2-src binding to these proteins is 
via the PxxP motif or if there is another motif that provides an alternative binding 
site for N2-src SH3 domain, which might help in understanding the effect of src 
splicing on its function. It would also be useful to mutate the extreme C-terminal 
PxxP motifs of dynamin I xa and inspect their binding to N1-src in order to map the 
exact binding site for N1-src. After mapping the exact binding site for N1-src, a 
mutant that does not bind to N1-src could be expressed in neurones to observe its 
effect on different types of vesicle endocytosis. It would also be intersting to inspect 
if only one phosphorylation site in dynamin PRD regulates N1-src binding or if 
multiple phosphorylation sites are needed to achieve the inhibitory effect. This can 
also be further investigated by expressing either a phosphonull or phosphomimetic 
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dynamin I in neurones to observe their effect on different types of vesicle 
endocytosis. Their effect on different types of endocytosis can be investigated by 
using morphological analysis of horse radish peroxidase (HRP) uptake for all 
endocytotic routes (Clayton et al., 2008), FM-1 43 uptake for endocytosis and 
dextran for bulk endocytosis (Clayton and Cousin, 2008), and by comparing the 
changes for the uptake of each one of them, the effect of N1-src interaction with 
dynamin can be studied. It is possible that N1-src i  involved in bulk endocytosis, 
since bulk endocytosis is activated after extensive timulation (Clayton et al., 2009) 
which result in more dynamin dephosphorylation (Clayton et al., 2009) and the N1-
src interaction with dynamin also increases after dephosphorylation.  It would also be 
useful to investigate whether some dynamin I binding partners will be src substrates 
in the presence and absence of either full dynamin I or just its PRD. This will show 
the extent of N1-src binding to dynamin I effect on proteins in the synaptic region 
and also provide a better understanding of synaptic fun tion and regulation. Using 
shRNA to specifically silence either dynamin I xa or xb expression and observe its 
effect on different endocytotic routes and protein phosphorylation would also be 
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